fluorodeoxyglucose f18 has been researched along with Colorectal Neoplasms in 621 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 34 (5.48) | 18.2507 |
2000's | 223 (35.91) | 29.6817 |
2010's | 302 (48.63) | 24.3611 |
2020's | 62 (9.98) | 2.80 |
Authors | Studies |
---|---|
Cai, D; Chen, S; Gu, J; Hu, P; Liu, G; Mao, W; Qi, C; Shi, H; Sui, X; Tan, H; Yu, H; Zhang, Y | 1 |
Borello, A; Ferrero, A; Guerra, M; Langella, S; Lo Tesoriere, R; Russolillo, N | 1 |
Baio, G; Dutta, AK; Mitchell-Hay, R; Phull, PS | 1 |
Agarwal, A; Bankar, S; Desouza, A; Kazi, M; Mokal, S; Rangarajan, V; Saklani, A; Thomas, AE | 1 |
Baik, SH; Jeon, TJ; Kang, J; Kim, S; Lee, HS; Lee, JH; Lee, KY; Park, EJ; Ryu, YH | 3 |
Albertsen, LN; Jaensch, C; Madsen, AH; Teil, J; Tornbjerg, SM | 1 |
Ahn, H; Jang, SH; Ju Lee, H; Lee, JH; Mi Lee, S; Oh, MH; Won Lee, J | 1 |
Dueland, S; Grut, H; Labori, KJ; Line, PD; Schulz, A | 1 |
Guo, X; Hao, Y; Lv, L; Song, S; Wang, L; Wang, X; Xin, B; Xu, J; Yang, Z | 1 |
Hattori, K; Kitagawa, Y; Li, L; Matsui, S; Mizuno, S; Nagano, O; Ogiri, M; Okabayashi, K; Seishima, R; Shigeta, K; Yamasaki, J | 1 |
Guo, D; Ma, J; Miao, W; Wang, Y; Wang, Z; Wu, F; Yan, L; Yang, G; Zhang, C; Zhang, R; Zuo, P | 1 |
Sang, S; Yu, Y; Zhang, X; Zhou, Y; Zhu, J; Zhu, Y | 1 |
Alavi, A; Hunt, S; Zandifar, A | 1 |
Ghorbani, A; Pourvali, K; Shakery, A; Shimi, G; Shirazi, FH; Zand, H | 1 |
Cai, D; Cao, Y; Mao, W; Qi, C; Shi, H; Sui, X; Tan, H; Yu, H; Zhang, Y | 1 |
Doki, Y; Eguchi, H; Furuyashiki, M; Hata, T; Kida, A; Miyoshi, N; Ogino, T; Sekido, Y; Takahashi, H; Tsuboyama, T; Uemura, M; Yukimoto, R | 1 |
Cui, Y; Du, B; Li, X; Li, Y; Ma, Y | 1 |
Ahmed, S; Bogoni, G; Carneiro-Ramos, MS; Carvalho, MK; Castanheira de Souza, NF; Cen, P; Champlin, R; Cherng, HJ; Clark, AH; Dağ, İ; Djawad, K; Ertaş, S; Fayad, L; Feng, L; Ferri, D; Flowers, CR; Gonca Okumuş, Z; González-Lafuente, L; Gu, W; Hagemeister, F; He, Q; Imaizumi, U; Imura, M; Jiang, H; Junho, CVC; Kagawa, K; Kaneko, D; Kebriaei, P; Kido, K; Kishimoto, N; Kröcher, O; Kurata, S; Kuroda, H; Lee, HJ; Liu, XH; Lucas Júnior, RM; Ma, L; Macapinlac, HA; Massi, MN; Miskad, UA; Nachtegaal, M; Nair, R; Nastoupil, LJ; Navarro-García, JA; Neelapu, SS; Neres-Santos, RS; Nieto, Y; Patellongi, IJ; Pinnix, CC; Ramdial, J; Reis Schneider, GA; Rezvani, K; Rodriguez, M; Rodríguez-Sánchez, E; Ruiz-Hurtado, G; Rusinovich, V; Rusinovich, Y; Safonova, OV; Sanuki, T; Shi, JB; Shpall, E; Srour, S; Steiner, R; Strati, P; Sudagidan, M; Tian, M; Tsukimoto, S; Turhan, U; Ünver, G; Vidal, JE; Wang, M; Wang, YM; Westin, J; Wu, L; Xiao, Y; Xu, G; Xu, Y; Yan, YY; Yegin, Z; Yılmaz, S; Yu, K; Yusuf, I; Zabilska, A; Zhang, H; Zhang, Q; Zhang, X; Zhang, XX | 1 |
Han, S; Hong, YS; Kim, HJ; Kim, JC; Kim, JS; Kim, S; Kim, SK; Kim, TS; Kim, TW; Kwak, JM; Kwak, JY; Kwon, HW; Lee, HS; Lee, JS; Lim, SB; Oh, HS; Oh, JH; Oh, M; Park, S; Yu, CS | 1 |
Jiang, Z; Li, D; Liu, W; Xiang, L; Yang, C; Zhou, H | 1 |
Imajo, M; Kato, K; Maeda, Y; Nishiyama, Y; Norikane, T; Okano, K; Saitoh, K; Soga, T; Yamamoto, Y | 1 |
Afchain, P; Baudin, É; Delabie, P; Hentic, O; Montravers, F; Rusu, T | 1 |
Beyhan, E; Çermik, TF; Cin, M; Erol Fenercioğlu, Ö; Şahin, R | 1 |
Akkus Gunduz, P; Araz, M; Erden, GA; Kir, KM; Kucuk, NO; Kuru Oz, D; Ozkan, E; Soydal, C; Yavuz, Y | 1 |
Diaz Nieto, R; Fenwick, SW; Gordon-Weeks, A; Jones, R; Kok, NF; Kuhlmann, KF; Malik, HZ; Poston, GJ; Tufo, A | 1 |
Eswaran, P; Kalyan, S; Kumar Ravichander, S; Maheswari Babu, S; Prashanth, A | 1 |
Chen, Y; Liu, H; Liu, L; Qu, G; Yang, X | 1 |
Biechele, G; Buchner, J; Froelich, MF; Grawe, F; Ingenerf, M; Kaiser, CG; Kunz, WG; Rübenthaler, J; Schmid-Tannwald, C; Schnitzer, ML; von Münchhausen, N | 1 |
Elias, S; Kranenburg, O; Lam, M; Strating, E; van de Loo, A | 1 |
Chen, Y; Guo, L; Ren, Q; Shao, X; Xu, X | 1 |
Bates, DDB; Chang, KJ; Kim, DH; Lalani, TK; Paroder, V; Pickhardt, PJ; Shaish, H | 1 |
Arslan, E; Baloğlu, MC; Beyhan, E; Çermik, TF; Ergül, N; Erol Fenercioğlu, Ö; Şahin, R | 1 |
Ichikawa, H; Kato, T; Kita, A; Shibutani, T; Sugiura, A; Tada, H; Watanabe, M | 1 |
Cao, M; Dong, Y; Sun, P; Tang, G; Wu, H; Zhong, J; Zhou, W | 1 |
Zirakchian Zadeh, M | 1 |
Arıkan, S; Demircioglu, MK; Duzkoylu, Y; Kılavuz, H; Sarı, S | 1 |
Aksoy, EK; Ekmen, MÖ | 1 |
Kleiner, S; Weber, W | 1 |
Loffeld, R | 1 |
Araki, K; Handa, T; Harimoto, N; Higuchi, T; Igarashi, T; Ishii, N; Kubo, N; Oyama, T; Shirabe, K; Tsukagoshi, M; Watanabe, A; Yamanaka, T; Yokobori, T | 1 |
Bremers, AJA; de Geus-Oei, LF; de Wilt, JHW; Elekonawo, FMK; Heijmen, L; Laurens, ST; Starremans, B | 1 |
Cao, Y; Guo, H; Hu, Z; Liu, H; Qu, Y; Shi, X; Tian, J; Zhang, X; Zhang, Z; Zheng, S | 1 |
Guney, IB; Kucuker, KA; Teke, Z; Yalav, O | 1 |
Alexiou, G; Argyropoulou, MI; Naka, C; Tsili, AC | 1 |
Kaye, EA; Sofocleous, CT; Vasiniotis Kamarinos, N | 1 |
Abgral, R; Amrane, K; le Pennec, R; Metges, JP; Schick, U | 1 |
Dormagen, JB; Dueland, S; Grut, H; Labori, KJ; Schulz, A; Stern, NM | 1 |
Bailly, C; Barbet, J; Bodet-Milin, C; Bossard, C; Bourgeois, M; Carlier, T; Cerato, E; David, A; Eugène, T; Faivre-Chauvet, A; Frampas, E; Goldenberg, DM; Kraeber-Bodere, F; Masson, D; Rauscher, A; Rousseau, C; Sharkey, RM; Touchefeu, Y | 1 |
Abbasi, S; Abd El-Wahab, A; Abdallah, M; Abebe, G; Aca-Aca, G; Adama, S; Adefegha, SA; Adidigue-Ndiome, R; Adiseshaiah, P; Adrario, E; Aghajanian, C; Agnese, W; Ahmad, A; Ahmad, I; Ahmed, MFE; Akcay, OF; Akinmoladun, AC; Akutagawa, T; Alakavuklar, MA; Álava-Rabasa, S; Albaladejo-Florín, MJ; Alexandra, AJE; Alfawares, R; Alferiev, IS; Alghamdi, HS; Ali, I; Allard, B; Allen, JD; Almada, E; Alobaid, A; Alonso, GL; Alqahtani, YS; Alqarawi, W; Alsaleh, H; Alyami, BA; Amaral, BPD; Amaro, JT; Amin, SAW; Amodio, E; Amoo, ZA; Andia Biraro, I; Angiolella, L; Anheyer, D; Anlay, DZ; Annex, BH; Antonio-Aguirre, B; Apple, S; Arbuznikov, AV; Arinsoy, T; Armstrong, DK; Ash, S; Aslam, M; Asrie, F; Astur, DC; Atzrodt, J; Au, DW; Aucoin, M; Auerbach, EJ; Azarian, S; Ba, D; Bai, Z; Baisch, PRM; Balkissou, AD; Baltzopoulos, V; Banaszewski, M; Banerjee, S; Bao, Y; Baradwan, A; Barandika, JF; Barger, PM; Barion, MRL; Barrett, CD; Basudan, AM; Baur, LE; Baz-Rodríguez, SA; Beamer, P; Beaulant, A; Becker, DF; Beckers, C; Bedel, J; Bedlack, R; Bermúdez de Castro, JM; Berry, JD; Berthier, C; Bhattacharya, D; Biadgo, B; Bianco, G; Bianco, M; Bibi, S; Bigliardi, AP; Billheimer, D; Birnie, DH; Biswas, K; Blair, HC; Bognetti, P; Bolan, PJ; Bolla, JR; Bolze, A; Bonnaillie, P; Borlimi, R; Bórquez, J; Bottari, NB; Boulleys-Nana, JR; Brighetti, G; Brodeur, GM; Budnyak, T; Budnyk, S; Bukirwa, VD; Bulman, DM; Burm, R; Busman-Sahay, K; Butcher, TW; Cai, C; Cai, H; Cai, L; Cairati, M; Calvano, CD; Camacho-Ordóñez, A; Camela, E; Cameron, T; Campbell, BS; Cansian, RL; Cao, Y; Caporale, AS; Carciofi, AC; Cardozo, V; Carè, J; Carlos, AF; Carozza, R; Carroll, CJW; Carsetti, A; Carubelli, V; Casarotta, E; Casas, M; Caselli, G; Castillo-Lora, J; Cataldi, TRI; Cavalcante, ELB; Cavaleiro, A; Cayci, Z; Cebrián-Tarancón, C; Cedrone, E; Cella, D; Cereda, C; Ceretti, A; Ceroni, M; Cha, YH; Chai, X; Chang, EF; Chang, TS; Chanteux, H; Chao, M; Chaplin, BP; Chaturvedi, S; Chaturvedi, V; Chaudhary, DK; Chen, A; Chen, C; Chen, HY; Chen, J; Chen, JJ; Chen, K; Chen, L; Chen, Q; Chen, R; Chen, SY; Chen, TY; Chen, WM; Chen, X; Chen, Y; Cheng, G; Cheng, GJ; Cheng, J; Cheng, YH; Cheon, HG; Chew, KW; Chhoker, S; Chiu, WN; Choi, ES; Choi, MJ; Choi, SD; Chokshi, S; Chorny, M; Chu, KI; Chu, WJ; Church, AL; Cirrincione, A; Clamp, AR; Cleff, MB; Cohen, M; Coleman, RL; Collins, SL; Colombo, N; Conduit, N; Cong, WL; Connelly, MA; Connor, J; Cooley, K; Correa Ramos Leal, I; Cose, S; Costantino, C; Cottrell, M; Cui, L; Cundall, J; Cutaia, C; Cutler, CW; Cuypers, ML; da Silva Júnior, FMR; Dahal, RH; Damiani, E; Damtie, D; Dan-Li, W; Dang, Z; Dasa, SSK; Davin, A; Davis, DR; de Andrade, CM; de Jong, PL; de Oliveira, D; de Paula Dorigam, JC; Dean, A; Deepa, M; Delatour, C; Dell'Aiera, S; Delley, MF; den Boer, RB; Deng, L; Deng, Q; Depner, RM; Derdau, V; Derici, U; DeSantis, AJ; Desmarini, D; Diffo-Sonkoue, L; Divizia, M; Djenabou, A; Djordjevic, JT; Dobrovolskaia, MA; Domizi, R; Donati, A; Dong, Y; Dos Santos, M; Dos Santos, MP; Douglas, RG; Duarte, PF; Dullaart, RPF; Duscha, BD; Edwards, LA; Edwards, TE; Eichenwald, EC; El-Baba, TJ; Elashiry, M; Elashiry, MM; Elashry, SH; Elliott, A; Elsayed, R; Emerson, MS; Emmanuel, YO; Emory, TH; Endale-Mangamba, LM; Enten, GA; Estefanía-Fernández, K; Estes, JD; Estrada-Mena, FJ; Evans, S; Ezra, L; Faria de, RO; Farraj, AK; Favre, C; Feng, B; Feng, J; Feng, L; Feng, W; Feng, X; Feng, Z; Fernandes, CLF; Fernández-Cuadros, ME; Fernie, AR; Ferrari, D; Florindo, PR; Fong, PC; Fontes, EPB; Fontinha, D; Fornari, VJ; Fox, NP; Fu, Q; Fujitaka, Y; Fukuhara, K; Fumeaux, T; Fuqua, C; Fustinoni, S; Gabbanelli, V; Gaikwad, S; Gall, ET; Galli, A; Gancedo, MA; Gandhi, MM; Gao, D; Gao, K; Gao, M; Gao, Q; Gao, X; Gao, Y; Gaponenko, V; Garber, A; Garcia, EM; García-Campos, C; García-Donas, J; García-Pérez, AL; Gasparri, F; Ge, C; Ge, D; Ge, JB; Ge, X; George, I; George, LA; Germani, G; Ghassemi Tabrizi, S; Gibon, Y; Gillent, E; Gillies, RS; Gilmour, MI; Goble, S; Goh, JC; Goiri, F; Goldfinger, LE; Golian, M; Gómez, MA; Gonçalves, J; Góngora-García, OR; Gonul, I; González, MA; Govers, TM; Grant, PC; Gray, EH; Gray, JE; Green, MS; Greenwald, I; Gregory, MJ; Gretzke, D; Griffin-Nolan, RJ; Griffith, DC; Gruppen, EG; Guaita, A; Guan, P; Guan, X; Guerci, P; Guerrero, DT; Guo, M; Guo, P; Guo, R; Guo, X; Gupta, J; Guz, G; Hajizadeh, N; Hamada, H; Haman-Wabi, AB; Han, TT; Hannan, N; Hao, S; Harjola, VP; Harmon, M; Hartmann, MSM; Hartwig, JF; Hasani, M; Hawthorne, WJ; Haykal-Coates, N; Hazari, MS; He, DL; He, P; He, SG; Héau, C; Hebbar Kannur, K; Helvaci, O; Heuberger, DM; Hidalgo, F; Hilty, MP; Hirata, K; Hirsch, A; Hoffman, AM; Hoffmann, JF; Holloway, RW; Holmes, RK; Hong, S; Hongisto, M; Hopf, NB; Hörlein, R; Hoshino, N; Hou, Y; Hoven, NF; Hsieh, YY; Hsu, CT; Hu, CW; Hu, JH; Hu, MY; Hu, Y; Hu, Z; Huang, C; Huang, D; Huang, DQ; Huang, L; Huang, Q; Huang, R; Huang, S; Huang, SC; Huang, W; Huang, Y; Huffman, KM; Hung, CH; Hung, CT; Huurman, R; Hwang, SM; Hyun, S; Ibrahim, AM; Iddi-Faical, A; Immordino, P; Isla, MI; Jacquemond, V; Jacques, T; Jankowska, E; Jansen, JA; Jäntti, T; Jaque-Fernandez, F; Jarvis, GA; Jatt, LP; Jeon, JW; Jeong, SH; Jhunjhunwala, R; Ji, F; Jia, X; Jia, Y; Jian-Bo, Z; Jiang, GD; Jiang, L; Jiang, W; Jiang, WD; Jiang, Z; Jiménez-Hoyos, CA; Jin, S; Jobling, MG; John, CM; John, T; Johnson, CB; Jones, KI; Jones, WS; Joseph, OO; Ju, C; Judeinstein, P; Junges, A; Junnarkar, M; Jurkko, R; Kaleka, CC; Kamath, AV; Kang, X; Kantsadi, AL; Kapoor, M; Karim, Z; Kashuba, ADM; Kassa, E; Kasztura, M; Kataja, A; Katoh, T; Kaufman, JS; Kaupp, M; Kehinde, O; Kehrenberg, C; Kemper, N; Kerr, CW; Khan, AU; Khan, MF; Khan, ZUH; Khojasteh, SC; Kilburn, S; Kim, CG; Kim, DU; Kim, DY; Kim, HJ; Kim, J; Kim, OH; Kim, YH; King, C; Klein, A; Klingler, L; Knapp, AK; Ko, TK; Kodavanti, UP; Kolla, V; Kong, L; Kong, RY; Kong, X; Kore, S; Kortz, U; Korucu, B; Kovacs, A; Krahnert, I; Kraus, WE; Kuang, SY; Kuehn-Hajder, JE; Kurz, M; Kuśtrowski, P; Kwak, YD; Kyttaris, VC; Laga, SM; Laguerre, A; Laloo, A; Langaro, MC; Langham, MC; Lao, X; Larocca, MC; Lassus, J; Lattimer, TA; Lazar, S; Le, MH; Leal, DB; Leal, M; Leary, A; Ledermann, JA; Lee, JF; Lee, MV; Lee, NH; Leeds, CM; Leeds, JS; Lefrandt, JD; Leicht, AS; Leonard, M; Lev, S; Levy, K; Li, B; Li, C; Li, CM; Li, DH; Li, H; Li, J; Li, L; Li, LJ; Li, N; Li, P; Li, T; Li, X; Li, XH; Li, XQ; Li, XX; Li, Y; Li, Z; Li, ZY; Liao, YF; Lin, CC; Lin, MH; Lin, Y; Ling, Y; Links, TP; Lira-Romero, E; Liu, C; Liu, D; Liu, H; Liu, J; Liu, L; Liu, LP; Liu, M; Liu, T; Liu, W; Liu, X; Liu, XH; Liu, Y; Liuwantara, D; Ljumanovic, N; Lobo, L; Lokhande, K; Lopes, A; Lopes, RMRM; López-Gutiérrez, JC; López-Muñoz, MJ; López-Santamaría, M; Lorenzo, C; Lorusso, D; Losito, I; Lu, C; Lu, H; Lu, HZ; Lu, SH; Lu, SN; Lu, Y; Lu, ZY; Luboga, F; Luo, JJ; Luo, KL; Luo, Y; Lutomski, CA; Lv, W; M Piedade, MF; Ma, J; Ma, JQ; Ma, JX; Ma, N; Ma, P; Ma, S; Maciel, M; Madureira, M; Maganaris, C; Maginn, EJ; Mahnashi, MH; Maierhofer, M; Majetschak, M; Malla, TR; Maloney, L; Mann, DL; Mansuri, A; Marelli, E; Margulis, CJ; Marrella, A; Martin, BL; Martín-Francés, L; Martínez de Pinillos, M; Martínez-Navarro, EM; Martinez-Quintanilla Jimenez, D; Martínez-Velasco, A; Martínez-Villaseñor, L; Martinón-Torres, M; Martins, BA; Massongo, M; Mathew, AP; Mathews, D; Matsui, J; Matsumoto, KI; Mau, T; Maves, RC; Mayclin, SJ; Mayer, JM; Maynard, ND; Mayr, T; Mboowa, MG; McEvoy, MP; McIntyre, RC; McKay, JA; McPhail, MJW; McVeigh, AL; Mebazaa, A; Medici, V; Medina, DN; Mehmood, T; Mei-Li, C; Melku, M; Meloncelli, S; Mendes, GC; Mendoza-Velásquez, C; Mercadante, R; Mercado, MI; Merenda, MEZ; Meunier, J; Mi, SL; Michels, M; Mijatovic, V; Mikhailov, V; Milheiro, SA; Miller, DC; Ming, F; Mitsuishi, M; Miyashita, T; Mo, J; Mo, S; Modesto-Mata, M; Moeller, S; Monte, A; Monteiro, L; Montomoli, J; Moore, EE; Moore, HB; Moore, PK; Mor, MK; Moratalla-López, N; Moratilla Lapeña, L; Moreira, R; Moreno, MA; Mörk, AC; Morton, M; Mosier, JM; Mou, LH; Mougharbel, AS; Muccillo-Baisch, AL; Muñoz-Serrano, AJ; Mustafa, B; Nair, GM; Nakanishi, I; Nakanjako, D; Naraparaju, K; Nawani, N; Neffati, R; Neil, EC; Neilipovitz, D; Neira-Borrajo, I; Nelson, MT; Nery, PB; Nese, M; Nguyen, F; Nguyen, MH; Niazy, AA; Nicolaï, J; Nogueira, F; Norbäck, D; Novaretti, JV; O'Donnell, T; O'Dowd, A; O'Malley, DM; Oaknin, A; Ogata, K; Ohkubo, K; Ojha, M; Olaleye, MT; Olawande, B; Olomo, EJ; Ong, EWY; Ono, A; Onwumere, J; Ortiz Bibriesca, DM; Ou, X; Oza, AM; Ozturk, K; Özütemiz, C; Palacio-Pastrana, C; Palaparthi, A; Palevsky, PM; Pan, K; Pantanetti, S; Papachristou, DJ; Pariani, A; Parikh, CR; Parissis, J; Paroul, N; Parry, S; Patel, N; Patel, SM; Patel, VC; Pawar, S; Pefura-Yone, EW; Peixoto Andrade, BCO; Pelepenko, LE; Peña-Lora, D; Peng, S; Pérez-Moro, OS; Perez-Ortiz, AC; Perry, LM; Peter, CM; Phillips, NJ; Phillips, P; Pia Tek, J; Piner, LW; Pinto, EA; Pinto, SN; Piyachaturawat, P; Poka-Mayap, V; Polledri, E; Poloni, TE; Ponessa, G; Poole, ST; Post, AK; Potter, TM; Pressly, BB; Prouty, MG; Prudêncio, M; Pulkki, K; Pupier, C; Qian, H; Qian, ZP; Qiu, Y; Qu, G; Rahimi, S; Rahman, AU; Ramadan, H; Ramanna, S; Ramirez, I; Randolph, GJ; Rasheed, A; Rault, J; Raviprakash, V; Reale, E; Redpath, C; Rema, V; Remucal, CK; Remy, D; Ren, T; Ribeiro, LB; Riboli, G; Richards, J; Rieger, V; Rieusset, J; Riva, A; Rivabella Maknis, T; Robbins, JL; Robinson, CV; Roche-Campo, F; Rodriguez, R; Rodríguez-de-Cía, J; Rollenhagen, JE; Rosen, EP; Rub, D; Rubin, N; Rubin, NT; Ruurda, JP; Saad, O; Sabell, T; Saber, SE; Sabet, M; Sadek, MM; Saejio, A; Salinas, RM; Saliu, IO; Sande, D; Sang, D; Sangenito, LS; Santos, ALSD; Sarmiento Caldas, MC; Sassaroli, S; Sassi, V; Sato, J; Sauaia, A; Saunders, K; Saunders, PR; Savarino, SJ; Scambia, G; Scanlon, N; Schetinger, MR; Schinkel, AFL; Schladweiler, MC; Schofield, CJ; Schuepbach, RA; Schulz, J; Schwartz, N; Scorcella, C; Seeley, J; Seemann, F; Seinige, D; Sengoku, T; Seravalli, J; Sgromo, B; Shaheen, MY; Shan, L; Shanmugam, S; Shao, H; Sharma, S; Shaw, KJ; Shen, BQ; Shen, CH; Shen, P; Shen, S; Shen, Y; Shen, Z; Shi, J; Shi-Li, L; Shimoda, K; Shoji, Y; Shun, C; Silva, MA; Silva-Cardoso, J; Simas, NK; Simirgiotis, MJ; Sincock, SA; Singh, MP; Sionis, A; Siu, J; Sivieri, EM; Sjerps, MJ; Skoczen, SL; Slabon, A; Slette, IJ; Smith, MD; Smith, S; Smith, TG; Snapp, KS; Snow, SJ; Soares, MCF; Soberman, D; Solares, MD; Soliman, I; Song, J; Sorooshian, A; Sorrell, TC; Spinar, J; Staudt, A; Steinhart, C; Stern, ST; Stevens, DM; Stiers, KM; Stimming, U; Su, YG; Subbian, V; Suga, H; Sukhija-Cohen, A; Suksamrarn, A; Suksen, K; Sun, J; Sun, M; Sun, P; Sun, W; Sun, XF; Sun, Y; Sundell, J; Susan, LF; Sutjarit, N; Swamy, KV; Swisher, EM; Sykes, C; Takahashi, JA; Talmor, DS; Tan, B; Tan, ZK; Tang, L; Tang, S; Tanner, JJ; Tanwar, M; Tarazi, Z; Tarvasmäki, T; Tay, FR; Teketel, A; Temitayo, GI; Thersleff, T; Thiessen Philbrook, H; Thompson, LC; Thongon, N; Tian, B; Tian, F; Tian, Q; Timothy, AT; Tingle, MD; Titze, IR; Tolppanen, H; Tong, W; Toyoda, H; Tronconi, L; Tseng, CH; Tu, H; Tu, YJ; Tung, SY; Turpault, S; Tuynman, JB; Uemoto, AT; Ugurlu, M; Ullah, S; Underwood, RS; Ungell, AL; Usandizaga-Elio, I; Vakonakis, I; van Boxel, GI; van den Beucken, JJJP; van der Boom, T; van Slegtenhorst, MA; Vanni, JR; Vaquera, A; Vasconcellos, RS; Velayos, M; Vena, R; Ventura, G; Verso, MG; Vincent, RP; Vitale, F; Vitali, S; Vlek, SL; Vleugels, MPH; Volkmann, N; Vukelic, M; Wagner Mackenzie, B; Wairagala, P; Waller, SB; Wan, J; Wan, MT; Wan, Y; Wang, CC; Wang, H; Wang, J; Wang, JF; Wang, K; Wang, L; Wang, M; Wang, S; Wang, WM; Wang, X; Wang, Y; Wang, YD; Wang, YF; Wang, Z; Wang, ZG; Warriner, K; Weberpals, JI; Weerachayaphorn, J; Wehrli, FW; Wei, J; Wei, KL; Weinheimer, CJ; Weisbord, SD; Wen, S; Wendel Garcia, PD; Williams, JW; Williams, R; Winkler, C; Wirman, AP; Wong, S; Woods, CM; Wu, B; Wu, C; Wu, F; Wu, P; Wu, S; Wu, Y; Wu, YN; Wu, ZH; Wurtzel, JGT; Xia, L; Xia, Z; Xia, ZZ; Xiao, H; Xie, C; Xin, ZM; Xing, Y; Xing, Z; Xu, S; Xu, SB; Xu, T; Xu, X; Xu, Y; Xue, L; Xun, J; Yaffe, MB; Yalew, A; Yamamoto, S; Yan, D; Yan, H; Yan, S; Yan, X; Yang, AD; Yang, E; Yang, H; Yang, J; Yang, JL; Yang, K; Yang, M; Yang, P; Yang, Q; Yang, S; Yang, W; Yang, X; Yang, Y; Yao, JC; Yao, WL; Yao, Y; Yaqub, TB; Ye, J; Ye, W; Yen, CW; Yeter, HH; Yin, C; Yip, V; Yong-Yi, J; Yu, HJ; Yu, MF; Yu, S; Yu, W; Yu, WW; Yu, X; Yuan, P; Yuan, Q; Yue, XY; Zaia, AA; Zakhary, SY; Zalwango, F; Zamalloa, A; Zamparo, P; Zampini, IC; Zani, JL; Zeitoun, R; Zeng, N; Zenteno, JC; Zepeda-Palacio, C; Zhai, C; Zhang, B; Zhang, G; Zhang, J; Zhang, K; Zhang, Q; Zhang, R; Zhang, T; Zhang, X; Zhang, Y; Zhang, YY; Zhao, B; Zhao, D; Zhao, G; Zhao, H; Zhao, Q; Zhao, R; Zhao, S; Zhao, T; Zhao, X; Zhao, XA; Zhao, Y; Zhao, Z; Zheng, Z; Zhi-Min, G; Zhou, CL; Zhou, HD; Zhou, J; Zhou, W; Zhou, XQ; Zhou, Z; Zhu, C; Zhu, H; Zhu, L; Zhu, Y; Zitzmann, N; Zou, L; Zou, Y | 1 |
Chen, X; Wang, H; Xue, Q; You, Z; Yuan, J; Zhao, J | 1 |
Christophi, C; Fang, C; Gan, H; Lee, ST; Liu, Z; Muralidharan, V; Pathmaraj, K; Sachinidis, J; Scott, AM; Tebbutt, N; Wong, P | 1 |
Cachin, F; Deluche, E; Labrunie, A; Lades, G; Lavau-Denes, S; Le Brun-Ly, V; Lecaille, C; Leobon, S; Monteil, J; Mundler, O; Rullier, E; Seitz, JF; Selvy, M; Smith, D; Terrebonne, E; Tubiana-Mathieu, N; Valli, N; Zasadny, X | 1 |
Choi, JY; Kim, YI; Lee, HS | 1 |
Choi, EK; Chung, YA; Im, JJ; Oh, JK; Seo, YY | 1 |
Guo, W; Hu, H; Huang, K; Jiang, H; Lin, X; Wang, S; Zhang, R | 1 |
Jiang, H; Jiang, HJ; Wang, ZC; Zhang, MY; Zhang, RJ | 1 |
Afaq, A; Arulampalam, T; Bhargava, A; Chen, SH; Dindyal, S; Endozo, R; Fraioli, F; Francis, D; Ganeshan, B; Groves, AM; Hanson, M; Hoy, L; Huang, J; Machesney, M; Miles, K; Ng, T; Raouf, S; Reay-Jones, N; Rodriquez, M; Shortman, R; Siddiqi, S; Sizer, B; Taylor, SA; Walls, D; Wan, S | 1 |
Jiang, J; Liu, S; Ma, X; Song, S; Sun, Y; Xu, J; Yang, Z; Zhang, Y | 1 |
Harada, Y; Kawamura, R; Shimizu, T; Suzuki, Y | 1 |
Hamada, K; Hashimoto, K; Honda, M; Kawamura, H; Nakayama, Y; Saginoya, T; Takada, T; Takano, Y; Todate, Y; Yamaguchi, H | 1 |
Bhatia, SN; Fleming, HE; Gertler, FB; Hao, L; Kelada, OJ; Ko, H; Mak, H; Pulver, EM; Rohani, N; Zhao, RT | 1 |
Cho, SS; Jeon, BH; Kim, BI; Kim, Y; Lee, JI; Moon, SM; Shin, US; Yang, KY | 1 |
Chan, ATC; Chan, CML; Ho, WM; King, AD; Leung, L; Ma, B; Mo, F; Poon, A; Wang, K; Wong, SCC | 1 |
Cerny, T; Fehr, M; Fornaro, J; Güller, U; Horber, D; Knitel, M; Koeberle, D; Müller, J | 1 |
Beeke, C; Chen, J; Karapetis, CS; Kumar, R; Padbury, R; Price, TJ; Ullah, S; Wong, GYM | 1 |
Agrawal, A; Engineer, R; Guruchannabasavaiah, B; Ostwal, V; Rangarajan, V; Saklani, A; Vallam, KC | 1 |
Andreatos, N; Margonis, GA; Pawlik, TM; Weiss, MJ | 1 |
Amouyal, G; Cholley, B; Déan, C; Pellerin, O; Pernot, S; Sapoval, M; Scotté, F | 1 |
Hara, AK; Nguyen, BD; Roarke, MC; Yang, M | 1 |
Kousgaard, SJ; Thorlacius-Ussing, O | 1 |
Beiderwellen, K; Deuschl, C; Forsting, M; Grüneisen, J; Herrmann, K; Heusch, P; Kirchner, J; Lauenstein, TC; Sawicki, LM; Umutlu, L | 1 |
Falcoz, PE; Filosso, PL; Guerrera, F; Massard, G; Nigra, V; Oliaro, A; Renaud, S; Ruffini, E; Santelmo, N; Schaeffer, M; Solidoro, P | 1 |
Jinguji, M; Kajiya, Y; Kitazono, M; Nakajo, M; Tani, A; Yoshiura, T | 1 |
Macbeth, F; Treasure, T | 1 |
Gonoi, W; Hashimoto, M; Nishioka, Y; Shindoh, J; Sugawara, T; Yoshida, S; Yoshioka, R | 1 |
Choy, I; Saw, RPM; Thompson, JF; Young, CJ; Zahid, A | 1 |
Ahn, TS; Baek, MJ; Lee, JW; Lee, SM | 1 |
Colville, D; Han, S; Horgan, PG; Khor, BY; McMillan, DC; McSorley, ST; Tsang, K | 1 |
Valente, MA | 1 |
Ahn, TS; Baek, MJ; Lee, JW; Lee, SM; Yoo, ID | 1 |
Doi, H; Hirata, K; Kaida, H; Kitajima, K; Minamimoto, R; Nakajo, M; Sofue, K; Tamaki, Y; Tsurusaki, M; Ueno, Y; Yamakado, K | 1 |
Chen, SW; Chen, YK | 1 |
André, T; Aparicio, T; Bachet, JB; Baron, S; Bastuji-Garin, S; Baumgaertner, I; Cherrak, I; de'Angelis, N; Ducreux, M; Durand Zaleski, I; Flicoteaux, R; Gornet, JM; Goujon, G; Hemery, F; Itti, E; Layese, R; Le Corvoisier, P; Luciani, A; Maoulida, H; Mons, M; Natella, PA; Retbi, A; Rhein, B; Rufat, P; Sobhani, I; Taieb, J; Tournigand, C | 1 |
Cha, DI; Hyun, SH; Lee, JH; Song, KD | 1 |
Jiang, HJ; Li, M; Li, X; Pan, WB; Wang, YQ; Xu, HL; Zhang, MY; Zhang, RJ | 1 |
Chen, X; Miao, C; Sun, P; Wu, Q; Zhao, Y; Zhu, M | 1 |
Abraham-Nordling, M; Palmer, G; Suzuki, C; Wallgren, H | 1 |
Dueland, S; Grut, H; Line, PD; Revheim, ME | 1 |
Chung, JH; Kim, S; Lee, SH; Pahk, K | 1 |
Amanavicius, N; Bharadwaz, A; Kramer, S; Larsen, LP; Morre Pedersen, E; Schlander, S; Sivesgaard, K; Sørensen, M; Tønner Nielsen, D; Viborg Mortensen, F | 1 |
Bains, M; Beets-Tan, RG; Erinjeri, J; Gonen, M; Gonzalez-Aguirre, A; Kemeny, NE; Kurilova, I; Petre, EN; Sofocleous, CT; Solomon, SB | 1 |
Cai, S; Li, J; Li, Q; Li, X; Li, Y; Liang, L; Liu, Q; Luo, D | 1 |
Chang, JG; Chen, SW; Chen, WT; Hsieh, TC; Kao, CH; Shen, WC; Yen, KY | 1 |
Abel, U; Apostolidis, L; Berger, AK; Dietrich, M; Freitag, A; Giesel, F; Grüllich, C; Haag, GM; Haberkorn, U; Jäger, D; Lordick, F; Lücke, S; Ose, J; Stange, A; Trierweiler, C; von Gall, C; Weber, TF | 1 |
An, H; Cheung, GTC; Chiu, KWH; Choy, TS; Lam, KO; Lau, JKS; Lee, VHF | 1 |
Emoto, S; Hata, K; Hojo, D; Kaneko, M; Kawai, K; Momose, T; Murono, K; Nishikawa, T; Nozawa, H; Otani, K; Sasaki, K; Takahashi, M; Tanaka, T | 1 |
Kim, SJ; Son, GM | 1 |
Hu, Y; Mao, W; Qiu, L; Shi, H; Tan, H; Zhang, H; Zhou, J | 1 |
Araki, K; Arima, K; Baba, H; Harimoto, N; Kuwano, H; Shirabe, K; Tetsuya, H; Watanabe, A; Yamashita, Y; Yoshizumi, T | 1 |
Kim, K; Kim, SJ; Pak, K | 1 |
Doroudinia, A; Dorudinia, A; Kaghazchi, F; Mehrian, P | 1 |
Bashir, U; Cook, GJ; Goda, JS; Goh, V; Siddique, M; Weeks, A | 1 |
Abuqbeitah, M; Akgün, E; Akovali, B; Asa, S; Demir, M; Gülsen, F; Sager, S; Sahin, O; Sayman, H; Sönmezoglu, K; Uslu-Beşli, L; Yeyin, N | 1 |
Ashrafinia, S; Bak-Fredslund, KP; Horsager, J; Keiding, S; Lu, L; Morsing, A; Munk, OL; Rahmim, A; Schmidtlein, CR; Subramaniam, RM | 1 |
Diab, RH; Einstein, SA; Erasmus, LJ; Mawlawi, OR; Meier, JG; Xu, G | 1 |
Abgral, R; Amrane, K; Metges, JP; Ollivier, L; Salaun, PY | 1 |
Alison, MR; Chen, CW; Chen, TH; Chiang, JM; Chiu, CT; Hsieh, SY; Huang, SW; Lim, SN; Lin, WR; Lin, YH; Su, MY; Tsai, CL; Wu, RC; Yeh, CT; Yu, JS | 1 |
Amorim, BJ; Berger, DL; Blaszkowsky, LS; Bordeianou, LG; Cañamaques, LG; Catalano, OA; Clark, JW; Ferrone, CR; Gervais, DA; Groshar, D; Hong, TS; Mahmood, U; Qadan, M; Ricciardi, R; Rosen, BR; Ryan, DP; Umutlu, L; Vangel, M; Wo, JY | 1 |
Miles, K; Yeoh, E | 1 |
Chen, JH; Chen, WT; Chien, CR; Kao, CH; Lin, WY; Lu, YY; Tsai, SC | 1 |
Domínguez Ferreras, E; García Vicente, AM; Jiménez Aragón, F; Molino Trinidad, C; Pineda Pineda, MD; Poblete García, VM; Sánchez Pérez, V; Soriano Castrejón, Á; Villa Guzmán, JC | 1 |
Bilgic, S; Elhan, AH; Gecim, EI; Kucuk, ON; Soydal, C | 1 |
Blickman, JG; Maffione, AM; Rampin, L; Rubello, D | 1 |
Borovicka, J; Müller, J; Plasswilm, L; Putora, PM; Schmidt, F | 1 |
Hendel, HW; Jensen, BV; Nielsen, D; Skougaard, K | 1 |
Kodama, H; Suzawa, N; Takaki, H; Takeda, K; Yamada, T; Yamakado, K | 1 |
Ceelen, W; De Bruyne, S; Geboes, K; Goethals, I; Laurent, S; Mertens, J; Peeters, M; Smeets, P; Troisi, R; Van Damme, N; Van de Wiele, C | 1 |
Chen, Y; Liu, B; Qu, B; Tian, J; Wang, H; Xu, B; Zhang, J | 1 |
Aridome, K; Fukukura, Y; Jinguji, M; Kajiya, Y; Koriyama, C; Nakajo, M; Nihara, T; Nishimata, N; Shimaoka, S; Tanaka, S; Tani, A | 1 |
Bartenstein, P; Fendler, WP; Hacker, M; Haug, AR; Heinemann, V; Ilhan, H; Jakobs, TF; Paprottka, PM; Philippe Tiega, DB | 1 |
Constantinesco, A; Goetz, C; Hassler, S; Hubele, F | 1 |
Boellaard, R; Huisman, MC; Kinahan, PE; Lammertsma, AA; Makris, NE | 1 |
Chen, SW; Chen, WT; Hsieh, TC; Kao, CH; Lin, TY; Wu, YC; Yen, KY | 1 |
Cho, SH; Kim, SH; Kim, SW; Kim, WC; Oh, ST; Park, JM; Yoo, IeR | 1 |
Boellaard, R; Hayes, W; Hoekstra, OS; Jongsma, F; Lammertsma, AA; Nissen, IA; van Velden, FH; Velasquez, LM | 1 |
Ignatov, V; Ivanov, G; Ivanov, K; Kolev, N; Tonev, A | 1 |
Cammarota, A; Capacchione, D; Gallicchio, R; Gattozzi, D; Giacomobono, S; Lettini, G; Mainenti, P; Molinari, L; Nardelli, A; Storto, G | 1 |
Chiu, CT; Hsu, CM; Huang, SW; Jeng, WJ; Su, MY; Yen, TC | 1 |
Fleming, M; Kennedy, MJ; Knox, M | 1 |
Boér, K; Borbély, K; Kásler, M; Németh, Z | 1 |
Athwal, T; Fenwick, SW; Malik, HZ; Poston, GJ; Wieshmann, H; Yip, VS | 1 |
Chen, ZF; Li, ZP; Rao, LJ; Shi, XC; Wang, XY; Yi, C; Yi, QQ; Zhang, XS | 1 |
Chung, YA; Han, EJ; Kim, SH; Lee, SH; Oh, JK; Park, HL; Park, SY; Park, YH | 1 |
Binns, D; Bogatyreva, E; Bradley, DP; Cullinane, C; de Jong, R; Hicks, RJ; McArthur, GA; Waldeck, KL | 1 |
Inoue, T; Jinnouchi, S; Minamimoto, R; Senda, M; Terauchi, T; Yoshida, T | 1 |
Benzon, EV; Brünner, N; Christensen, IJ; Engelmann, BE; Gerds, TA; Hansson, SH; Holländer, NH; Højgaard, L; Kjær, A; Kristensen, MH; Löfgren, J; Loft, A; Markova, E; Nielsen, HJ; Sloth, C | 1 |
Ayez, N; de Ridder, J; de Wilt, JH; Oyen, WJ; Verhoef, C; Wiering, B | 1 |
Ammori, BJ; Bonanni, L; de'Liguori Carino, N; Deshpande, R; O'Reilly, DA; Sherlock, DJ; Tam, E; Valle, JW | 1 |
Hong, YS; Kim, HO; Kim, JC; Kim, JS; Kim, TW; Lee, HS; Yu, CS | 1 |
Gollub, MJ; Grewal, RK; Moskowitz, CS; Panu, N; Sohn, M; Thipphavong, S; Zheng, J | 1 |
Christophi, C; Lau, LF; Lee, ST; Muralidharan, V; Scott, AM; Williams, DS | 1 |
Chen, F; Hu, P; Lu, D; Lyu, Q; Ma, L; Zhang, J; Zhang, Z | 1 |
Annunziata, S; Caldarella, C; Galiandro, F; Treglia, G | 1 |
Bamias, A; Datseris, IE; Exarhos, D; Panagiotidis, E; Rondogianni, P; Skilakaki, M; Vlontzou, E | 1 |
Fjeld, JG; Haugvik, SP; Johnsrud, K; Mathisen, Ø; Revheim, ME; Skretting, A | 1 |
Abbadi, RA; Cheow, HK; Ford, HE; Harper, SJ; Huguet, EL; Jah, A; Jamieson, NV; Praseedom, RK; Sadat, U; Whitley, S; Wilson, CB | 1 |
Agrawal, K; Bomanji, J; Groves, A; Saad, ZZ; Sajjan, RS; Syed, R | 1 |
Datseris, IE; Fountzilas, G; Kotoula, V; Krikelis, D; Pianou, N; Rondogianni, P; Samartzis, A; Skoura, E; Xanthakis, I | 1 |
Chang, D; Harris, C; Kauser, A; Lake, ES; Lapsia, S; Subar, D; Wadhwani, S | 1 |
Choi, JM; Choi, YH; Han, YM; Jang, DK; Kim, JW; Lee, M; Lee, SA; Moon, HR; Oh, S; Yeum, TS | 1 |
Aftimos, P; Awada, A; Charette, N; Deleporte, A; Engelholm, JL; Flamen, P; Garcia, C; Hendlisz, A; Hoerner, F; Lemort, M; Machiels, G; Paesmans, M; Piccart, M; Vandeputte, C | 1 |
Feng, B; Fu, Z; Hu, M; Kong, L; Yu, JM; Zhang, GL; Zhang, XL; Zhang, Y; Zhao, F | 1 |
Brendle, C; Claussen, CD; Gatidis, S; Königsrainer, I; Müller, M; Pfannenberg, AC; Schmidt, H; Schraml, C; Schwenzer, NF | 1 |
Goh, V; Groves, AM; Hatt, M; Ingrand, P; Le Rest, CC; Tixier, F; Visvikis, D | 1 |
Allegri, V; Ambrosini, V; Castellucci, P; Fanti, S; Ghedini, P; Grassi, I; Guidalotti, PL; Montini, GC; Nanni, C | 1 |
Hendel, HW; Høgdall, EV; Jensen, BV; Johannesen, HH; Nielsen, D; Schou, JV; Skougaard, K | 1 |
Chen, SW; Chen, WT; Chiang, HC; Chiang, SF; Hsieh, TC; Kao, CH; Yen, KY | 1 |
Cappelli, A; Castellucci, P; D'Errico, A; Di Fabio, F; Ercolani, G; Giampalma, E; Golfieri, R; Pinna, AD; Pinto, C; Rojas Llimpe, FL; Serra, C | 1 |
Byun, BH; Choi, CW; Kim, BI; Lim, I; Lim, SM; Moon, SM; Shin, US | 1 |
Bärwolf, R; Freesmeyer, M; Zirnsak, M | 1 |
Comans, EF; Hoekstra, OS; Kazemier, G; Meijer, S; Meijerink, MR; Nielsen, K; Oprea-Lager, DE; Pieters, IC; Scheffer, HJ; Schreurs, HW; Sietses, C; van den Tol, PM; van Tilborg, AA; van Waesberghe, JH | 1 |
Garcheva, M; Gocheva, L; Zlatareva, D | 1 |
Kato, K; Kawachi, T; Kohara, S; Naganawa, S; Sobajima, A; Sone, Y | 1 |
Caglar, M; Karabulut, E; Yener, C | 1 |
Ito, M; Kato, T; Kobayashi, K; Miyatake, Y; Miyauchi, M; Ono, M; Tanaka, T; Yamamoto, N; Yasuda, S | 1 |
Su, B; Wan, J; Xu, B | 1 |
Cano Cano, JM; Domínguez Ferreras, E; Espinosa Arranz, J; García Vicente, AM; Gómez López, OV; Jiménez Aragón, F; Jiménez Londoño, GA; León Martin, A; Sánchez Pérez, V; Soriano Castrejón, ÁM | 1 |
Bluemel, C; Giammarile, F; Herrmann, K; Lopci, E; Maffione, AM; Rubello, D | 1 |
Agarwal, A; Kachnic, LA; Marcus, C; Nene, P; Subramaniam, RM; Xiao, J | 1 |
Aouf, A; Biersack, HJ; Ezziddin, S; Ghamari, S; Mayer, K; Meyer, C; Pieper, CC; Sabet, A | 1 |
Hwang, JP; Jeong, SY; Woo, SK; Yoon, SY | 1 |
Bottino, D; DeMario, M; Geho, D; Goss, GD; Hansen, AR; Jarutat, T; Jonker, DJ; Karanikas, V; Lassen, UN; Mau-Sorensen, M; Meulendijks, D; Roessler, M; Schellens, JH; Schostack, KJ; Simcox, ME; Siu, LL; Vega-Harring, SM; Wang, K; Zhong, H | 1 |
Hasegawa, S; Inamoto, S; Inoue, M; Itatani, Y; Iwamoto, M; Kawada, K; Kimura, H; Nakamoto, Y; Okuyama, H; Sakai, Y; Sasazuki, T; Shirasawa, S; Toda, K; Togashi, K | 1 |
Choi, M; Heilbrun, LK; Kollepara, SL; Philip, PA; Shields, AF; Smith, D | 1 |
Cho, A; Kang, WJ; Kim, YT; Lee, JD; Lee, JH; Lee, JW; Yun, M | 1 |
Bard, V; Brenner, B; Goldberg, N; Gordon, N; Groshar, D; Kashtan, H; Kundel, Y; Purim, O; Sulkes, A; Wasserberg, N | 1 |
Liu, FY; Wang, JY; Yang, TS; Yen, TC | 1 |
Fujiwara, T; Inada, R; Kishimoto, H; Kondou, Y; Mori, Y; Nagasaka, T; Watanabe, A | 1 |
Chi, D; Luo, Y; Meng, N; Wang, K; Yu, T; Zhao, Y | 1 |
Chau, I; Chua, SS; Cook, GJ; Cunningham, D; Drake, B; Du, Y; Koh, DM; Tam, HH; Zerizer, I | 1 |
Charette, N; Deleporte, A; Flamen, P; Garcia, C; Guiot, T; Hendlisz, A; Paesmans, M; Vandeputte, C | 1 |
Chen, Z; Li, Z; Peng, G; Wang, X; Zhang, B; Zhang, X | 1 |
Chen, F; Hu, P; Hu, R; Liao, S; Lyu, Q; Zhang, J; Zhang, Z | 1 |
Adachi, S; Koizumi, M; Kojo, M; Kubota, K; Matsuno, S; Morioka, N; Nishimura, M; Nishioka, S; Seto, H; Yamamoto, H | 1 |
de Geus-Oei, LF; Heerschap, A; Heijmen, L; Oyen, WJ; Punt, CJ; ter Voert, EE; van Laarhoven, HW; van Spronsen, DJ | 1 |
Duman, G; Güner, A; Karyağar, S; Kece, C; Kesici, U; Küçütulu, U | 1 |
Cambioli, S; Castellucci, P; Fanti, S; Ghedini, P; Tabacchi, E | 1 |
Han, EJ; Kim, SH; O, JH; Park, HL; Yoo, IeR | 1 |
Bergamaschi, R; Matthews, R; Safaie, E | 1 |
Ahn, SJ; Marashdeh, W; Marcus, C; Subramaniam, RM; Taghipour, M | 1 |
Da Prat, V; de Braud, F; Di Bartolomeo, M; Iaculli, A; Inno, A; Morosi, C; Orlandi, A; Pietrantonio, F; Spada, D | 1 |
Allen, PJ; Cercek, A; Correa-Gallego, C; D'Angelica, MI; DeMatteo, RP; Fong, Y; Gavane, S; Gewirtz, AN; Grewal, R; Jarnagin, WR; Kemeny, N; Kingham, TP; Klimstra, DS | 1 |
Cheon, GJ; Chung, JK; Edmund Kim, E; Jeong, SY; Kang, KW; Lee, DS; Lee, JM; Lee, SJ; Paeng, JC; Seo, HJ; Yi, NJ | 1 |
Chang, JG; Chang, YS; Chen, SW; Ho, CM; Kao, CH; Lin, CY; Yang, SF | 1 |
Itabashi, M; Kameoka, S; Kondo, C; Momose, M; Ogawa, S; Sakai, S | 1 |
Donswijk, ML; Hess, S; Lam, MG; Mulders, T | 1 |
Laurens, ST; Oyen, WJ | 1 |
Delaney, CP; Herrmann, KA; Krishnamurthi, S; Nguyen, NC; Partovi, S; Paspulati, RM | 1 |
Audollent, R; Dohan, A; Eveno, C; Jouvin, I; Pocard, M; Sarda, L; Soyer, P | 1 |
Chen, F; Date, H; Hasegawa, S; Hatano, E; Iwamoto, M; Kawada, K; Nakamoto, Y; Sakai, Y; Toda, K; Togashi, K; Uemoto, S | 1 |
Bradley, KM; Franklin, JM; Gleeson, FV; McGowan, DR; Parvizi, N; Teoh, EJ | 1 |
Chen, CC; Huang, AT; Huang, KC; Huang, YY; Lee, PI; Liu, MC | 1 |
Brendle, C; la Fougère, C; Nikolaou, K; Pfannenberg, C; Rempp, H; Schmidt, H; Schraml, C; Schwenzer, NF | 1 |
Barjat, H; Emmas, SA; Honndorf, VS; Pichler, BJ; Quintanilla-Martinez, L; Schmidt, H; Stahlschmidt, A; Wehrl, HF; Wiehr, S | 1 |
Arslanoglu, A; Gonzalez-Guindalini, FD; Parekh, K; Seyal, AR; Tochetto, SM; Velichko, YS; Yaghmai, V | 1 |
Camacho, JC; Edalat, F; Galt, JR; Kendi, AT; Kim, HS; Kokabi, N | 1 |
Li, Y; Qin, Y; Tian, M; Wang, D; Wang, X; Yu, L | 1 |
Cengiz, M; Halaç, M; Kemik, A; Kocael, A; Kocael, P; Şimşek, O; Sönmezoğlu, K; Ulualp, K; Vatankulu, B | 1 |
Comans, EF; Meijerink, MR; Nielsen, K; Scheffer, HJ; van den Bergh, J; van den Tol, PM; van der Meijs, BB; van Kuijk, C; van Tilborg, AA; Vroomen, LG | 1 |
Feng, Y; Huang, G; Jiang, Y; Liu, J; Liu, Y; Ni, Y; Song, S; Tong, L; Wu, C; Xia, Q; Yin, T | 1 |
Brandi, L; Carbonelli, C; Cavazza, A; Cesario, A; Di Paolo, ML; Gasparini, E; Lococo, F; Paci, M; Rapicetta, C; Ricchetti, T; Serra, S; Sgarbi, G; Sverzellati, N | 1 |
Bach-Gansmo, T; Dormagen, JB; Godt, JC; Holtedahl, JE; Johansen, CK; Kløw, NE; Labori, KJ; Schulz, A; Viktil, E | 1 |
Choi, YJ; Hwang, HS; Kim, MJ; Kwon, MJ; Lee, BH | 1 |
Cai, G; Cai, S; Li, D; Li, X; Peng, J; Shi, D; Xu, Y | 1 |
Hur, BY; Jeon, JH; Kang, B; Lee, JM; Paeng, JC; Song, YS; Woo, S | 1 |
Baik, SH; Jeon, TJ; Kang, J; Lee, JH; Lee, KY; Lim, BJ; Ryu, YH; Sohn, SK | 1 |
Bodelle, B; Fischer, S; Grünwald, F; Luboldt, HJ; Luboldt, W; Vogl, TJ; Wiedemann, B | 1 |
Ciunci, CA; Epstein, AJ; Paulson, EC; Vachani, A; Veenstra, CM; Zafar, HM | 1 |
Choe, JG; Kim, S; Pahk, K; Rhee, S | 1 |
Asao, T; Fujii, T; Katoh, T; Kigure, W; Kuwano, H; Morita, H; Suto, T; Tsutsumi, S; Yajima, R | 1 |
Choi, YJ; Han, YM; Hwang, HS; Koh, SH; Park, HC | 1 |
Kakugawa, Y; Matsuda, T; Matsumoto, M; Muramatsu, Y; Saito, H; Saito, Y; Sekiguchi, M; Terauchi, T | 1 |
Han, YH; Jeong, HJ; Lim, ST; Sohn, MH | 1 |
Ameye, L; Delaunoit, T; Deleporte, A; Demolin, G; Flamen, P; Garcia, C; Gauthier, N; Guiot, T; Hendlisz, A; Holbrechts, S; Lhommel, R; Maréchal, R; Van den Eynde, M; Vierasu, I; Woff, E | 1 |
Han, JK; Hur, BY; Joo, I; Kang, KW; Lee, DH; Lee, JM; Suh, KS; Yi, NJ | 1 |
Ehara, S; Ishida, K; Kato, K; Kawashima, K; Matsuo, M; Nakamura, R; Otsuka, K; Tomabechi, M | 1 |
Boas, FE; Do, RK; Gavane, S; Gonen, M; Kishore, S; Osborne, JR; Shady, W; Sofocleous, CT; Ulaner, GA; Ziv, E | 1 |
Boellaard, R; Hoekstra, OS; Menke-van der Houven van Oordt, CW; Mulder, ER; Roth, C; van Helden, EJ; Verheul, HM | 1 |
Carrasquillo, JA; Do, RK; Gonen, M; Pandit-Taskar, N; Shady, W; Sofocleous, CT; Sotirchos, VS | 1 |
Byeon, JS; Hwang, SW; Kim, KJ; Kim, WS; Kwak, MS; Lee, HS; Lee, JM; Myung, SJ; Park, SH; Yang, DH; Yang, SK | 1 |
Ahn, SJ; Marashdeh, W; Marcus, C; Mena, E; Subramaniam, RM; Taghipour, M; Wray, R | 1 |
Chong, S; Huang, YT; Hugh, TJ; Lin, M; Ng, WL; Park, J | 1 |
Kawasaki, H; Koyama, K; Nagai, H; Sasaki, K; Sato, M; Yoshimi, F | 1 |
Chang, JY; Jung, HK; Jung, SA; Kim, BS; Kim, SE; Lee, KE; Moon, CM; Ryu, MS; Shim, KN; Son, HM; Yoon, HJ | 1 |
Gökçek, A; Güreşci, S; Özmen, Ö; Şimşek, G; Tatci, E; Uzman, M; Yeniova, AÖ | 1 |
Asakura, K; Endo, M; Hotta, K; Igarashi, K; Imai, K; Ito, S; Kakushima, N; Kawata, N; Matsubayashi, H; Oishi, T; Ono, H; Shimoda, T; Takizawa, K; Tanaka, M; Yamaguchi, Y | 1 |
Hasegawa, H; Kitagawa, Y; Murakami, K; Okabayashi, K; Shigeta, K; Suzuki, Y; Tsuruta, M | 1 |
Bae, SU; Cho, KB; Choi, BW; Kim, HW; Song, BI; Won, KS | 1 |
Hansen, AF; Jensen, MR; Nordholm-Carstensen, A | 1 |
Aitken, K; Athauda, A; Chau, I; Cook, GJ; Cunningham, D; Kalaitzaki, E; Khan, K; Rao, S; Starling, N; Watkins, D | 1 |
Chiti, A; Costa, G; Lopci, E; Pedicini, V; Poretti, D; Rodari, M; Solbiati, L; Torzilli, G; Viganò, L | 1 |
Balci, D; Bilgic, S; Elhan, AH; Gecim, E; Kucuk, NO; Soydal, C | 1 |
Hadas, M; Halankar, J; Hussey, D; Langer, D; Metser, U; Mohan, R; Tamir, S | 1 |
Bang, JI; Han, SW; Jeong, SY; Kang, GH; Kim, JH; Kim, TY; Lee, KH; Lim, Y; Paeng, JC; Park, KJ | 1 |
Cho, IH; Chung, SM; Kim, KO; Kim, TN | 1 |
Dudek, W; Grützmann, R; Schreiner, W; Sirbu, H; Stapel, P; Vassos, N | 1 |
Arslan, E; Bayrak, S; Bektas, CT; Bektas, H; Kinaci, E; Ozakay, A; Sevinc, MM; Yardimci, AH | 1 |
Bellahcène, A; Bellier, J; Bletard, N; Castronovo, V; Chiavarina, B; Dehon, R; Delvenne, P; Demetter, P; Durieux, F; Goldman, S; Hustinx, R; Lovinfosse, P; Nokin, MJ; Peulen, O; Sherer, F; Turtoi, A; Uchida, K; Verset, L | 1 |
Anaye, A; Denys, A; Dunet, V; Halkic, N; Meuli, RA; Prior, JO; Schmidt, S; Sempoux, C | 1 |
Beeke, C; Chen, J; Karapetis, C; Kumar, R; Padbury, R; Price, T; Ullah, S; Wong, GYM | 1 |
Bouazza, F; Covas, A; Deleporte, A; El Nakadi, I; Flamen, P; Garcia, C; Hendlisz, A; Lecocq, C; Liberale, G; Muylle, K | 1 |
Kong, L; Shi, F; Zhang, NS; Zhu, H | 1 |
Fischer, G; Hakami, YA; Huellner, MW; Veit-Haibach, P; Wagner, F; Warnock, G | 1 |
Ferguson, CD; Luis, CR; Steinke, K | 1 |
Bipat, S; IJzermans, JN; Oyen, WJ; Planting, AS; Stoker, J; van Leeuwen, MS | 1 |
de la Morena, E; Gasent Blesa, JM; Laforga Canales, JB; Vázquez, C; Vilaseca Martínez, D | 1 |
Sharma, RI; Smith, TA | 1 |
Cheng, C; Dimitrakopoulou-Strauss, A; Haberkorn, U; Klippel, S; Koczan, D; Pan, L; Strauss, LG; Willis, S | 2 |
Fujii, H; Fukushi, M; Hirayama, A; Inoue, K; Ito, M; Kitamura, H; Kurosawa, H; Moriyama, N; Sato, T; Tanaka, T; Tsunoda, Y | 2 |
Ignatov, V; Ivanov, K; Kolev, N; Madzhov, R; Temelkov, T | 1 |
Bipat, S; Coenegrachts, K; De Geeter, F; Rigauts, H; Stoker, J; ter Beek, L; Walgraeve, N | 1 |
Almusa, O; Daly, B; Shreve, P | 1 |
Dehdashti, F; Fernandez, FG; Finkelstein, SE; Hawkins, WG; Linehan, DC; Siegel, BA; Strasberg, SM | 1 |
Hattori, H; Matsuoka, H; Nishimura, H; Yamamoto, K | 1 |
Chen, Y; Huang, G; Liu, J; Sun, X; Tong, J; Xue, H; Zhang, C; Zheng, P | 1 |
Iyer, RB; Vikram, R | 1 |
Arora, A; Pathak, S; Purandare, NC; Rajnish, A; Rangarajan, V; Shah, S | 1 |
Badiee, S; Chu, B; Coakley, F; Franc, BL; Hawkins, RA; Singer, L; Webb, EM | 1 |
Ameye, L; Delatte, P; Flamen, P; Ghanem, G; Hendlisz, A; Van Den Eynde, M; Vanderlinden, B | 1 |
Cherk, MH; Moore, M; Serpell, J; Swain, S; Topliss, DJ | 1 |
Assumpcao, L; Buijs, M; Choti, MA; Gleisner, AL; Pawlik, TM; Schulick, RD; Vossen, JA | 1 |
Seto, J | 1 |
Kitagawa, M; Kobayashi, H; Ochiai, R; Omagari, J; Ono, K; Yamashita, Y; Yoshida, T | 1 |
Berglund, A; Byström, P; Frödin, JE; Garske, U; Glimelius, B; Jacobsson, H; Nygren, P; Sundin, A | 1 |
Herbertson, RA; Lee, ST; Scarsbrook, AF; Scott, AM; Tebbutt, N | 1 |
Baur-Melnyk, A; Becker, CR; Haug, A; Hermann, KA; Reiser, MF; Schmidt, GP; Tiling, R; Utzschneider, S | 1 |
Beheshti, M; Dirisamer, A; Flöry, D; Halpern, BS; Langsteger, W; Mayerhoefer, ME; Wolf, F | 1 |
Oyen, WJ; Ruers, TJ; Vogel, WV; Wiering, B | 1 |
Brown, G; Houghton, SL; Husband, JE; Potter, KC; Thomas, K | 1 |
Dimitrakopoulou-Strauss, A; Haberkorn, U; Hoffend, J; Koczan, D; Pan, L; Strauss, LG | 1 |
Chen, X; Song, JH; Wang, TS; Xing, Y; Zhao, JH | 1 |
Domeki, Y; Kaji, Y; Kitajima, K; Murakami, K; Suganuma, N; Sugimura, K; Sunagawa, M; Tsubaki, M; Yamasaki, E | 1 |
de Geus-Oei, LF; Oyen, WJ; van der Graaf, WT; van Laarhoven, HW; Vriens, D | 1 |
de Geus-Oei, LF; Krabbe, PF; Oyen, WJ; Timmer-Bonte, JN; van Laarhoven, HW; Visser, EP; Vriens, D | 1 |
Broccoli, P; D'Urso, S; Danieli, R; Fusco, N; Maurici, M; Orlacchio, A; Schillaci, O; Simonetti, G; Yamgoue, M | 1 |
Arslan, C; Kilickap, S | 1 |
Comans, EF; de Jong, KP; Dekker, HM; Krabbe, PF; Oyen, WJ; Pruim, J; Roumen, RM; Ruers, TJ; van der Sijp, JR; Wiering, B | 1 |
Addeo, P; Bucci, L; Camera, L; D'Antonio, D; Mainenti, PP; Mainolfi, C; Manchia, A; Mancini, M; Maurea, S; Pace, L; Persico, F; Persico, G; Salvatore, M; Speranza, A; Tanga, M | 1 |
Adie, S; Chu, F; Morris, DL; Yip, C | 1 |
Bouillet, P; El Badaoui, A; Lavau-Denes, S; Le Brun-Ly, V; Leobon, S; Mahmoudi, N; Martin, J; Maubon, A; Monteil, J; Pouquet, M; Roudaut, PY; Tubiana-Mathieu, N; Vandroux, JC; Venat-Bouvet, L; Verbeke, S | 1 |
Coha, B; Daković, M; Gardasanić, J; Latić, A; Mitrecić, D; Radmilović, K; Stefanić, M | 1 |
Bartolomei, M; Crosta, C; De Cicco, C; De Roberto, G; Fiori, G; Paganelli, G; Ravizza, D; Santoro, L; Tamayo, D; Trovato, C | 1 |
De Weer, S; Debucquoy, A; Devos, E; Haustermans, K; Landuyt, W; Van Den Heuvel, F; Vermaelen, P | 1 |
Asakura, M; Haba, R; Hagiike, M; Izuishi, K; Kameyama, R; Nishiyama, Y; Takebayashi, R; Yamamoto, Y | 1 |
de Geus-Oei, LF; Heerschap, A; Krabbe, PF; Oyen, WJ; Punt, CJ; van Asten, JJ; van Laarhoven, HW; Visser, EP; Vriens, D | 1 |
Chen, Y; Li, T; Liu, J; Qu, B; Tian, J; Wang, H; Wang, S; Zhang, J | 1 |
Antoch, G; Bockisch, A; Forsting, M; Hahn, S; Hamami, M; Heusner, T; Peng, Z; Zhan, Y; Zhou, X | 1 |
Bochet, J; Hameg, A; Le Stanc, E; Tainturier, C; Vilain, D; Wattel, C | 1 |
Amthauer, H; Denecke, T; Grabik, W; Grieser, C; Hamm, B; Hänninen, EL; Lüdemann, L; Ricke, J; Rühl, R; Schnapauff, D; Steffen, IG; Wust, P | 1 |
Hyun, IY; Yun, MY | 1 |
Armstrong, K; Groeneveld, PW; Mahmoud, NN; Mitra, N; Wirtalla, C; Zafar, HM | 1 |
Erturk, SM; Madan, R; Shyn, PB; Silverman, SG; Wu, C | 1 |
Fiala, P; Hlavatá, Z; Majidi, A; Martanovic, P; Paulíny, P; Pazderová, N; Povinec, P; Sálek, T | 1 |
Freeman, M; Hendler, A; McSweeney, S; Metser, U; You, J | 1 |
Fan, W; Li, W | 1 |
El-Maghraby, T | 1 |
Jee, KN; Lee, JH; Namgung, H; Park, DG; Park, SG; Song, IH | 1 |
Bradley, KM; Chowdhury, FU; Scarsbrook, AF; Shah, N | 1 |
Bal, CS; Halanaik, D; Kumar, R; Malhotra, A; Reddy, RM; Shamim, SA; Shandal, V | 1 |
Khoo, JB; Lu, SJ; Ng, DC; Osmany, S | 1 |
Karyagar, S; Karyagar, SS; Kece, C; Ozdil, B | 1 |
Itabashi, M; Kameoka, S; Kondo, C; Kusakabe, K; Kyoto, Y; Momose, M | 1 |
Coffey, JP | 1 |
Campbell, J; Gates, VL; Ho, CL; Lewandowski, RJ; Qing, F; Salem, R; Savin, M; Tang, B; Thie, J; Wong, CY | 1 |
Shie, P | 1 |
Caamaño, AG; Figueiras, RG; Goh, V; Martin, CV; Naveira, AB; Padhani, AR | 1 |
Dede, F | 1 |
Assenat, E; Aufort, S; Bacigalupo, L; Eberlé, MC; Gallix, B; Ychou, M | 1 |
Lin, M; Morgan, M; Ng, WL; Shon, IH; Wong, K | 1 |
Boterberg, T; Ceelen, W; Goethals, I; Ham, H; Smeets, P; Verstraete, K | 1 |
Bamba, Y; Itabashi, M; Kameoka, S | 1 |
Kim, SK; Kim, TS; Lee, JW; Lee, SM; Moon, SH | 1 |
Al-Nahhas, A; Gordon, F; Habib, N; Hodolic, M; Karunanithy, N; Tait, NP; Wasan, HS | 1 |
Chang, ZH; Guo, QY; Liu, ZY; Lu, ZM | 1 |
Bipat, S; Niekel, MC; Stoker, J | 1 |
Adang, EM; Comans, EF; de Jong, KP; Dekker, HM; Krabbe, PF; Oyen, WJ; Pruim, J; Roumen, RM; Ruers, TJ; van der Sijp, JR; Wiering, B | 1 |
Bomanji, J; Caplin, M; Desai, K; Quigley, AM; Toumpanakis, C; Watkins, J; Woodward, N | 1 |
Mori, S; Oguchi, K | 1 |
Chen, YM; Guan, ZW; Liu, B; Liu, CB; Qu, BL; Tian, JH; Wang, H; Wang, RM; Xu, BX; Zhang, JM | 1 |
Bal, CS; Halanaik, D; Kumar, G; Kumar, R; Malhotra, A; Shamim, SA; Shandal, V | 1 |
Dehdashti, F; Strasberg, SM | 1 |
Kim, J; Visioni, A | 1 |
Talbot, JN | 1 |
Bleichrodt, R; Boerman, O; de Jong, G; Franssen, G; Hendriks, T; Oyen, W | 1 |
Iagaru, AH; Leung, AN; Mittra, ES | 1 |
Han, A; Xue, J; Yu, J; Yue, J; Zheng, J; Zhu, D | 1 |
Buecher, B; Deleau, C; des Varannes, SB; Flamant, M; Frampas, E; Galmiche, JP; Kraeber-Bodéré, F; Matysiak-Budnik, T; Rousseau, C | 1 |
Brouwers, AH; de Jong, S; de Vries, EG; Heijink, DM; Kleibeuker, JH; Koornstra, JJ; Nagengast, WB; Oosterhuis, D | 1 |
Delbeke, D; Martin, WH | 2 |
Buvat, I; Emonts, P; Flamen, P; Garcia, C; Hendlisz, A; Necib, H; Vanderlinden, B; Wagner, A | 2 |
Funahashi, K; Kaneko, H; Ushigome, M | 1 |
Chen, JH; Chen, YK; Cheng, RH; Chiu, JS; Chou, HH; Tsui, CC | 1 |
Chin, FT; Conti, PS; Fisher, GA; Kunz, P; Quon, A; Subbarayan, M; Zissen, MH | 1 |
Fabregat, J; Gamez, C; Lladó, L; Martinez, L; Rafecas, A; Ramos, E; Ruiz, S; Serrano, T; Torras, J; Valls, C | 1 |
De Palma, GD; Iodice, D; Magliulo, M; Mainenti, PP; Pace, L; Salvatore, M; Segreto, S; Storto, G | 1 |
Chung, WS; Kim, MJ; Kim, YE; Lee, JD; Seo, HJ | 1 |
de Geus-Oei, LF; Heerschap, A; Oyen, WJ; van Laarhoven, HW; Vriens, D | 1 |
Lin, M | 1 |
Bhattacharya, A; Gupta, R; Kapoor, R; Kashyap, R; Mittal, BR; Senthil, R; Singh, B | 1 |
Cai, S; He, Y; Peng, J; Sheng, J; Xu, J; Zhang, Z | 1 |
Briggs, RH; Chowdhury, FU; Lodge, JP; Scarsbrook, AF | 1 |
De Haan, HA; Gambhir, SS; Iagaru, AH; Reid, TR; Sze, DY | 1 |
Boyd, K; Brush, J; Chappell, F; Crawford, F; Dozier, M; Dunlop, M; Fenwick, E; Glanville, J; McIntosh, H; Renehan, A; Weller, D | 1 |
Akita, M; Higashi, R; Hirakawa, T; Hiraoka, S; Hori, K; Kaji, E; Kato, J; Okumura, Y; Saito, S; Suzuki, H; Takahashi, S; Uraoka, T; Yamamoto, K | 1 |
Izuishi, K; Masaki, T; Mori, H; Morishita, A; Nishiyama, Y; Sano, T; Suzuki, Y; Takebayashi, R; Yamamoto, Y | 1 |
Ameye, L; Awada, A; Covas, A; Deleporte, A; Emonts, P; Flamen, P; Garcia, C; Golfinopoulos, V; Hendlisz, A; Machiels, G; Paesmans, M; Piccart, M; Toussaint, E; Vanderlinden, B | 1 |
Ell, PJ; Engledow, AH; Groves, AM; Imber, C; Pakzad, F; Skipworth, JR | 1 |
Bukofzer, G; Chakravartty, A; Cole, TB; Day, M; Donawho, CK; Fox, GB; Holich, KD; Luo, Y; Mudd, SR; Palma, JP; Reuter, DR; Tapang, P; Voorbach, MJ | 1 |
Hong, R; Lim, SC | 1 |
Gao, X; Geng, J; Qin, Y; Tian, M; Wang, D; Yu, L | 1 |
Au-Yeung, AW; Lo, AX; Luk, WH | 1 |
Hasegawa, S; Hida, K; Kawada, K; Kawada, M; Matsumoto, T; Murakami, T; Nakamoto, Y; Sakai, Y; Togashi, K | 1 |
de Geus-Oei, LF; Disselhorst, JA; Oyen, WJ; Visser, EP; Vriens, D | 1 |
Araz, M; Ibis, E; Kir, KM; Ozkan, E; Soydal, C | 1 |
Chowdhury, FU; Culverwell, AD; Scarsbrook, AF | 1 |
Goethals, I; Lambert, B; Mees, G; Mertens, K; Van de Wiele, C | 1 |
Bailly, P; Chatelain, D; Daouk, J; Diouf, M; El Esper, I; Fin, L; Meyer, ME; Morvan, J; Régimbeau, JM; Slama, J | 1 |
Buckens, CF; van den Bosch, MA; van Hillegersberg, R; van Kessel, CS; van Leeuwen, MS; Verkooijen, HM | 1 |
Abel, U; Berger, AK; Delorme, S; Haag, GM; Haberkorn, U; Jäger, D; Kloor, M; Lordick, F; Ose, J; Stange, A; von Gall, C; Weber, TF | 1 |
Gao, X; Tian, M; Yu, L; Zhang, Y | 1 |
Blackman, G; Ell, P; Endozo, R; Engledow, A; Goh, V; Groves, AM; Halligan, S; Peck, J; Rodriguez-Justo, M; Shastry, M; Taylor, S | 1 |
Bleichrodt, RP; Boerman, OC; de Jong, GM; Dekker, HM; Gotthardt, M; Hendriks, T; Mus, RD; Oyen, WJ; Visser, EP | 1 |
Miyake, KK; Nakamoto, Y; Togashi, K | 1 |
Ha, HK; Kim, HJ; Kim, JC; Kim, JS; Kwak, JY; Yu, CS | 1 |
Bonomo, L; Castaldi, P; De Gaetano, AM; Filograna, L; Gatto, AM; Giordano, A; Rufini, V | 1 |
Endozo, R; Engledow, A; Goh, V; Groves, AM; Halligan, S; Meagher, M; Peck, J; Rodriguez-Justo, M; Shastry, M; Taylor, SA | 1 |
Chalian, H; Tochetto, SM; Töre, HG; Yaghmai, V | 1 |
Armstrong, K; Bonaccorsi, D; Kramer, S; Langlotz, CP; Zafar, HM | 1 |
Al-Nahhas, A; Chondrogiannis, S; Evangelista, L; Marzola, MC; Rubello, D | 1 |
Alesi, E; Krystal, GW; Tatum, JL | 1 |
Ceelen, W; De Bruyne, S; Ferdinande, L; Geboes, K; Laurent, S; Libbrecht, L; Mertens, J; Peeters, M; Smeets, P; Troisi, R; Van Damme, N; Van de Wiele, C | 1 |
Graser, A; Haug, AR; Meinel, FG; Reiser, MF; Rist, C; Schramm, N | 1 |
Barot, TC; Gulec, SA; Hall, M; Pennington, K; Schwartzentruber, D; Suthar, RR; Wheeler, J | 1 |
Adalet, I; Asoglu, O; Balik, E; Has, D; Isik, G; Kapran, Y; Kilic, L; Kuyumcu, S; Ozkan, ZG; Sanli, Y; Turkmen, C | 1 |
Al-Nahhas, A; Ariff, B; Barwick, T; Habib, N; Hatice, G; Tait, P; Towey, D; Wasan, H; Zerizer, I | 1 |
Asada, T; Chijiiwa, K; Haruyama, Y; Hotokezaka, M; Nagamachi, S; Uchiyama, S | 1 |
Doxani, C; Poulou, LS; Thanos, L; Vakrinos, G; Voulgarelis, M; Xyla, V; Ziakas, PD; Ziogas, DC | 1 |
Onal, C; Parlak, C; Reyhan, M; Sonmez, S; Topkan, E | 1 |
Christophi, C; Kwok, M; Lau, L; Lee, ST; Muralidharan, V; Scott, AM | 1 |
Aras, G; Araz, M; Ozkan, E; Soydal, C | 1 |
Cheng, J; Dai, D; Ma, WC; Song, XY; Xu, WG; Xu, XX; Zhu, L; Zhu, X | 1 |
Badger, SA; Diamond, T; Jones, C; Lynch, TB; McKie, LD; Taylor, MA | 1 |
Bussink, J; de Geus-Oei, LF; de Wilt, JH; Hatt, M; Heijmen, L; Oyen, WJ; Punt, CJ; van Laarhoven, HW; Visser, EP; Visvikis, D | 1 |
Kochhar, R; Liong, SY; Manoharan, P; Renehan, AG | 1 |
Chen, JH; Chien, CR; Ding, HJ; Kao, CH; Lin, WY; Lu, YY | 1 |
Choi, KY; Kang, WK; Kim, JS; Kim, SH; Kim, SW; Lee, JE; Oh, ST; Yoo, IeR | 1 |
Allende-Riera, A; Cabello-García, D; Cárdenas-Negro, JC; De Sequera-Rahola, M; Martínez-Gimeno, E; Muñoz-Iglesias, J; Ochoa-Figueroa, MA; Uña-Gorospe, J | 1 |
Endozo, R; Engledow, A; Goh, V; Groves, AM; Halligan, S; Kozarski, R; Peck, J; Rodriguez-Justo, M; Shastry, M; Taylor, SA | 1 |
Huijbregts, JE; Koopman, M; Lam, MG; Rosenbaum, CE; van den Bosch, MA; Veldhuis, WB | 1 |
Breitenstein, S; Burger, IA; Hany, TF; Samarin, A; Schwarz, EI; Weber, A | 1 |
Boerman, O; Bussink, J; de Geus-Oei, LF; Heerschap, A; Heijmen, L; Oyen, WJ; Punt, CJ; Span, PN; Sweep, CG; Ter Voert, EG; van Laarhoven, HW; Zerbi, V | 1 |
Detry, R; Gigot, JF; Kartheuser, A; Lonneux, M; Pauwels, S; Reffad, AM | 1 |
Koslin, DB | 1 |
Higashiyama, S; Kawabe, J; Koyama, K; Ochi, H; Okamura, T; Ozawa, N; Yamada, R | 1 |
Delbeke, D; Vitola, J | 1 |
Jörg, L; Langsteger, W | 1 |
Clavien, PA; Hagge, R; Killius, J; Nelson, RC; Paulson, EK; Rohren, EM; Wong, TZ | 1 |
Bading, JR; Conti, PS; Jadvar, H; Tatlidil, R | 1 |
Borrego Dorado, I; Vázquez Albertino, R | 1 |
Carrió, I; Castellucci, P; Costansa, JM; Doménech-Torné, F; Lomeña, F; Pérez, G; Setoain, J; Setoain-Quinquer, J; Simó, M | 1 |
Agoston, P; Esik, O; Fekésházy, A; Galuska, L; Kálvin, B; Lengyel, E; Lengyel, Z; Szakáll, S; Székely, J; Trón, L | 1 |
Filice, C; Prati, U; Roveda, L; Trotta, F | 1 |
Kanai, M; Kawai, Y; Nakamoto, Y; Takabayashi, A; Taki, Y; Tanaka, T | 1 |
Aufschnaiter, M; Hammer, J; Heinisch, M; Jörg, L; Klug, R; Kurz, F; Langsteger, W; Rechberger, E | 1 |
Beyer, T; Townsend, DW | 1 |
Goldsmith, SJ; Kostakoglu, L | 1 |
Dimitrakopoulou-Strauss, A; Kontaxakis, G; Pavlopoulos, S; Santos, A; Strauss, LG; Thireou, T | 2 |
Kaim, AH; von Schulthess, GK | 1 |
Dimitrakopoulou-Strauss, A; Rudi, J; Strauss, LG | 1 |
Arulampalam, TH; Costa, DC; Ell, PJ; Francis, DL; Luthra, SK; Taylor, I; Townsend, C; Visvikis, D | 1 |
Bourguet, P | 1 |
Chin, BB; Wahl, RL | 1 |
Cuocolo, A; Giuliani, A; Mainolfi, C; Maurea, S; Sciaudone, G; Selvaggi, F | 1 |
Dietlein, M; Schicha, H; Schwaiger, M; Weber, W | 1 |
Cohade, C; Fayad, LM; Fishman, EK; Wahl, RL | 1 |
Uno, K | 1 |
Bêlohlávek, O; Kantorová, I; Lipská, L; Schneiderová, M; Trubaĉ, M; Visokai, V | 1 |
Cohade, C; Leal, J; Osman, M; Wahl, RL | 1 |
Schiepers, C | 1 |
Bohdiewicz, PJ; Dworkin, HJ; Gaskill, M; Kondas, D; Wong, CY | 1 |
Barrington, SF; Leslie, MD; Plunkett, TA; Tutt, AN | 1 |
Even-Sapir, E; Figer, A; Gutman, M; Lerman, H; Livshitz, G; Miller, E | 1 |
Böhm, B; Geoghegan, J; Gottschild, D; Hellfritzsch, H; Petrovich, A; Scheele, J; Voth, M | 1 |
Diehl, M; Döbert, N; Grünwald, F; Hamscho, N; Menzel, C; Zaplatnikov, K | 1 |
Arulampalam, TH; Ell, PJ; Francis, DL; Taylor, I; Visvikis, D | 1 |
Arulampalam, TH; Costa, DC; Croasdale, I; Ell, PJ; Francis, DL; Luthra, SK; Taylor, I; Visvikis, D | 1 |
Koumanis, DJ; Meterissian, S; Tzimas, GN | 1 |
Colombet-Lamau, C; de Beco, V; Grahek, D; Kerrou, K; Montravers, F; Petegnief, Y; Talbot, JN; Younsi, N | 1 |
Bozzetti, F; Crippa, F; Gavazzi, C; Mariani, L | 1 |
Ames, JT; Blodgett, TM; McCook, BM; Meltzer, CC; Torok, FS | 1 |
Oyen, WJ; Ruers, TJ; Wiering, B | 1 |
Chin, VT; Costello, SP; Court, FG; Kirkwood, ID; Maddern, GJ; Morrison, CP; Teague, BD | 1 |
Bumm, R; Dresel, S; Hahn, K; Meimarakis, G; Rosa, F; Stahl, A; Tatsch, K | 1 |
Dehdashti, F; Drebin, JA; Fernandez, FG; Linehan, DC; Siegel, BA; Strasberg, SM | 1 |
Metser, U | 1 |
Burger, C; Dimitrakopoulou-Strauss, A; Irngartinger, G; Rudi, J; Rühl, A; Strauss, LG; Stremmel, W | 1 |
Hustinx, R | 1 |
Rummeny, E; Schwaiger, M; Stollfuss, J; Wieder, H | 1 |
Barker, D; Dworkin, HJ; Gates, V; Hill, EA; Lewandowski, R; Nagle, C; Qing, F; Salem, R; Wong, CY; Wong, KT | 1 |
Clavien, PA; Hany, TF; Kadry, Z; McCormack, L; Selzner, M; Wildbrett, P | 1 |
Amesur, N; Avril, N; Bienert, M; Carr, BI; Geller, DA; McCook, B; Sheetz, M | 1 |
Kula, Z; Pietrzak, T; Romanowicz, G; Szefer, J; Zuchora, Z | 1 |
Amir, R; Bourgeot, B; Liehn, JC; Marcus, C; Papathanassiou, D | 1 |
Bueno, JG; Domínguez Grande, ML; Fernández, JP; Kosvintseva, O; Oromendía, AO; Pozo, MA; Suárez, AM; Zomeño, M | 1 |
Ernst, O; Hebbar, M; Huglo, D; Pruvot, FR; Steinling, M; Truant, S | 1 |
de Geus, LF; de Waal, RM; Oyen, WJ; Peeters, CF; Ruers, TJ; Ruiter, DJ; Westphal, JR; Wobbes, T | 1 |
Kuang, A; Tang, G | 1 |
Kang, KW; Kim, SK; Lee, ES; Park, SY; Roh, JW; Sim, JS | 1 |
Allen-Auerbach, MS; Czernin, J; Fueger, BJ; Halpern, BS; Hecht, JR; Kim, JH; Phelps, ME; Ratib, O; Weber, WA | 1 |
Antoch, G; Bockisch, A; Forsting, M; Kuehl, H; Stergar, H; Veit, P | 1 |
Choi, MY; Chung, JK; Jeong, JM; Kim, JH; Lee, DS; Lee, KM; Lee, MC; Park, JG | 1 |
Adusumilli, P; Fong, Y; Song, TJ | 1 |
Changchien, CR; Chen, JS; Ho, KC; Liu, FY; Liu, SH; Yeh, CY; Yen, TC | 1 |
Collins, JM; Mangner, TJ; Muzik, O; Shields, AF; Sun, H | 1 |
Ell, PJ | 1 |
Arslan, N; Dehdashti, F; Siegel, BA | 1 |
Bipat, S; Bossuyt, PM; Comans, EF; Pijl, ME; Stoker, J; van Leeuwen, MS; Zwinderman, AH | 1 |
Baker, JG; Bednarczyk, EM; Nabi, HA; Zubeldia, JM | 1 |
Bucerius, J; Flacke, S; Hortling, N; Jaeger, U; Joe, A; Palmedo, H; Reinhardt, M; Strunk, H | 1 |
Heiba, SI; Katzel, JA | 1 |
Khandani, AH; Semelka, RC | 1 |
de Geus-Oei, LF; Heerschap, A; Kaanders, JH; Krabbe, PF; Lok, J; Oyen, WJ; Punt, CJ; Rijpkema, M; Ruers, T; van der Kogel, AJ; van Laarhoven, HW; Wiering, B | 1 |
Lonneux, M | 1 |
Comte, F; Eberlé, MC; Lamy, PJ | 1 |
Akhurst, T; Blumgart, L; Burt, BM; Fong, Y; Jarnagin, W; Kates, TJ; Larson, SM; Mazumdar, M; Riedel, ER; Yeung, H | 1 |
Jager, GJ; Krabbe, PF; Oyen, WJ; Ruers, TJ; Wiering, B | 1 |
Arveux, P; Bedenne, L; Bey, P; Bismuth, MJ; Conroy, T; Faivre, J; Guillemin, F; Lejeune, C; Zanni, C | 1 |
Aramaki, T; Furukawa, H; Ikuma, H; Seki, A; Yamagushi, S; Yokoe, K; Yuen, S | 1 |
Gates, VL; Geschwind, JF; Goin, JE; Lewandowski, RJ; Salem, R; Thurston, KG; Van Buskirk, M; Wong, CY | 1 |
Horst, S; Kocak, E; Mantil, J; Martin, EW; Young, D | 1 |
Aderka, D; Davidson, T; Goshen, E; Zwas, ST | 2 |
Erturk, SM; Fujii, H; Ichikawa, T; Ros, PR; Yasuda, S | 1 |
Esteves, FP; Halkar, RK; Schuster, DM | 1 |
Chang, HM; Kim, HC; Kim, JC; Kim, JH; Park, IJ; Ryu, JS; Ryu, MH; Yeo, JS; Yu, CS | 1 |
de Geus-Oei, LF; Krabbe, PF; Oyen, WJ; Punt, CJ; Ruers, TJ; Wiering, B | 1 |
Endo, K; Hanaoka, H; Higuchi, T; Iida, Y; Ishikita, T; Koyama, K; Miyakubo, M; Oriuchi, N | 1 |
Amthauer, H; Denecke, T; Gutberlet, M; Hänninen, EL; Hildebrandt, B; Langrehr, J; Miersch, A; Nicolaou, A; Plotkin, M; Ricke, J; Riess, H; Ruf, J; Rühl, R; Stroszczynski, C | 1 |
Danno, K; Fukunaga, H; Gu, J; Hatazawa, J; Ikeda, M; Monden, M; Nishimura, T; Sekimoto, M; Takemasa, I; Tatsumi, M; Yamamoto, H | 1 |
Dekker, HM; Krabbe, PF; Oyen, WJ; Ruers, TJ; Wiering, B | 2 |
Hicks, RJ; Lau, EW; Ware, RE | 1 |
Corstens, FH; de Geus-Oei, LF; Leer, JW; Oyen, WJ; Punt, CJ; Ruers, TJ | 1 |
Frizelle, FA; Lolohea, S; Robertson, GM; Watson, AJ | 1 |
Deandreis, D; Pelosi, E | 1 |
Al-Nahhas, A; Canelo, R; Habib, N; Jiao, L; Pagou, M; Szyszko, T; Tait, P; Wasan, H | 1 |
Higashi, T; Nakamoto, Y; Okada, T; Saga, T; Sakamoto, S; Senda, M; Togashi, K | 1 |
Bellon-Guardia, M; Cabello-García, D; Ferrón-Orihuela, A; Gomez-Rio, M; Gutiérrez-Sáinz, J; Llamas-Elvira, JM; Ramos-Font, C; Rebollo-Aguirre, AC; Rodríguez-Fernández, A | 1 |
Dimitrakopoulou-Strauss, A; Haberkorn, U; Klippel, S; Pan, L; Schönleben, K; Strauss, LG | 1 |
Gulec, SA | 1 |
Heffernan, EJ; Skehan, SJ | 1 |
Bourguet, P; Metges, JP; Mitry, E; Monteil, J; Planchamp, F; Tubiana-Mathieu, N | 1 |
Collins, CD; Duffy, GJ; Malone, DE; Ridge, CA; Sheehan, JJ; Skehan, SJ; Ward, EV | 1 |
Herbertson, RA; Lee, ST; Scott, AM; Tebbutt, N | 1 |
Ben-Haim, M; Even-Sapir, E; Figer, A; Geva, R; Klausner, JM; Lubezky, N; Metser, U; Nakache, R; Shmueli, E | 1 |
Dicken, V; Hoffmann, AL; Karssemeijer, N; Oyen, WJ; Ruers, TJ; van Dalen, JA; Vogel, WV; Wiering, B | 1 |
Akhurst, T; Bhargava, A; Fong, Y; Hricak, H; Klimstra, D; Larson, S; Riedl, CC; Stanziale, SF; Tuorto, S | 1 |
Advani, RH; Allred, C; Benson, AB; Brown, E; Burstein, HJ; Carlson, RW; Coleman, RE; Czuczman, MS; Delbeke, D; Edge, SB; Ettinger, DS; Grannis, FW; Hillner, BE; Hoffman, JM; Kiel, K; Komaki, R; Larson, SM; Mankoff, DA; Podoloff, DA; Rosenzweig, KE; Skibber, JM; Yahalom, J; Yu, JM; Zelenetz, AD | 1 |
Antoch, G; Beyer, T; Bockisch, A; Hauth, EA; Schleucher, R; Stergar, H; Veit-Haibach, P | 1 |
Bloomston, M; Hall, NC; Knopp, MV; Martin, EW; Povoski, SP; Sarikaya, I; Zhang, J | 1 |
Fleshman, JW; Strasberg, SM; Yang, YY | 1 |
Klippenstein, DL; Lamonica, DM | 1 |
Hemandas, AK; Hickish, T; Robson, NK; Talbot, RW | 1 |
Al-Saif, OH; Bloomston, M; Cao, Z; Hall, NC; Knopp, MV; Kocak, E; Marsh, S; Martin, EW; Murrey, DA; Povoski, SP; Sarikaya, I; Zhang, J | 1 |
Al-Nahhas, A; Carnaghi, C; Chiti, A; Doci, R; Luttmann, F; Rimassa, L; Rodari, M; Rubello, D; Santoro, A; Tondulli, L; Torzilli, G; Tronconi, MC; Zuradelli, M | 1 |
Al-Saif, OH; Arnold, MW; Bloomston, M; Hall, NC; Hinkle, G; Martin, EW; Povoski, SP; Sun, D | 1 |
Chen, LB; Song, HZ; Tong, JL; Wang, YC; Zhu, H | 1 |
Collins, CD | 1 |
Burkill, G; Miles, K | 1 |
Amthauer, H; Denecke, T; Hänninen, EL; Hildebrandt, B; Langrehr, J; Lehmkuhl, L; Ricke, J; Rühl, R; Steffen, I; Streitparth, F | 1 |
Clavien, PA; Fried, M; Gerlach, T; Gubler, C; Hany, T; Jochum, W; Mullhaupt, B; Petrowsky, H; Wildi, SM | 1 |
Corstens, FH; de Geus-Oei, LF; Hermsen, R; Kamm, YJ; Krabbe, PF; Oyen, WJ; Punt, CJ; van Hoorn, BA; van Laarhoven, HW; Visser, EP | 1 |
Høyer, M; Keiding, S; Mortensen, FV; Sørensen, M; Vilstrup, H | 1 |
Dresel, S; Schlag, PM | 1 |
Balan, KK; Gibbs, P; Huguet, EL; Jamieson, NV; Old, S; Praseedom, RK | 1 |
Haji, A | 1 |
Bai, RJ; Gao, S; Li, YJ; Zhang, Y | 1 |
Antoch, G; Barkhausen, J; Bockisch, A; Frilling, A; Kuehl, H; Rosenbaum-Krumme, S; Stergar, H; Veit-Haibach, P; Vogt, F | 1 |
Amthauer, H; Denecke, T; Grieser, C; Hildebrandt, B; Lopez Hänninen, E; Plotkin, M; Podrabsky, P; Ricke, J; Rühl, R; Stelter, L; Stiepani, H; Werk, M | 1 |
Breitenstein, S; Hany, TF; Lago, MP; Mende, KA; Soyka, JD; Strobel, K; Tschopp, A; Veit-Haibach, P | 1 |
André, T; Aparicio, T; Cherqui, D; Delbaldo, C; Gornet, JM; Itti, E; Le Guludec, D; Lebtahi, R; Meignan, M; Montravers, F; Panis, Y; Rougier, P; Sobhani, I; Talbot, JN; Tiret, E; Vaylet, C | 1 |
Endo, S; Kudo, SE; Nagata, K; Okawa, T; Ota, Y | 1 |
Brown, G; Cook, GJ; Cunningham, D; Jackson, C; Koh, DM; Kong, G; Lewington, V; Sharma, B | 1 |
Ahmad, MN; Nadeem, N; Zafar, AM | 1 |
Antoch, G; Bockisch, A; Forsting, M; Kuehl, H | 1 |
Geus-Oei, LF; Oyen, WJ | 1 |
Fujii, H; Ito, M; Kuwano, H; Saito, N; Tsunoda, Y | 1 |
Castaldo, ET; Chari, RS; Delbeke, D; Gao, F; Hawkins, WG; Linehan, DC; Pinson, CW; Siegel, BA; Strasberg, SM; Tan, MC; Wright, JK | 1 |
Bashir, H; Nunan, TO; Shabo, G | 1 |
Boerman, OC; Oyen, WJ; Ruers, TJ; Scheer, MG; Stollman, TH; Vogel, WV | 1 |
Anderson, CJ; Connett, JM; Cutler, PD; Dehdashti, F; Meares, CF; Philpott, GW; Schwarz, SW; Siegel, BA; Welch, MJ; Zinn, KR | 1 |
Ball, D; Bohdiewicz, PJ; Dworkin, H; Juni, JE | 1 |
Bohdiewicz, PJ; Dworkin, HJ; Fink-Bennett, D; Juni, JE; Nagle, C; Scott, GC; Wilner, F | 1 |
Aerts, R; Beets, G; De Roo, M; Filez, L; Kerremans, R; Mortelmans, L; Penninckx, F; Schiepers, C | 1 |
Alpert, NM; Fischman, AJ; Goldberg, MA; Lee, MJ; Mueller, PR; Thrall, JH | 1 |
Campbell, MG; Chapman, WC; Delbeke, D; Pinson, CW; Powers, TA; Sandler, MP; Vitola, JV; Wright, JK | 1 |
Fischman, AJ | 1 |
Cronin, B; Cunningham, D; Findlay, M; Flower, M; Hickish, T; Husband, J; Iveson, A; Ott, R; Pratt, B; Young, H | 1 |
Bradfield, H; Gupta, N | 1 |
Chu, KM; Fulham, M; Lai, DT; Sheldon, DM; Solomon, M; Stephen, MS; Storey, DW; Thompson, JF | 1 |
Wagner, HN | 2 |
Delbeke, D; Mazer, MJ; Meranze, SG; Pinson, CW; Vitola, JV | 1 |
Arildsen, RC; Chapman, WC; Delbeke, D; Pinson, CW; Powers, TA; Sandler, MP; Vitola, JV; Wright, JK | 1 |
Bender, H; Biersack, HJ; Kozak, B; Oehr, P; Robertz-Vaupel, GM; Ruhlmann, J; Schomburg, A; Vaupel, H; Wolter, H | 1 |
Cohen, AM | 1 |
Birnbaum, EH; Dehdashti, F; Flanagan, FL; Fleshman, JW; Kodner, IJ; Ogunbiyi, OA; Philpott, GW; Read, TE; Siegel, BA; Trask, DD | 1 |
Abdel-Nabi, H; Carbone, GM; Cronin, VR; Doerr, RJ; Galantowicz, PJ; Lamonica, DM; Spaulding, MB | 1 |
Dehdashti, F; Flanagan, FL; Kodner, IJ; Ogunbiyi, OA; Siegel, BA | 1 |
Dimitrakopoulou-Strauss, A; Doll, J; Hohenberger, P; Irngartinger, G; Oberdorfer, F; Schlag, P; Strauss, LG; van Kaick, G | 1 |
Abdel-Dayem, HM; Abujudeh, H; Atay, S; El-Zeftawy, HM; Luo, JQ; Marans, HY; Mithilesh, K; Naddaf, SY; Omar, WS; Radin, AI; Wong, S | 1 |
Dimitrakopoulou-Strauss, A; Gutzler, F; Moehler, M; Raeth, U; Strauss, LG; Stremmel, W | 1 |
Bausart, R; Declerck, P; Delval, D; Jamar, F; Lonneux, M; Moens, R; Pauwels, S; Van Mael, P; Willockx, R; Zreik, H | 1 |
Franzius, C; Schober, O; Sciuk, J | 1 |
Ott, DJ | 1 |
Delbeke, D | 1 |
Bangard, M; Bangard, N; Bender, H; Biersack, HJ; Metten, N; Mezger, J; Schomburg, A | 1 |
Abella-Columna, E; Greiss, HB; Haseman, MK; Hofer, GA; Myers, RW; Pounds, TR; Tesar, RD; Valk, PE | 1 |
Akhurst, T; Larson, SM | 1 |
Akhurst, T; Blumgart, LH; Cohen, A; Finn, RD; Fong, Y; Kemeny, N; Larson, SM; Macapinlac, H; Saldinger, PF; Yeung, H | 1 |
Daenen, F; Detroz, B; Honoré, P; Hustinx, R; Jacquet, N; Paulus, P; Rigo, P | 1 |
Baier, P; Dingeldey, A; Einert, A; Farthmann, EH; Imdahl, A; Mix, M; Nitzsche, EU; Reinhardt, MJ | 1 |
Czernin, J; Gambhir, SS; Huebner, RH; Park, KC; Phelps, ME; Schwimmer, J; Shepherd, JE | 1 |
Delbeke, D; Patton, JA; Sandler, MP | 1 |
Amthauer, H; Beier, J; Felix, R; Herbel, A; Hosten, N; Kreissig, R; Lemke, AJ; Puls, R; Rohlfing, T; Stroszczynski, C | 1 |
Bangard, M; Bender, H; Biersack, HJ; Decker, P; Grünwald, F; Willkomm, P | 1 |
Ak, I; Pauwels, EK; Stokkel, MP | 1 |
Flamen, P; Mortelmans, L; Van Cutsem, E | 1 |
Alavi, A; Duarte, PS; Pourdehnad, M; Sinha, P; Yamamoto, AJ; Zhuang, H | 1 |
Arulampalam, TH; Costa, DC; Ell, PJ; Loizidou, M; Taylor, I; Visvikis, D | 1 |
Dehdashti, F; Drebin, JA; Linehan, D; Siegel, BA; Strasberg, SM | 1 |
Czernin, JR; Gambhir, SS; Park, KC; Phelps, ME; Schiepers, C; Schwimmer, J; Shepherd, JE | 1 |
Bleichrodt, RP; Filez, L; Flamen, P; Hoekstra, OS; Homans, F; Maes, A; Mortelmans, L; Peeters, M; Penninckx, F; Stroobants, S; Van Cutsem, E | 1 |
DePalatis, LR; Desai, DC; Martin, EW; Soble, D; Zervos, EE | 1 |
Ariannejad, M; Czernin, J; Gambhir, SS; Meta, J; Phelps, ME; Schiepers, C; Seltzer, M; Silverman, DH; Valk, P | 1 |
Aerts, R; D'Hoore, A; Filez, L; Flamen, P; Mortelmans, L; Penninckx, F; Topal, B; Van Cutsem, E | 1 |
Draisma, A; Pauwels, EK; Stokkel, MP | 1 |
Haberkorn, U | 1 |
Amthauer, H; Felix, R; Schlag, PM; Stroszczynski, C | 1 |
Coates, G; Nahmias, C; Rawlinson, J; Skehan, SJ; Somers, S; Zealley, IA | 1 |
Arnold, MW; Badgwell, BD; Burak, WE; Martin, EW; Zervos, EE | 1 |
Arulampalam, T; Boulos, P; Costa, D; Ell, P; Taylor, I; Visvikis, D | 1 |
Corstens, FH; Jager, GJ; Langenhoff, BS; Neeleman, N; Oyen, WJ; Ruers, TJ; Strijk, S; Wobbes, T | 1 |
Arulampalam, TH; Bomanji, JB; Costa, DC; Ell, PJ | 1 |
Dehdashti, F; Gordon, BA; Rydzewski, B; Siegel, BA; Strasberg, SM; Teefey, SA | 1 |
Siegal, BA; Strasberg, SM | 1 |
Gambhir, SS; Park, KC; Schwimmer, J | 1 |
Cabrera Villegas, A; Gámez Cenzano, C; Martín Urreta, JC | 1 |
Bomanji, JB; Costa, DC; Ell, PJ | 1 |
Arulampalam, TH; Costa, DC; Ell, PJ; Francis, DL; Islam, MS; Mulligan, R; Taylor, I; Townsend, C; Visvikis, D | 1 |
Binns, D; Hicks, RJ; Hogg, A; Kalff, V; McKenzie, AF; Ware, RE | 1 |
Askienazy, S; Bok, B; Grall, Y; Meignan, M; Misset, JL; Rain, JD; Talbot, JN | 1 |
Nabi, HA; Zubeldia, JM | 1 |
Flamen, P | 1 |
Bellomi, M; Fazio, F; Landoni, C; Leo, F; Leon, ME; Pastorino, U; Pelosi, G; Picchio, M; Solli, PG; Sonzogni, A; Spaggiari, L; Veronesi, G | 1 |
Even-Sapir, E; Figer, A; Gutman, M; Inbar, M; Lerman, H; Livshitz, G; Rabau, M | 1 |
Dworkin, HJ; Gates, VL; Raman, S; Salem, R; Wong, CY | 1 |
Ito, K; Kato, T | 1 |
Agoston, P; Esik, O; Fekésházy, A; Galuska, L; Kálvin, B; Lengyel, E; Lengyel, Z; Szakáll, S; Székely, J; Trón, L; Várady, E | 1 |
Dimitrakopoulou, A; Engenhart, R; Haberkorn, U; Oberdorfer, F; Ostertag, H; Romahn, J; Strauss, LG; van Kaick, G | 1 |
Conti, PS; Strauss, LG | 1 |
Aaltonen, J; Brownell, AL; Karonen, SL; Korpela, H; Lindgren, J; Lindroth, L; Nikkinen, P | 1 |
105 review(s) available for fluorodeoxyglucose f18 and Colorectal Neoplasms
Article | Year |
---|---|
Molecular imaging in management of colorectal metastases by the interventional oncologist.
Topics: Colorectal Neoplasms; Fluorodeoxyglucose F18; Humans; Molecular Imaging; Neoplasm Staging; Oncologists; Positron-Emission Tomography | 2022 |
Topics: Acquired Immunodeficiency Syndrome; Acute Kidney Injury; Adult; Animals; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; beta Catenin; Biomarkers; Brain Ischemia; Brazil; Cardio-Renal Syndrome; Cholestasis, Intrahepatic; Colorectal Neoplasms; Cyclin-Dependent Kinase 8; Cytomegalovirus; Cytomegalovirus Infections; Drug Design; Female; Fluorides; Fluorine; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Ganciclovir; Glutamates; Heart; Hematopoietic Stem Cell Transplantation; Heterografts; HIV Infections; Humans; Inflammation; Ischemia; Kidney; Lower Extremity; Lymphoma, Large B-Cell, Diffuse; Male; Mice; Mice, Inbred C57BL; Monoamine Oxidase; Positron-Emission Tomography; Potassium Channels; Pregnancy; Pregnancy Complications; Prognosis; Prospective Studies; Protein Kinase Inhibitors; Pyridines; Rats; Rats, Sprague-Dawley; Reperfusion; Reperfusion Injury; Retrospective Studies; Sodium; Stem Cell Transplantation; Stroke; Structure-Activity Relationship; Systole; Tetraethylammonium; Tissue Distribution; Transplantation, Autologous; Varicose Veins; Vena Cava, Inferior | 2023 |
Fibroblast Activation Protein Inhibitor-PET Imaging in Colorectal Cancer.
Topics: Colorectal Neoplasms; Fibroblasts; Fluorodeoxyglucose F18; Gallium Radioisotopes; Humans; Immunotherapy; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography | 2023 |
Lymph nodes primary staging of colorectal cancer in 18F-FDG PET/MRI: a systematic review and meta-analysis.
Topics: Colorectal Neoplasms; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Magnetic Resonance Imaging; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity | 2023 |
Radiologic T staging of colon cancer: renewed interest for clinical practice.
Topics: Colonic Neoplasms; Colorectal Neoplasms; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiology | 2023 |
PET/CT in assessment of colorectal liver metastases: a comprehensive review with emphasis on
Topics: Colorectal Neoplasms; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals | 2023 |
[Importance of FDG-PET/computed tomography in colorectal cancer].
Topics: Colorectal Neoplasms; Fluorodeoxyglucose F18; Humans; Neoplasm Recurrence, Local; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity | 2019 |
Imaging of colorectal cancer liver metastases using contrast-enhanced US, multidetector CT, MRI, and FDG PET/CT: a meta-analysis.
Topics: Adult; Aged; Aged, 80 and over; Colorectal Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Magnetic Resonance Imaging; Male; Middle Aged; Multidetector Computed Tomography; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Sensitivity and Specificity; Ultrasonography; Young Adult | 2021 |
Image-Guided Thermal Ablation for Colorectal Liver Metastases.
Topics: Biopsy; Clinical Decision-Making; Colorectal Neoplasms; Cryosurgery; Fluorodeoxyglucose F18; Humans; Laser Therapy; Liver Neoplasms; Margins of Excision; Metastasectomy; Microwaves; Patient Selection; Positron Emission Tomography Computed Tomography; Predictive Value of Tests; Radiofrequency Ablation; Radiopharmaceuticals; Surgery, Computer-Assisted; Treatment Outcome; Tumor Burden | 2020 |
Topics: 3T3-L1 Cells; A Kinase Anchor Proteins; Acetates; Achilles Tendon; Acute Kidney Injury; Acute Pain; Acyclic Monoterpenes; Adenine Nucleotides; Adhesins, Escherichia coli; Adipocytes; Adipocytes, Brown; Adipogenesis; Administration, Inhalation; Administration, Oral; Adrenal Cortex Hormones; Adsorption; Adult; Aeromonas hydrophila; Africa; Aged; Aged, 80 and over; Agrobacterium tumefaciens; Air; Air Pollutants; Air Pollution; Air Pollution, Indoor; Algorithms; Alkaloids; Alkynes; Allosteric Regulation; Amines; Amino Acid Sequence; Amino Acids; Amino Acids, Branched-Chain; Aminoisobutyric Acids; Aminopyridines; Amyotrophic Lateral Sclerosis; Anaerobic Threshold; Angiography; Angiotensin II Type 1 Receptor Blockers; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animal Distribution; Animal Feed; Animal Nutritional Physiological Phenomena; Animals; Ankle Joint; Anti-Bacterial Agents; Anti-HIV Agents; Anti-Inflammatory Agents; Antibodies, Bacterial; Antifungal Agents; Antimalarials; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Antioxidants; Antiretroviral Therapy, Highly Active; Antiviral Agents; Aotidae; Apelin; Apoptosis; Arabidopsis Proteins; Argentina; Arginine; Artemisinins; Arthritis, Experimental; Arthritis, Rheumatoid; Arthroscopy; Aspergillus; Aspergillus niger; Asteraceae; Asthma; ATP Binding Cassette Transporter, Subfamily B, Member 1; ATP Binding Cassette Transporter, Subfamily G, Member 2; Auditory Cortex; Autoantibodies; Autophagy; Bacteria; Bacterial Infections; Bacterial Proteins; Bacterial Typing Techniques; Base Composition; Base Sequence; Basketball; Beclin-1; Benzhydryl Compounds; Benzimidazoles; Benzo(a)pyrene; Benzofurans; Benzoxazines; Bereavement; beta Catenin; beta-Lactamase Inhibitors; beta-Lactamases; beta-Lactams; Betacoronavirus; Betaine; Binding Sites; Biofilms; Biological Assay; Biological Availability; Biological Evolution; Biomarkers; Biomechanical Phenomena; Biopolymers; Biopsy; Bismuth; Blood Glucose; Blood Platelets; Blood Pressure; Body Composition; Body Weight; Bone Marrow; Bone Marrow Cells; Bone Regeneration; Boron; Botrytis; Brain Ischemia; Brain Neoplasms; Brain-Derived Neurotrophic Factor; Brazil; Breast Neoplasms; Breath Tests; Bronchoalveolar Lavage Fluid; Burkholderia; C-Reactive Protein; Caenorhabditis elegans; Caenorhabditis elegans Proteins; Calcification, Physiologic; Calcium; Calcium Signaling; Calorimetry, Differential Scanning; Cameroon; Camptothecin; Candida; Candida albicans; Capillaries; Carbapenem-Resistant Enterobacteriaceae; Carbapenems; Carbohydrate Conformation; Carbon; Carbon Dioxide; Carbon Isotopes; Carcinoma, Ovarian Epithelial; Cardiac Output; Cardiomyopathy, Hypertrophic; Cardiotonic Agents; Cardiovascular Diseases; Caregivers; Carps; Case-Control Studies; Catalase; Catalysis; Cats; CD4 Lymphocyte Count; Cell Culture Techniques; Cell Differentiation; Cell Line, Tumor; Cell Membrane; Cell Movement; Cell Proliferation; Cell Survival; Cells, Cultured; Cellulose; Centrosome; Ceratopogonidae; Chickens; Child; China; Cholera Toxin; Choline; Cholinesterases; Chromatography, High Pressure Liquid; Chromatography, Liquid; Chromatography, Micellar Electrokinetic Capillary; Chromatography, Reverse-Phase; Chronic Disease; Cinnamates; Cities; Citrates; Climate Change; Clinical Trials, Phase III as Topic; Coal; Coal Mining; Cohort Studies; Coinfection; Colchicine; Colony Count, Microbial; Colorectal Neoplasms; Coloring Agents; Common Cold; Complement Factor H; Computational Biology; Computer Simulation; Continuous Positive Airway Pressure; Contrast Media; Coordination Complexes; Coronary Artery Bypass; Coronavirus 3C Proteases; Coronavirus Infections; Coronavirus Protease Inhibitors; Corynebacterium glutamicum; Cosmetics; COVID-19; Creatinine; Cross-Sectional Studies; Crotonates; Crystallography, X-Ray; Cues; Culicidae; Culture Media; Curcuma; Cyclopentanes; Cyclopropanes; Cymbopogon; Cystine; Cytochrome P-450 CYP2B6; Cytochrome P-450 CYP2C19; Cytochrome P-450 CYP2C19 Inhibitors; Cytokines; Databases, Genetic; Death; Dendritic Cells; Density Functional Theory; Depsides; Diabetes Mellitus, Type 2; Diamond; Diarylheptanoids; Dibenzofurans; Dibenzofurans, Polychlorinated; Diclofenac; Diet; Dietary Carbohydrates; Dietary Supplements; Diffusion Magnetic Resonance Imaging; Dioxins; Diphenylamine; Disease Outbreaks; Disease Susceptibility; Disulfides; Dithiothreitol; Dizocilpine Maleate; DNA Methylation; DNA-Binding Proteins; DNA, Bacterial; Dogs; Dose-Response Relationship, Drug; Double-Blind Method; Doublecortin Protein; Drosophila melanogaster; Droughts; Drug Carriers; Drug Combinations; Drug Delivery Systems; Drug Liberation; Drug Resistance; Drug Resistance, Bacterial; Drug Resistance, Neoplasm; Drug Screening Assays, Antitumor; Dust; Dynactin Complex; Dysferlin; Echo-Planar Imaging; Echocardiography; Edaravone; Egypt; Elasticity; Electrodes; Electrolytes; Emodin; Emtricitabine; Endometriosis; Endothelium, Vascular; Endotoxins; Energy Metabolism; Energy Transfer; Enterobacteriaceae; Enterococcus faecalis; Enterotoxigenic Escherichia coli; Environmental Monitoring; Enzyme Inhibitors; Epidemiologic Factors; Epigenesis, Genetic; Erythrocytes; Escherichia coli; Escherichia coli Infections; Escherichia coli Vaccines; Esophageal Neoplasms; Esophagectomy; Esophagogastric Junction; Esterases; Esterification; Ethanol; Ethiopia; Ethnicity; Eucalyptus; Evidence-Based Practice; Exercise; Exercise Tolerance; Extracorporeal Membrane Oxygenation; Family; Fatty Acids; Feedback; Female; Ferric Compounds; Fibrin Fibrinogen Degradation Products; Filtration; Fish Diseases; Flavonoids; Flavonols; Fluorodeoxyglucose F18; Follow-Up Studies; Food Microbiology; Food Preservation; Forests; Fossils; Free Radical Scavengers; Freund's Adjuvant; Fruit; Fungi; Gallium; Gender Identity; Gene Expression Regulation; Gene Expression Regulation, Neoplastic; Gene Expression Regulation, Plant; Gene Knockdown Techniques; Genes, Bacterial; Genes, Plant; Genetic Predisposition to Disease; Genitalia; Genotype; Glomerulonephritis, IGA; Glottis; Glucocorticoids; Glucose; Glucuronides; Glutathione Transferase; Glycogen Synthase Kinase 3 beta; Gram-Negative Bacterial Infections; Gram-Positive Bacterial Infections; Grassland; Guinea Pigs; Half-Life; Head Kidney; Heart Atria; Heart Rate; Heart Septum; HEK293 Cells; Hematopoietic Stem Cells; Hemodynamics; Hep G2 Cells; Hepacivirus; Hepatitis C; Hepatitis C, Chronic; Hepatocytes; Hesperidin; High-Frequency Ventilation; High-Temperature Requirement A Serine Peptidase 1; Hippocampus; Hirudins; History, 20th Century; History, 21st Century; HIV Infections; Homeostasis; Hominidae; Housing, Animal; Humans; Hydrocarbons, Brominated; Hydrogen Bonding; Hydrogen Peroxide; Hydrogen-Ion Concentration; Hydroxybutyrates; Hydroxyl Radical; Hypertension; Hypothyroidism; Image Interpretation, Computer-Assisted; Immunoconjugates; Immunogenic Cell Death; Indoles; Infant, Newborn; Infant, Premature; Infarction, Middle Cerebral Artery; Inflammation; Inflammation Mediators; Infrared Rays; Inhibitory Concentration 50; Injections, Intravenous; Interferon-gamma; Interleukin-23; Interleukin-4; Interleukin-6; Intermediate Filaments; Intermittent Claudication; Intestine, Small; Iridoid Glucosides; Iridoids; Iron; Isomerism; Isotope Labeling; Isoxazoles; Itraconazole; Kelch-Like ECH-Associated Protein 1; Ketoprofen; Kidney Failure, Chronic; Kinetics; Klebsiella pneumoniae; Lactams, Macrocyclic; Lactobacillus; Lactulose; Lakes; Lamivudine; Laparoscopy; Laparotomy; Laryngoscopy; Leucine; Limit of Detection; Linear Models; Lipid A; Lipopolysaccharides; Listeria monocytogenes; Liver; Liver Cirrhosis; Logistic Models; Longitudinal Studies; Losartan; Low Back Pain; Lung; Lupinus; Lupus Erythematosus, Systemic; Machine Learning; Macular Degeneration; Madin Darby Canine Kidney Cells; Magnetic Phenomena; Magnetic Resonance Imaging; Magnetic Resonance Spectroscopy; Magnetics; Malaria, Falciparum; Male; Mannans; MAP Kinase Signaling System; Mass Spectrometry; Melatonin; Membrane Glycoproteins; Membrane Proteins; Meniscectomy; Menisci, Tibial; Mephenytoin; Mesenchymal Stem Cells; Metal Nanoparticles; Metal-Organic Frameworks; Methionine; Mice; Mice, Inbred C57BL; Mice, Knockout; Mice, Nude; Mice, Obese; Mice, Transgenic; Microbial Sensitivity Tests; Microcirculation; MicroRNAs; Microscopy, Video; Microtubules; Microvascular Density; Microwaves; Middle Aged; Minimally Invasive Surgical Procedures; Models, Animal; Models, Biological; Models, Molecular; Models, Theoretical; Molecular Docking Simulation; Molecular Structure; Molecular Weight; Morus; Mouth Floor; Multicenter Studies as Topic; Multiple Sclerosis; Multiple Sclerosis, Relapsing-Remitting; Muscle, Skeletal; Myocardial Ischemia; Myocardium; NAD; NADP; Nanocomposites; Nanoparticles; Naphthols; Nasal Lavage Fluid; Nasal Mucosa; Neisseria meningitidis; Neoadjuvant Therapy; Neoplasm Invasiveness; Neoplasm Recurrence, Local; Neoplasms, Experimental; Neural Stem Cells; Neuroblastoma; Neurofilament Proteins; Neurogenesis; Neurons; New York; NF-E2-Related Factor 2; NF-kappa B; Nicotine; Nitriles; Nitrogen; Nitrogen Fixation; North America; Observer Variation; Occupational Exposure; Ochrobactrum; Oils, Volatile; Olea; Oligosaccharides; Omeprazole; Open Field Test; Optimism; Oregon; Oryzias; Osmolar Concentration; Osteoarthritis; Osteoblasts; Osteogenesis; Ovarian Neoplasms; Ovariectomy; Oxadiazoles; Oxidation-Reduction; Oxidative Stress; Oxygen; Ozone; p38 Mitogen-Activated Protein Kinases; Pakistan; Pandemics; Particle Size; Particulate Matter; Patient-Centered Care; Pelargonium; Peptides; Perception; Peripheral Arterial Disease; Peroxides; Pets; Pharmaceutical Preparations; Pharmacogenetics; Phenobarbital; Phenols; Phenotype; Phosphates; Phosphatidylethanolamines; Phosphines; Phospholipids; Phosphorus; Phosphorylation; Photoacoustic Techniques; Photochemotherapy; Photosensitizing Agents; Phylogeny; Phytoestrogens; Pilot Projects; Plant Components, Aerial; Plant Extracts; Plant Immunity; Plant Leaves; Plant Oils; Plants, Medicinal; Plasmodium berghei; Plasmodium falciparum; Platelet Activation; Platelet Function Tests; Pneumonia, Viral; Poaceae; Pogostemon; Poloxamer; Poly I; Poly(ADP-ribose) Polymerase Inhibitors; Polychlorinated Biphenyls; Polychlorinated Dibenzodioxins; Polycyclic Compounds; Polyethylene Glycols; Polylysine; Polymorphism, Genetic; Polymorphism, Single Nucleotide; Population Dynamics; Portasystemic Shunt, Transjugular Intrahepatic; Positron Emission Tomography Computed Tomography; Postoperative Complications; Postprandial Period; Potassium Cyanide; Predictive Value of Tests; Prefrontal Cortex; Pregnancy; Prepulse Inhibition; Prevalence; Procalcitonin; Prodrugs; Prognosis; Progression-Free Survival; Proline; Proof of Concept Study; Prospective Studies; Protein Binding; Protein Conformation; Protein Domains; Protein Folding; Protein Multimerization; Protein Sorting Signals; Protein Structure, Secondary; Proton Pump Inhibitors; Protozoan Proteins; Psychometrics; Pulse Wave Analysis; Pyridines; Pyrrolidines; Quality of Life; Quantum Dots; Quinoxalines; Quorum Sensing; Radiopharmaceuticals; Rain; Random Allocation; Randomized Controlled Trials as Topic; Rats; Rats, Sprague-Dawley; Rats, Wistar; RAW 264.7 Cells; Reactive Oxygen Species; Receptor, Angiotensin, Type 1; Receptor, PAR-1; Receptors, CXCR4; Receptors, Estrogen; Receptors, Glucocorticoid; Receptors, Interleukin-1; Receptors, Interleukin-17; Receptors, Notch; Recombinant Fusion Proteins; Recombinant Proteins; Reducing Agents; Reflex, Startle; Regional Blood Flow; Regression Analysis; Reperfusion Injury; Reproducibility of Results; Republic of Korea; Respiratory Tract Diseases; Retrospective Studies; Reverse Transcriptase Inhibitors; Rhinitis, Allergic; Risk Assessment; Risk Factors; Rituximab; RNA, Messenger; RNA, Ribosomal, 16S; ROC Curve; Rosmarinic Acid; Running; Ruthenium; Rutin; Sarcolemma; Sarcoma; Sarcopenia; Sarcoplasmic Reticulum; SARS-CoV-2; Scavenger Receptors, Class A; Schools; Seasons; Seeds; Sequence Analysis, DNA; Severity of Illness Index; Sex Factors; Shock, Cardiogenic; Short Chain Dehydrogenase-Reductases; Signal Transduction; Silver; Singlet Oxygen; Sinusitis; Skin; Skin Absorption; Small Molecule Libraries; Smoke; Socioeconomic Factors; Soil; Soil Microbiology; Solid Phase Extraction; Solubility; Solvents; Spain; Spectrometry, Mass, Electrospray Ionization; Spectroscopy, Fourier Transform Infrared; Speech; Speech Perception; Spindle Poles; Spleen; Sporothrix; Staphylococcal Infections; Staphylococcus aureus; Stereoisomerism; Stomach Neoplasms; Stress, Physiological; Stroke Volume; Structure-Activity Relationship; Substrate Specificity; Sulfonamides; Surface Properties; Surface-Active Agents; Surveys and Questionnaires; Survival Rate; T-Lymphocytes, Cytotoxic; Tandem Mass Spectrometry; Temperature; Tenofovir; Terpenes; Tetracycline; Tetrapleura; Textiles; Thermodynamics; Thiobarbituric Acid Reactive Substances; Thrombin; Thyroid Hormones; Thyroid Neoplasms; Tibial Meniscus Injuries; Time Factors; Tissue Distribution; Titanium; Toluidines; Tomography, X-Ray Computed; Tooth; Tramadol; Transcription Factor AP-1; Transcription, Genetic; Transfection; Transgender Persons; Translations; Treatment Outcome; Triglycerides; Ubiquinone; Ubiquitin-Specific Proteases; United Kingdom; United States; Up-Regulation; Vascular Stiffness; Veins; Ventricular Remodeling; Viral Load; Virulence Factors; Virus Replication; Vitis; Voice; Voice Quality; Wastewater; Water; Water Pollutants, Chemical; Water-Electrolyte Balance; Weather; Wildfires; Wnt Signaling Pathway; Wound Healing; X-Ray Diffraction; Xenograft Model Antitumor Assays; Young Adult; Zoogloea | 2022 |
Prognostic Significance of Pretreatment 18F-FDG PET/CT Volumetric Parameters in Patients With Colorectal Liver Metastasis: A Systematic Review and Meta-analysis.
Topics: Colorectal Neoplasms; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Positron Emission Tomography Computed Tomography; Prognosis | 2021 |
Incidental colorectal FDG uptake on PET/CT scan and lesions observed during subsequent colonoscopy: a systematic review.
Topics: Aged; Colonoscopy; Colorectal Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Incidental Findings; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals | 2017 |
Present and future roles of FDG-PET/CT imaging in the management of gastrointestinal cancer: an update.
Topics: Animals; Colorectal Neoplasms; Fluorodeoxyglucose F18; Gastrointestinal Neoplasms; Humans; Positron Emission Tomography Computed Tomography; Stomach Neoplasms; Tomography, X-Ray Computed | 2017 |
Diagnostic accuracy of F-18 FDG PET/CT for characterization of colorectal focal FDG uptake: a systematic review and meta-analysis.
Topics: Colorectal Neoplasms; Fluorodeoxyglucose F18; Humans; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity | 2019 |
Diagnostic performance of F-18 FDG PET/CT for prediction of KRAS mutation in colorectal cancer patients: a systematic review and meta-analysis.
Topics: Colorectal Neoplasms; Fluorodeoxyglucose F18; Humans; Mutation; Positron Emission Tomography Computed Tomography; Predictive Value of Tests; Proto-Oncogene Proteins p21(ras); Radiopharmaceuticals | 2019 |
Simultaneous positron emission tomography and magnetic resonance imaging for the detection and characterisation of liver lesions in patients with colorectal cancer: A pictorial review.
Topics: Colorectal Neoplasms; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Magnetic Resonance Imaging; Multimodal Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Whole Body Imaging | 2019 |
Use of FDG-PET or PET/CT to detect recurrent colorectal cancer in patients with elevated CEA: a systematic review and meta-analysis.
Topics: Carcinoembryonic Antigen; Colorectal Neoplasms; Fluorodeoxyglucose F18; Humans; Multimodal Imaging; Neoplasm Recurrence, Local; Positron-Emission Tomography; ROC Curve; Tomography, X-Ray Computed | 2013 |
[Clinical use of 18F-FDG PET/CT in colorectal carcinoma].
Topics: Carcinoma; Colorectal Neoplasms; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Neoplasm Recurrence, Local; Neoplasm Staging; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Tomography, X-Ray Computed; Treatment Outcome | 2013 |
The role of 18F-FDG-PET and PET/CT in patients with colorectal liver metastases undergoing selective internal radiation therapy with yttrium-90: a first evidence-based review.
Topics: Colorectal Neoplasms; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Positron-Emission Tomography; Prognosis; Tomography, X-Ray Computed; Treatment Outcome; Yttrium Radioisotopes | 2014 |
Incidentally detected increased FDG uptake in bowel and its correlation with hystopathological data: our experience in a case series study.
Topics: Adenocarcinoma; Case-Control Studies; Colonoscopy; Colorectal Neoplasms; Fluorodeoxyglucose F18; Humans; Incidental Findings; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies; Whole Body Imaging | 2014 |
Diagnostic accuracy and impact on management of (18)F-FDG PET and PET/CT in colorectal liver metastasis: a meta-analysis and systematic review.
Topics: Colorectal Neoplasms; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Magnetic Resonance Imaging; Multimodal Imaging; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Tomography, X-Ray Computed | 2015 |
FDG PET/CT in the management of colorectal and anal cancers.
Topics: Adult; Aged; Anus Neoplasms; Colorectal Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Multimodal Imaging; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Tomography, X-Ray Computed | 2014 |
Diagnostic Value of (18)F-FDG PET/CT in Detecting Local Recurrent Colorectal Cancer: A Pooled Analysis of 26 Individual Studies.
Topics: Colorectal Neoplasms; Fluorodeoxyglucose F18; Humans; Neoplasm Recurrence, Local; Positron Emission Tomography Computed Tomography; Predictive Value of Tests; Radiopharmaceuticals | 2015 |
Bevacizumab-based neoadjuvant chemotherapy for colorectal cancer liver metastases: Pitfalls and helpful tricks in a review for clinicians.
Topics: Bevacizumab; Colorectal Neoplasms; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Neoadjuvant Therapy; Positron Emission Tomography Computed Tomography; Treatment Outcome | 2015 |
[18F]Fluorodeoxyglucose PET/Computed Tomography in Gastrointestinal Malignancies.
Topics: Colorectal Neoplasms; Fluorodeoxyglucose F18; Gastrointestinal Neoplasms; Humans; Liver Neoplasms; Multimodal Imaging; Neoplasm Recurrence, Local; Neoplasm Staging; Pancreatic Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Stomach Neoplasms; Tomography, X-Ray Computed | 2014 |
Impact of Fluorodeoxyglucose PET/Computed Tomography on the Management of Patients with Colorectal Cancer.
Topics: Colorectal Neoplasms; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Multimodal Imaging; Neoplasm Recurrence, Local; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed | 2015 |
Prognostic significance of (18)FDG PET/CT in colorectal cancer patients with liver metastases: a meta-analysis.
Topics: Colorectal Neoplasms; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Survival Analysis; Tomography, X-Ray Computed | 2015 |
[Positron emission tomography/computed tomography in follow-up programmes for patients with colorectal cancer].
Topics: Aftercare; Colorectal Neoplasms; Fluorodeoxyglucose F18; Humans; Neoplasm Recurrence, Local; Positron Emission Tomography Computed Tomography; Practice Guidelines as Topic; Radiopharmaceuticals | 2016 |
[Imaging in the diagnosis of colorectal liver metastases and extrahepatic abnormalities].
Topics: Colorectal Neoplasms; Diagnosis, Differential; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Lung Neoplasms; Magnetic Resonance Imaging; Radiography; Tomography, Emission-Computed; Ultrasonography | 2008 |
[Role of sentinel lymph nodes and lymphatic mapping of colorectal cancer].
Topics: Colorectal Neoplasms; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Lymphatic Metastasis; Neoplasm Staging; Positron-Emission Tomography; Sensitivity and Specificity; Sentinel Lymph Node Biopsy | 2005 |
Diagnostic value of FDG-PET in recurrent colorectal carcinoma: a meta-analysis.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma; Colorectal Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Recurrence; ROC Curve; Sensitivity and Specificity | 2009 |
PET/CT imaging in the diagnosis, staging, and follow-up of colorectal cancer.
Topics: Colorectal Neoplasms; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Neoplasm Staging; Positron-Emission Tomography; Tomography, X-Ray Computed | 2008 |
Established, emerging and future roles of PET/CT in the management of colorectal cancer.
Topics: Colonoscopy; Colorectal Neoplasms; Cost-Benefit Analysis; Fluorodeoxyglucose F18; Humans; Neoplasm Recurrence, Local; Neoplasm Staging; Neoplasm, Residual; Positron-Emission Tomography; Radiopharmaceuticals; Radiotherapy Planning, Computer-Assisted; Sensitivity and Specificity; Tomography, X-Ray Computed; United Kingdom | 2009 |
Controversies in the management of colorectal liver metastases: role of PET and PET/CT.
Topics: Biopsy, Needle; Catheter Ablation; Chemotherapy, Adjuvant; Colorectal Neoplasms; Cryosurgery; Diagnostic Imaging; Female; Fluorodeoxyglucose F18; Hepatectomy; Humans; Liver Neoplasms; Magnetic Resonance Imaging; Male; Neoadjuvant Therapy; Neoplasm Staging; Positron-Emission Tomography; Preoperative Care; Prognosis; Risk Assessment; Sensitivity and Specificity; Survival Analysis; Tomography, X-Ray Computed; Treatment Outcome | 2008 |
Monitoring and predicting response to therapy with 18F-FDG PET in colorectal cancer: a systematic review.
Topics: Colorectal Neoplasms; Fluorodeoxyglucose F18; Humans; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Subtraction Technique; Treatment Outcome | 2009 |
[18F]FDG PET/CT imaging of colorectal cancer: a pictorial review.
Topics: Colorectal Neoplasms; Fluorodeoxyglucose F18; Humans; Neoplasm Staging; Positron-Emission Tomography; Tomography, X-Ray Computed; Treatment Outcome | 2010 |
Incidental focal hypermetabolic colorectal lesions identified by positron emission tomography: prevalence of malignancy.
Topics: Colorectal Neoplasms; Fluorodeoxyglucose F18; Humans; Incidental Findings; Positron-Emission Tomography; Prevalence; Radiopharmaceuticals; United States; Whole Body Imaging | 2011 |
The role of functional imaging in colorectal cancer.
Topics: Colorectal Neoplasms; Contrast Media; Diffusion Magnetic Resonance Imaging; Fluorodeoxyglucose F18; Humans; Imaging, Three-Dimensional; Lymphatic Metastasis; Neoplasm Recurrence, Local; Neovascularization, Pathologic; Patient Selection; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed; Whole Body Imaging | 2010 |
Positron emission tomography and colorectal cancer.
Topics: Colorectal Neoplasms; Early Detection of Cancer; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Neoplasm Staging; Positron-Emission Tomography; Prognosis | 2011 |
Diagnostic imaging of colorectal liver metastases with CT, MR imaging, FDG PET, and/or FDG PET/CT: a meta-analysis of prospective studies including patients who have not previously undergone treatment.
Topics: Colorectal Neoplasms; Contrast Media; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Magnetic Resonance Imaging; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, X-Ray Computed | 2010 |
Role of FDG-PET staging in selecting the optimum patient for hepatic resection of metastatic colorectal cancer.
Topics: Colorectal Neoplasms; Fluorodeoxyglucose F18; Hepatectomy; Humans; Liver Neoplasms; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals | 2010 |
Positron emission tomography for benign and malignant disease.
Topics: Breast Neoplasms; Colorectal Neoplasms; Dermatitis, Contact; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Lung Neoplasms; Male; Melanoma; Neoplasm Metastasis; Neoplasm Recurrence, Local; Neoplasms; Positron-Emission Tomography; Prostatic Neoplasms; Radiopharmaceuticals; Sensitivity and Specificity; Solitary Pulmonary Nodule; Tomography, X-Ray Computed | 2011 |
Molecular imaging using positron emission tomography in colorectal cancer.
Topics: Colorectal Neoplasms; Fluorodeoxyglucose F18; Humans; Molecular Imaging; Neoplasm Staging; Positron-Emission Tomography; Radiography; Radiotherapy Planning, Computer-Assisted | 2011 |
The value of FDG positron emission tomography/computerised tomography (PET/CT) in pre-operative staging of colorectal cancer: a systematic review and economic evaluation.
Topics: Cohort Studies; Colorectal Neoplasms; Cost-Benefit Analysis; Fluorodeoxyglucose F18; Humans; Monte Carlo Method; Multimodal Imaging; Neoplasm Staging; Positron-Emission Tomography; Preoperative Period; Quality-Adjusted Life Years; Radiopharmaceuticals; Randomized Controlled Trials as Topic; Sensitivity and Specificity; Tomography, X-Ray Computed | 2011 |
Optimizing the role of FDG PET-CT for potentially operable metastatic colorectal cancer.
Topics: Carcinoembryonic Antigen; Colonography, Computed Tomographic; Colorectal Neoplasms; Cost-Benefit Analysis; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Multimodal Imaging; Neoplasm Invasiveness; Neoplasm Recurrence, Local; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, X-Ray Computed | 2012 |
Preoperative imaging of colorectal liver metastases after neoadjuvant chemotherapy: a meta-analysis.
Topics: Colorectal Neoplasms; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Magnetic Resonance Imaging; Multimodal Imaging; Neoadjuvant Therapy; Positron-Emission Tomography; Sensitivity and Specificity; Tomography, X-Ray Computed | 2012 |
Clinical applications of (18)F-FDG PET in the management of hepatobiliary and pancreatic tumors.
Topics: Adenocarcinoma; Bile Duct Neoplasms; Bile Ducts, Intrahepatic; Biliary Tract Neoplasms; Carcinoma, Hepatocellular; Cholangiocarcinoma; Colorectal Neoplasms; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Liver Neoplasms; Multimodal Imaging; Pancreatic Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed | 2012 |
FDG-PET for detecting local tumor recurrence of ablated liver metastases: a diagnostic meta-analysis.
Topics: Area Under Curve; Catheter Ablation; Colorectal Neoplasms; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Multimodal Imaging; Neoplasm Recurrence, Local; Positron-Emission Tomography; Radiopharmaceuticals; Radiosurgery; ROC Curve; Tomography, X-Ray Computed | 2012 |
A systematic review and meta-analysis of pretherapeutic lymph node staging of colorectal cancer by 18F-FDG PET or PET/CT.
Topics: Colorectal Neoplasms; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Multimodal Imaging; Neoplasm Staging; Positron-Emission Tomography; Tomography, X-Ray Computed | 2012 |
Update on gastrointestinal imaging.
Topics: Cholangiography; Choledochal Cyst; Colonography, Computed Tomographic; Colorectal Neoplasms; Fluorodeoxyglucose F18; Gallstones; Gastrointestinal Diseases; Humans; Magnetic Resonance Imaging; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, Emission-Computed | 2002 |
Positron emission tomography for evaluation of colorectal carcinoma.
Topics: Carcinoma; Colorectal Neoplasms; Cost-Benefit Analysis; Fluorodeoxyglucose F18; Humans; Neoplasm Metastasis; Neoplasm Recurrence, Local; Neoplasm Staging; Radiopharmaceuticals; Tomography, Emission-Computed | 2002 |
[A proposal for the rational use of the PET in oncology].
Topics: Brain Neoplasms; Colorectal Neoplasms; Consensus; Cost-Benefit Analysis; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Lung Neoplasms; Lymphoma; Melanoma; Neoplasms; Practice Guidelines as Topic; Radiopharmaceuticals; Sensitivity and Specificity; Solitary Pulmonary Nodule; Spain; Tomography, Emission-Computed | 2002 |
[Cost-effective PET investigations in oncology].
Topics: Breast Neoplasms; Carcinoma, Non-Small-Cell Lung; Colorectal Neoplasms; Cost-Benefit Analysis; Diagnosis, Differential; Esophageal Neoplasms; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Hungary; Lung Neoplasms; Lymphoma; Medicare; Melanoma; Neoplasm Staging; Neoplasms; Predictive Value of Tests; Radiopharmaceuticals; Solitary Pulmonary Nodule; Tomography, Emission-Computed; Tomography, X-Ray Computed; United States | 2002 |
[18F-fluorodeoxyglucose positron emission tomography in colorectal cancer: value in primary staging and follow-up].
Topics: Colorectal Neoplasms; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Neoplasm Staging; Radiopharmaceuticals; Tomography, Emission-Computed | 2002 |
18F-FDG PET evaluation of the response to therapy for lymphoma and for breast, lung, and colorectal carcinoma.
Topics: Breast Neoplasms; Carcinoma, Non-Small-Cell Lung; Colorectal Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymphoma; Male; Predictive Value of Tests; Radionuclide Imaging; Radiopharmaceuticals; Sensitivity and Specificity; Treatment Outcome | 2003 |
[Combined functional and morphological imaging with PET/CT systems].
Topics: Carcinoma, Bronchogenic; Colorectal Neoplasms; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymphatic Metastasis; Neoplasms; Radiopharmaceuticals; Time Factors; Tomography, Emission-Computed; Tomography, X-Ray Computed | 2003 |
[Standards, Options and Recommendations for the use of PET-FDG in cancerology. Results in digestive system neoplasms].
Topics: Colorectal Neoplasms; Digestive System Neoplasms; Esophageal Neoplasms; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Neuroendocrine Tumors; Pancreatic Neoplasms; Radiopharmaceuticals; Stomach Neoplasms; Tomography, Emission-Computed | 2003 |
18F-Fluoro-2-deoxyglucose positron emission tomography in the evaluation of gastrointestinal malignancies.
Topics: Adult; Colorectal Neoplasms; Digestive System Neoplasms; Esophageal Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Pancreatic Neoplasms; Radiopharmaceuticals; Stomach Neoplasms; Tomography, Emission-Computed | 2003 |
[Diagnosis of colorectal cancer with FDG-PET].
Topics: Colorectal Neoplasms; Diagnosis, Differential; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Neoplasm Metastasis; Neoplasm Recurrence, Local; Radiopharmaceuticals; Tomography, Emission-Computed | 2003 |
The role of positron emission tomography in the management of colorectal cancer.
Topics: Colorectal Neoplasms; Fluorodeoxyglucose F18; Humans; Neoplasm Metastasis; Neoplasm Recurrence, Local; Radiography; Radiopharmaceuticals; Tomography, Emission-Computed | 2004 |
[Positron-emission tomography in oncology].
Topics: Colorectal Neoplasms; Evidence-Based Medicine; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Lung Neoplasms; Lymphoma; Melanoma; Neoplasms; Neoplasms, Unknown Primary; Neuroendocrine Tumors; Predictive Value of Tests; Radiopharmaceuticals; Tomography, Emission-Computed | 2003 |
Positron emission tomography and colorectal carcinoma: an update.
Topics: Adenocarcinoma; Colorectal Neoplasms; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Lymphatic Metastasis; Mass Screening; Neoplasm Invasiveness; Neoplasm Recurrence, Local; Neoplasm Staging; Radiopharmaceuticals; Tomography, Emission-Computed | 2004 |
PET and PET-CT for evaluation of colorectal carcinoma.
Topics: Colorectal Neoplasms; Fluorodeoxyglucose F18; Humans; Image Interpretation, Computer-Assisted; Neoplasm Recurrence, Local; Neoplasm Staging; Prognosis; Radiopharmaceuticals; Subtraction Technique; Tomography, Emission-Computed; Tomography, X-Ray Computed; Treatment Outcome | 2004 |
Role of FDG-PET in the diagnosis and treatment of colorectal liver metastases.
Topics: Colorectal Neoplasms; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Neoplasm Recurrence, Local; Patient Care Planning; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, Emission-Computed; Tomography, X-Ray Computed | 2004 |
PET imaging in assessing gastrointestinal tumors.
Topics: Carcinoma; Colorectal Neoplasms; Esophageal Neoplasms; Fluorodeoxyglucose F18; Gastrointestinal Neoplasms; Humans; Neoplasm Staging; Pancreatic Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals | 2004 |
[Fluorine-18-2-deoxy-2-fluoro-D-glucose positron emission tomography in colorectal cancer].
Topics: Colorectal Neoplasms; Fluorodeoxyglucose F18; Humans; Positron-Emission Tomography; Radiopharmaceuticals | 2005 |
PET/CT in oncology: a major technology for cancer care.
Topics: Brain Neoplasms; Colorectal Neoplasms; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Lung Neoplasms; Lymphoma; Neoplasms; Positron-Emission Tomography; Thyroid Neoplasms; Tomography, X-Ray Computed | 2005 |
Colorectal liver metastases: CT, MR imaging, and PET for diagnosis--meta-analysis.
Topics: Colorectal Neoplasms; Fluorodeoxyglucose F18; Gadolinium; Humans; Liver Neoplasms; Magnetic Resonance Imaging; Positron-Emission Tomography; Sensitivity and Specificity; Tomography, Spiral Computed; Tomography, X-Ray Computed | 2005 |
PET-scan in colorectal cancer.
Topics: Colorectal Neoplasms; Fluorodeoxyglucose F18; Glucose; Humans; Neoplasm Recurrence, Local; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals | 2005 |
[Combined role of tumor markers and 18fluoro-deoxyglucose-positron emission tomography (18FDG-PET) in follow-up of cancer patients].
Topics: Biomarkers, Tumor; Breast Neoplasms; Colorectal Neoplasms; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Male; Neoplasm Metastasis; Ovarian Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals | 2005 |
The impact of fluor-18-deoxyglucose-positron emission tomography in the management of colorectal liver metastases.
Topics: Colorectal Neoplasms; Female; Fluorodeoxyglucose F18; Hepatectomy; Humans; Liver Neoplasms; Male; Neoplasm Recurrence, Local; Neoplasm Staging; Positron-Emission Tomography; Prognosis; Risk Assessment; Sensitivity and Specificity; Survival Analysis; Treatment Outcome | 2005 |
PET imaging for evaluation of metastatic colorectal cancer of the liver.
Topics: Aged; Colorectal Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Liver; Liver Neoplasms; Male; Middle Aged; Neoplasm Recurrence, Local; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, X-Ray Computed | 2006 |
Gastrointestinal tract malignancies and positron emission tomography: an overview.
Topics: Colorectal Neoplasms; Esophageal Neoplasms; Fluorodeoxyglucose F18; Humans; Neoplasm Recurrence, Local; Positron-Emission Tomography; Radiopharmaceuticals; Stomach Neoplasms; Tomography, X-Ray Computed | 2006 |
PET and PET/CT using 18F-FDG in the diagnosis and management of cancer patients.
Topics: Breast Neoplasms; Carcinoma; Colorectal Neoplasms; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymphoma; Neoplasm Staging; Neoplasms; Positron-Emission Tomography; Tomography, Emission-Computed; Whole Body Imaging | 2006 |
The role of positron emission tomography in the management of recurrent colorectal cancer: a review.
Topics: Colorectal Neoplasms; Diagnosis, Differential; Fluorodeoxyglucose F18; Humans; Neoplasm Recurrence, Local; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity | 2007 |
The role of 18F-fluoro-deoxy-glucose positron emission tomography (FDG-PET) in the management of patients with colorectal cancer.
Topics: Colorectal Neoplasms; Diagnosis, Differential; Fluorodeoxyglucose F18; Humans; Neoplasm Recurrence, Local; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity | 2007 |
[Recommendations for clinical practice: use of TEP-FDG in cancer of the esophagus, stomach, colon and rectum, anal canal, large intestine, pancreas and bile ducts, liver and endocrine tumors (digestive system)].
Topics: Anus Neoplasms; Bile Duct Neoplasms; Colorectal Neoplasms; Digestive System Neoplasms; Endocrine Gland Neoplasms; Esophageal Neoplasms; Fluorodeoxyglucose F18; Gastrointestinal Neoplasms; Humans; Intestine, Large; Liver Neoplasms; Pancreatic Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Stomach Neoplasms | 2007 |
The expanding role of PET technology in the management of patients with colorectal cancer.
Topics: Colorectal Neoplasms; Female; Fluorodeoxyglucose F18; Forecasting; Humans; Immunohistochemistry; Male; Neoplasm Recurrence, Local; Neoplasm Staging; Positron-Emission Tomography; Prognosis; Risk Factors; Role; Sensitivity and Specificity; Survival Analysis | 2007 |
Detection and management of extrahepatic colorectal cancer in patients with resectable liver metastases.
Topics: Colorectal Neoplasms; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Lung Neoplasms; Lymph Node Excision; Lymphatic Metastasis; Peritoneal Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed | 2007 |
PET/CT in oncology: for which tumours is it the reference standard?
Topics: Breast Neoplasms; Colorectal Neoplasms; Contrast Media; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Lung Neoplasms; Lymphoma; Neoplasm Metastasis; Neoplasm Recurrence, Local; Neoplasm Staging; Neoplasms; Radiopharmaceuticals; Reference Standards; Sensitivity and Specificity; Tomography, Emission-Computed; Tomography, X-Ray Computed | 2007 |
Colorectal cancer: imaging surveillance following resection of primary tumour.
Topics: Biomarkers, Tumor; Carcinoembryonic Antigen; Colonography, Computed Tomographic; Colorectal Neoplasms; Contrast Media; Diagnostic Imaging; Fluorodeoxyglucose F18; Humans; Neoplasm Recurrence, Local; Neoplasm Staging; Practice Guidelines as Topic; Radiopharmaceuticals; Sensitivity and Specificity | 2007 |
PET in colorectal cancer.
Topics: Adult; Aged, 80 and over; Colorectal Neoplasms; Female; Fluorodeoxyglucose F18; History, 18th Century; Humans; Liver Neoplasms; Male; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals | 2008 |
Management of recurrent colorectal cancer with positron emission tomography.
Topics: Colorectal Neoplasms; Fluorodeoxyglucose F18; Humans; Neoplasm Recurrence, Local; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, X-Ray Computed | 2007 |
Predictive and prognostic value of FDG-PET.
Topics: Carcinoma, Non-Small-Cell Lung; Colorectal Neoplasms; Diagnosis, Differential; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymphoma; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals | 2008 |
Positron emission tomography scanning is coming to a hospital near you soon!
Topics: Colorectal Neoplasms; Diagnosis, Differential; Esophageal Neoplasms; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymphoma; Neoplasm Recurrence, Local; Neoplasm Staging; Neoplasms; Outcome and Process Assessment, Health Care; Radiopharmaceuticals; Tomography, Emission-Computed; Tomography, X-Ray Computed; United Kingdom | 2008 |
[Role of 18F-FDG positron emission tomography in surgical evaluation].
Topics: Carcinoma, Bronchogenic; Colorectal Neoplasms; Fluorodeoxyglucose F18; Glycolysis; Humans; Lung Neoplasms; Neoplasms; Pancreatic Neoplasms; Sensitivity and Specificity; Tomography, Emission-Computed | 1998 |
Oncological applications of FDG PET imaging: brain tumors, colorectal cancer, lymphoma and melanoma.
Topics: Artifacts; Brain Neoplasms; Colorectal Neoplasms; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Lymphoma; Melanoma; Neoplasm Staging; Radiopharmaceuticals; Tomography, Emission-Computed | 1999 |
Positron emission tomography imaging of colorectal cancer.
Topics: Colorectal Neoplasms; Fluorodeoxyglucose F18; Humans; Neoplasm Metastasis; Neoplasm Staging; Radiopharmaceuticals; Tomography, Emission-Computed | 1999 |
[Role of positron emission tomography is the evaluation of digestive tract tumors].
Topics: Colorectal Neoplasms; Diagnosis, Differential; Fluorodeoxyglucose F18; Gastrointestinal Neoplasms; Humans; Pancreatic Neoplasms; Pancreatitis; Tomography, Emission-Computed | 1999 |
A meta-analysis of the literature for whole-body FDG PET detection of recurrent colorectal cancer.
Topics: Colorectal Neoplasms; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Neoplasm Recurrence, Local; Pelvic Neoplasms; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, Emission-Computed | 2000 |
Positron emission tomography with 2-[18F]fluoro-2-deoxy-D-glucose in oncology. Part II. The clinical value in detecting and staging primary tumours.
Topics: Breast Neoplasms; Colorectal Neoplasms; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Lung Neoplasms; Male; Melanoma; Neoplasm Staging; Neoplasms; Ovarian Neoplasms; Radiopharmaceuticals; Skin Neoplasms; Tomography, Emission-Computed | 2000 |
A new imaging technique for colorectal cancer: positron emission tomography.
Topics: Carcinoembryonic Antigen; Colorectal Neoplasms; Fluorodeoxyglucose F18; Humans; Neoplasm Metastasis; Neoplasm Recurrence, Local; Neoplasm Staging; Radiopharmaceuticals; Tomography, Emission-Computed; Whole-Body Irradiation | 2000 |
Positron emission tomography and colorectal cancer.
Topics: Colorectal Neoplasms; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Neoplasm Recurrence, Local; Neoplasm Staging; Radiopharmaceuticals; Tomography, Emission-Computed | 2001 |
Positron emission tomography with 2-[18F]-fluoro-2-deoxy-D-glucose in oncology. Part IIIb: Therapy response monitoring in colorectal and lung tumours, head and neck cancer, hepatocellular carcinoma and sarcoma.
Topics: Adenocarcinoma; Animals; Antineoplastic Agents; Bone Neoplasms; Carcinoma, Hepatocellular; Colorectal Neoplasms; Evaluation Studies as Topic; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Liver Neoplasms; Lung Neoplasms; Male; Neoplasm Metastasis; Neoplasms; Outcome Assessment, Health Care; Sarcoma; Soft Tissue Neoplasms; Tomography, Emission-Computed | 2001 |
[The role of diagnostic PET in treatment planning before tumor surgery].
Topics: Breast Neoplasms; Carcinoma, Bronchogenic; Clinical Trials as Topic; Colorectal Neoplasms; Combined Modality Therapy; Diagnosis, Differential; Esophageal Neoplasms; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Glucose; Humans; Lung Neoplasms; Lymph Node Excision; Lymphatic Metastasis; Male; Neoplasm Recurrence, Local; Neoplasms; Prognosis; Prospective Studies; Radiopharmaceuticals; Sarcoma; Soft Tissue Neoplasms; Thyroid Neoplasms; Time Factors; Tomography, Emission-Computed; Tomography, X-Ray Computed | 2001 |
[Influence of positron emission tomography on surgical therapy planning in recurrent colorectal cancer].
Topics: Adult; Colorectal Neoplasms; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Metastasis; Neoplasm Recurrence, Local; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, Emission-Computed | 2001 |
Selection of patients for resection of hepatic metastases: improved detection of extrahepatic disease with FDG pet.
Topics: Colorectal Neoplasms; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Liver Neoplasms; Neoplasm Metastasis; Neoplasm Recurrence, Local; Patient Selection; Radiopharmaceuticals; Tomography, Emission-Computed | 2001 |
The clinical application of positron emission tomography to colorectal cancer management.
Topics: Colorectal Neoplasms; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Neoplasm Recurrence, Local; Neoplasm Staging; Radiopharmaceuticals; Tomography, Emission-Computed | 2001 |
[Positron emission tomography (PET) in clinical oncology. Part II].
Topics: Adult; Aged; Colorectal Neoplasms; False Negative Reactions; False Positive Reactions; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymph Nodes; Lymphoma; Male; Melanoma; Middle Aged; Neoplasm Metastasis; Neoplasm Recurrence, Local; Neoplasms; Predictive Value of Tests; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, Emission-Computed; Tomography, X-Ray Computed | 2002 |
Clinical role of positron emission tomography in oncology.
Topics: Colorectal Neoplasms; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Lung Neoplasms; Lymphoma; Melanoma; Neoplasms; Radiopharmaceuticals; Tomography, Emission-Computed | 2001 |
Clinical applications of (18)F-FDG in oncology.
Topics: Colorectal Neoplasms; Female; Fluorodeoxyglucose F18; Genital Neoplasms, Female; Head and Neck Neoplasms; Humans; Lung Neoplasms; Lymphoma; Melanoma; Radiopharmaceuticals; Skin Neoplasms; Tomography, Emission-Computed | 2002 |
Positron emission tomography in colorectal cancer.
Topics: Adenocarcinoma; Colorectal Neoplasms; Fluorodeoxyglucose F18; Humans; Neoplasm Recurrence, Local; Neoplasm Staging; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, Emission-Computed | 2002 |
[Current status of nuclear medicine. Clinical application of FDG-PET for cancer diagnosis. Colorectal cancer].
Topics: Colorectal Neoplasms; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Magnetic Resonance Imaging; Male; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, Emission-Computed; Tomography, X-Ray Computed | 2002 |
[Cost-effective PET scans in oncology].
Topics: Breast Neoplasms; Colorectal Neoplasms; Cost-Benefit Analysis; Diagnosis, Differential; Esophageal Neoplasms; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Hungary; Lung Neoplasms; Lymphoma; Medicare; Melanoma; Neoplasm Staging; Neoplasms; Radiopharmaceuticals; Tomography, Emission-Computed; United States | 2002 |
The applications of PET in clinical oncology.
Topics: Brain Neoplasms; Colorectal Neoplasms; Deoxyglucose; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Neoplasms; Tomography, Emission-Computed | 1991 |
57 trial(s) available for fluorodeoxyglucose f18 and Colorectal Neoplasms
Article | Year |
---|---|
Radiomic analysis for predicting prognosis of colorectal cancer from preoperative
Topics: China; Colorectal Neoplasms; Fluorodeoxyglucose F18; Humans; Positron Emission Tomography Computed Tomography; Prognosis | 2022 |
Topics: 3T3-L1 Cells; A Kinase Anchor Proteins; Acetates; Achilles Tendon; Acute Kidney Injury; Acute Pain; Acyclic Monoterpenes; Adenine Nucleotides; Adhesins, Escherichia coli; Adipocytes; Adipocytes, Brown; Adipogenesis; Administration, Inhalation; Administration, Oral; Adrenal Cortex Hormones; Adsorption; Adult; Aeromonas hydrophila; Africa; Aged; Aged, 80 and over; Agrobacterium tumefaciens; Air; Air Pollutants; Air Pollution; Air Pollution, Indoor; Algorithms; Alkaloids; Alkynes; Allosteric Regulation; Amines; Amino Acid Sequence; Amino Acids; Amino Acids, Branched-Chain; Aminoisobutyric Acids; Aminopyridines; Amyotrophic Lateral Sclerosis; Anaerobic Threshold; Angiography; Angiotensin II Type 1 Receptor Blockers; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animal Distribution; Animal Feed; Animal Nutritional Physiological Phenomena; Animals; Ankle Joint; Anti-Bacterial Agents; Anti-HIV Agents; Anti-Inflammatory Agents; Antibodies, Bacterial; Antifungal Agents; Antimalarials; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Antioxidants; Antiretroviral Therapy, Highly Active; Antiviral Agents; Aotidae; Apelin; Apoptosis; Arabidopsis Proteins; Argentina; Arginine; Artemisinins; Arthritis, Experimental; Arthritis, Rheumatoid; Arthroscopy; Aspergillus; Aspergillus niger; Asteraceae; Asthma; ATP Binding Cassette Transporter, Subfamily B, Member 1; ATP Binding Cassette Transporter, Subfamily G, Member 2; Auditory Cortex; Autoantibodies; Autophagy; Bacteria; Bacterial Infections; Bacterial Proteins; Bacterial Typing Techniques; Base Composition; Base Sequence; Basketball; Beclin-1; Benzhydryl Compounds; Benzimidazoles; Benzo(a)pyrene; Benzofurans; Benzoxazines; Bereavement; beta Catenin; beta-Lactamase Inhibitors; beta-Lactamases; beta-Lactams; Betacoronavirus; Betaine; Binding Sites; Biofilms; Biological Assay; Biological Availability; Biological Evolution; Biomarkers; Biomechanical Phenomena; Biopolymers; Biopsy; Bismuth; Blood Glucose; Blood Platelets; Blood Pressure; Body Composition; Body Weight; Bone Marrow; Bone Marrow Cells; Bone Regeneration; Boron; Botrytis; Brain Ischemia; Brain Neoplasms; Brain-Derived Neurotrophic Factor; Brazil; Breast Neoplasms; Breath Tests; Bronchoalveolar Lavage Fluid; Burkholderia; C-Reactive Protein; Caenorhabditis elegans; Caenorhabditis elegans Proteins; Calcification, Physiologic; Calcium; Calcium Signaling; Calorimetry, Differential Scanning; Cameroon; Camptothecin; Candida; Candida albicans; Capillaries; Carbapenem-Resistant Enterobacteriaceae; Carbapenems; Carbohydrate Conformation; Carbon; Carbon Dioxide; Carbon Isotopes; Carcinoma, Ovarian Epithelial; Cardiac Output; Cardiomyopathy, Hypertrophic; Cardiotonic Agents; Cardiovascular Diseases; Caregivers; Carps; Case-Control Studies; Catalase; Catalysis; Cats; CD4 Lymphocyte Count; Cell Culture Techniques; Cell Differentiation; Cell Line, Tumor; Cell Membrane; Cell Movement; Cell Proliferation; Cell Survival; Cells, Cultured; Cellulose; Centrosome; Ceratopogonidae; Chickens; Child; China; Cholera Toxin; Choline; Cholinesterases; Chromatography, High Pressure Liquid; Chromatography, Liquid; Chromatography, Micellar Electrokinetic Capillary; Chromatography, Reverse-Phase; Chronic Disease; Cinnamates; Cities; Citrates; Climate Change; Clinical Trials, Phase III as Topic; Coal; Coal Mining; Cohort Studies; Coinfection; Colchicine; Colony Count, Microbial; Colorectal Neoplasms; Coloring Agents; Common Cold; Complement Factor H; Computational Biology; Computer Simulation; Continuous Positive Airway Pressure; Contrast Media; Coordination Complexes; Coronary Artery Bypass; Coronavirus 3C Proteases; Coronavirus Infections; Coronavirus Protease Inhibitors; Corynebacterium glutamicum; Cosmetics; COVID-19; Creatinine; Cross-Sectional Studies; Crotonates; Crystallography, X-Ray; Cues; Culicidae; Culture Media; Curcuma; Cyclopentanes; Cyclopropanes; Cymbopogon; Cystine; Cytochrome P-450 CYP2B6; Cytochrome P-450 CYP2C19; Cytochrome P-450 CYP2C19 Inhibitors; Cytokines; Databases, Genetic; Death; Dendritic Cells; Density Functional Theory; Depsides; Diabetes Mellitus, Type 2; Diamond; Diarylheptanoids; Dibenzofurans; Dibenzofurans, Polychlorinated; Diclofenac; Diet; Dietary Carbohydrates; Dietary Supplements; Diffusion Magnetic Resonance Imaging; Dioxins; Diphenylamine; Disease Outbreaks; Disease Susceptibility; Disulfides; Dithiothreitol; Dizocilpine Maleate; DNA Methylation; DNA-Binding Proteins; DNA, Bacterial; Dogs; Dose-Response Relationship, Drug; Double-Blind Method; Doublecortin Protein; Drosophila melanogaster; Droughts; Drug Carriers; Drug Combinations; Drug Delivery Systems; Drug Liberation; Drug Resistance; Drug Resistance, Bacterial; Drug Resistance, Neoplasm; Drug Screening Assays, Antitumor; Dust; Dynactin Complex; Dysferlin; Echo-Planar Imaging; Echocardiography; Edaravone; Egypt; Elasticity; Electrodes; Electrolytes; Emodin; Emtricitabine; Endometriosis; Endothelium, Vascular; Endotoxins; Energy Metabolism; Energy Transfer; Enterobacteriaceae; Enterococcus faecalis; Enterotoxigenic Escherichia coli; Environmental Monitoring; Enzyme Inhibitors; Epidemiologic Factors; Epigenesis, Genetic; Erythrocytes; Escherichia coli; Escherichia coli Infections; Escherichia coli Vaccines; Esophageal Neoplasms; Esophagectomy; Esophagogastric Junction; Esterases; Esterification; Ethanol; Ethiopia; Ethnicity; Eucalyptus; Evidence-Based Practice; Exercise; Exercise Tolerance; Extracorporeal Membrane Oxygenation; Family; Fatty Acids; Feedback; Female; Ferric Compounds; Fibrin Fibrinogen Degradation Products; Filtration; Fish Diseases; Flavonoids; Flavonols; Fluorodeoxyglucose F18; Follow-Up Studies; Food Microbiology; Food Preservation; Forests; Fossils; Free Radical Scavengers; Freund's Adjuvant; Fruit; Fungi; Gallium; Gender Identity; Gene Expression Regulation; Gene Expression Regulation, Neoplastic; Gene Expression Regulation, Plant; Gene Knockdown Techniques; Genes, Bacterial; Genes, Plant; Genetic Predisposition to Disease; Genitalia; Genotype; Glomerulonephritis, IGA; Glottis; Glucocorticoids; Glucose; Glucuronides; Glutathione Transferase; Glycogen Synthase Kinase 3 beta; Gram-Negative Bacterial Infections; Gram-Positive Bacterial Infections; Grassland; Guinea Pigs; Half-Life; Head Kidney; Heart Atria; Heart Rate; Heart Septum; HEK293 Cells; Hematopoietic Stem Cells; Hemodynamics; Hep G2 Cells; Hepacivirus; Hepatitis C; Hepatitis C, Chronic; Hepatocytes; Hesperidin; High-Frequency Ventilation; High-Temperature Requirement A Serine Peptidase 1; Hippocampus; Hirudins; History, 20th Century; History, 21st Century; HIV Infections; Homeostasis; Hominidae; Housing, Animal; Humans; Hydrocarbons, Brominated; Hydrogen Bonding; Hydrogen Peroxide; Hydrogen-Ion Concentration; Hydroxybutyrates; Hydroxyl Radical; Hypertension; Hypothyroidism; Image Interpretation, Computer-Assisted; Immunoconjugates; Immunogenic Cell Death; Indoles; Infant, Newborn; Infant, Premature; Infarction, Middle Cerebral Artery; Inflammation; Inflammation Mediators; Infrared Rays; Inhibitory Concentration 50; Injections, Intravenous; Interferon-gamma; Interleukin-23; Interleukin-4; Interleukin-6; Intermediate Filaments; Intermittent Claudication; Intestine, Small; Iridoid Glucosides; Iridoids; Iron; Isomerism; Isotope Labeling; Isoxazoles; Itraconazole; Kelch-Like ECH-Associated Protein 1; Ketoprofen; Kidney Failure, Chronic; Kinetics; Klebsiella pneumoniae; Lactams, Macrocyclic; Lactobacillus; Lactulose; Lakes; Lamivudine; Laparoscopy; Laparotomy; Laryngoscopy; Leucine; Limit of Detection; Linear Models; Lipid A; Lipopolysaccharides; Listeria monocytogenes; Liver; Liver Cirrhosis; Logistic Models; Longitudinal Studies; Losartan; Low Back Pain; Lung; Lupinus; Lupus Erythematosus, Systemic; Machine Learning; Macular Degeneration; Madin Darby Canine Kidney Cells; Magnetic Phenomena; Magnetic Resonance Imaging; Magnetic Resonance Spectroscopy; Magnetics; Malaria, Falciparum; Male; Mannans; MAP Kinase Signaling System; Mass Spectrometry; Melatonin; Membrane Glycoproteins; Membrane Proteins; Meniscectomy; Menisci, Tibial; Mephenytoin; Mesenchymal Stem Cells; Metal Nanoparticles; Metal-Organic Frameworks; Methionine; Mice; Mice, Inbred C57BL; Mice, Knockout; Mice, Nude; Mice, Obese; Mice, Transgenic; Microbial Sensitivity Tests; Microcirculation; MicroRNAs; Microscopy, Video; Microtubules; Microvascular Density; Microwaves; Middle Aged; Minimally Invasive Surgical Procedures; Models, Animal; Models, Biological; Models, Molecular; Models, Theoretical; Molecular Docking Simulation; Molecular Structure; Molecular Weight; Morus; Mouth Floor; Multicenter Studies as Topic; Multiple Sclerosis; Multiple Sclerosis, Relapsing-Remitting; Muscle, Skeletal; Myocardial Ischemia; Myocardium; NAD; NADP; Nanocomposites; Nanoparticles; Naphthols; Nasal Lavage Fluid; Nasal Mucosa; Neisseria meningitidis; Neoadjuvant Therapy; Neoplasm Invasiveness; Neoplasm Recurrence, Local; Neoplasms, Experimental; Neural Stem Cells; Neuroblastoma; Neurofilament Proteins; Neurogenesis; Neurons; New York; NF-E2-Related Factor 2; NF-kappa B; Nicotine; Nitriles; Nitrogen; Nitrogen Fixation; North America; Observer Variation; Occupational Exposure; Ochrobactrum; Oils, Volatile; Olea; Oligosaccharides; Omeprazole; Open Field Test; Optimism; Oregon; Oryzias; Osmolar Concentration; Osteoarthritis; Osteoblasts; Osteogenesis; Ovarian Neoplasms; Ovariectomy; Oxadiazoles; Oxidation-Reduction; Oxidative Stress; Oxygen; Ozone; p38 Mitogen-Activated Protein Kinases; Pakistan; Pandemics; Particle Size; Particulate Matter; Patient-Centered Care; Pelargonium; Peptides; Perception; Peripheral Arterial Disease; Peroxides; Pets; Pharmaceutical Preparations; Pharmacogenetics; Phenobarbital; Phenols; Phenotype; Phosphates; Phosphatidylethanolamines; Phosphines; Phospholipids; Phosphorus; Phosphorylation; Photoacoustic Techniques; Photochemotherapy; Photosensitizing Agents; Phylogeny; Phytoestrogens; Pilot Projects; Plant Components, Aerial; Plant Extracts; Plant Immunity; Plant Leaves; Plant Oils; Plants, Medicinal; Plasmodium berghei; Plasmodium falciparum; Platelet Activation; Platelet Function Tests; Pneumonia, Viral; Poaceae; Pogostemon; Poloxamer; Poly I; Poly(ADP-ribose) Polymerase Inhibitors; Polychlorinated Biphenyls; Polychlorinated Dibenzodioxins; Polycyclic Compounds; Polyethylene Glycols; Polylysine; Polymorphism, Genetic; Polymorphism, Single Nucleotide; Population Dynamics; Portasystemic Shunt, Transjugular Intrahepatic; Positron Emission Tomography Computed Tomography; Postoperative Complications; Postprandial Period; Potassium Cyanide; Predictive Value of Tests; Prefrontal Cortex; Pregnancy; Prepulse Inhibition; Prevalence; Procalcitonin; Prodrugs; Prognosis; Progression-Free Survival; Proline; Proof of Concept Study; Prospective Studies; Protein Binding; Protein Conformation; Protein Domains; Protein Folding; Protein Multimerization; Protein Sorting Signals; Protein Structure, Secondary; Proton Pump Inhibitors; Protozoan Proteins; Psychometrics; Pulse Wave Analysis; Pyridines; Pyrrolidines; Quality of Life; Quantum Dots; Quinoxalines; Quorum Sensing; Radiopharmaceuticals; Rain; Random Allocation; Randomized Controlled Trials as Topic; Rats; Rats, Sprague-Dawley; Rats, Wistar; RAW 264.7 Cells; Reactive Oxygen Species; Receptor, Angiotensin, Type 1; Receptor, PAR-1; Receptors, CXCR4; Receptors, Estrogen; Receptors, Glucocorticoid; Receptors, Interleukin-1; Receptors, Interleukin-17; Receptors, Notch; Recombinant Fusion Proteins; Recombinant Proteins; Reducing Agents; Reflex, Startle; Regional Blood Flow; Regression Analysis; Reperfusion Injury; Reproducibility of Results; Republic of Korea; Respiratory Tract Diseases; Retrospective Studies; Reverse Transcriptase Inhibitors; Rhinitis, Allergic; Risk Assessment; Risk Factors; Rituximab; RNA, Messenger; RNA, Ribosomal, 16S; ROC Curve; Rosmarinic Acid; Running; Ruthenium; Rutin; Sarcolemma; Sarcoma; Sarcopenia; Sarcoplasmic Reticulum; SARS-CoV-2; Scavenger Receptors, Class A; Schools; Seasons; Seeds; Sequence Analysis, DNA; Severity of Illness Index; Sex Factors; Shock, Cardiogenic; Short Chain Dehydrogenase-Reductases; Signal Transduction; Silver; Singlet Oxygen; Sinusitis; Skin; Skin Absorption; Small Molecule Libraries; Smoke; Socioeconomic Factors; Soil; Soil Microbiology; Solid Phase Extraction; Solubility; Solvents; Spain; Spectrometry, Mass, Electrospray Ionization; Spectroscopy, Fourier Transform Infrared; Speech; Speech Perception; Spindle Poles; Spleen; Sporothrix; Staphylococcal Infections; Staphylococcus aureus; Stereoisomerism; Stomach Neoplasms; Stress, Physiological; Stroke Volume; Structure-Activity Relationship; Substrate Specificity; Sulfonamides; Surface Properties; Surface-Active Agents; Surveys and Questionnaires; Survival Rate; T-Lymphocytes, Cytotoxic; Tandem Mass Spectrometry; Temperature; Tenofovir; Terpenes; Tetracycline; Tetrapleura; Textiles; Thermodynamics; Thiobarbituric Acid Reactive Substances; Thrombin; Thyroid Hormones; Thyroid Neoplasms; Tibial Meniscus Injuries; Time Factors; Tissue Distribution; Titanium; Toluidines; Tomography, X-Ray Computed; Tooth; Tramadol; Transcription Factor AP-1; Transcription, Genetic; Transfection; Transgender Persons; Translations; Treatment Outcome; Triglycerides; Ubiquinone; Ubiquitin-Specific Proteases; United Kingdom; United States; Up-Regulation; Vascular Stiffness; Veins; Ventricular Remodeling; Viral Load; Virulence Factors; Virus Replication; Vitis; Voice; Voice Quality; Wastewater; Water; Water Pollutants, Chemical; Water-Electrolyte Balance; Weather; Wildfires; Wnt Signaling Pathway; Wound Healing; X-Ray Diffraction; Xenograft Model Antitumor Assays; Young Adult; Zoogloea | 2022 |
Comparison of 18FDG-PET/CT and conventional follow-up methods in colorectal cancer: A randomised prospective study.
Topics: Adult; Aged; Aged, 80 and over; Carcinoembryonic Antigen; Colorectal Neoplasms; Female; Fluorodeoxyglucose F18; Follow-Up Studies; France; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Positron Emission Tomography Computed Tomography; Prospective Studies | 2021 |
Prognostic significance of bone marrow and spleen
Topics: Aged; Bone Marrow; Colorectal Neoplasms; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Male; Positron Emission Tomography Computed Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies; Spleen; Survival Rate | 2021 |
Colorectal cancer (CRC) monitoring by 6-monthly 18FDG-PET/CT: an open-label multicentre randomised trial.
Topics: Aged; Colorectal Neoplasms; Costs and Cost Analysis; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Male; Middle Aged; Monitoring, Physiologic; Positron Emission Tomography Computed Tomography | 2018 |
Early metabolic response in sequential FDG-PET/CT under cetuximab is a predictive marker for clinical response in first-line metastatic colorectal cancer patients: results of the phase II REMOTUX trial.
Topics: Adult; Aged; Camptothecin; Cetuximab; Colorectal Neoplasms; Female; Fluorodeoxyglucose F18; Fluorouracil; Humans; Leucovorin; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Progression-Free Survival; Prospective Studies | 2018 |
Response assessment of colorectal liver metastases with contrast enhanced CT/18F-FDG PET.
Topics: Adult; Aged; Colorectal Neoplasms; Contrast Media; Female; Fluorodeoxyglucose F18; Humans; Image Enhancement; Iopamidol; Liver Neoplasms; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Spain; Tomography, X-Ray Computed; Treatment Outcome | 2013 |
Comparison of EORTC criteria and PERCIST for PET/CT response evaluation of patients with metastatic colorectal cancer treated with irinotecan and cetuximab.
Topics: Adult; Aged; Aged, 80 and over; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Camptothecin; Cetuximab; Colorectal Neoplasms; Denmark; Digestive System Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Image Interpretation, Computer-Assisted; Irinotecan; Lung Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Multimodal Imaging; Outcome Assessment, Health Care; Positron-Emission Tomography; Prevalence; Radiopharmaceuticals; Reproducibility of Results; Risk Assessment; Sensitivity and Specificity; Survival Analysis; Survival Rate; Tomography, X-Ray Computed; Treatment Outcome | 2013 |
Impact of 18F-FDG-PET/CT on treatment strategy in colorectal cancer lung metastasis before lung radiofrequency ablation.
Topics: Ablation Techniques; Adult; Aged; Aged, 80 and over; Colorectal Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Incidental Findings; Lung Neoplasms; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Prospective Studies; Radiofrequency Therapy; Tomography, X-Ray Computed | 2013 |
Positron emission tomography/computed tomography and biomarkers for early treatment response evaluation in metastatic colon cancer.
Topics: Adult; Aged; Aged, 80 and over; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Bevacizumab; Biomarkers, Tumor; Capecitabine; Colorectal Neoplasms; Deoxycytidine; Female; Fluorodeoxyglucose F18; Fluorouracil; Humans; Male; Middle Aged; Multimodal Imaging; Neoplasm Metastasis; Organoplatinum Compounds; Oxaliplatin; Positron-Emission Tomography; Prognosis; Prospective Studies; Radiopharmaceuticals; Survival Analysis; Tomography, X-Ray Computed | 2014 |
Does CEA and CA 19-9 combined increase the likelihood of 18F-FDG in detecting recurrence in colorectal patients with negative CeCT?
Topics: Adult; Aged; Aged, 80 and over; Antigens, Tumor-Associated, Carbohydrate; Biomarkers, Tumor; Carcinoembryonic Antigen; Colorectal Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Probability; Recurrence; Tomography, X-Ray Computed | 2014 |
Correlating tumor metabolic progression index measured by serial FDG PET-CT, apparent diffusion coefficient measured by magnetic resonance imaging (MRI) and blood genomics to patient's outcome in advanced colorectal cancer: the CORIOLAN study.
Topics: Aged, 80 and over; Colorectal Neoplasms; Diffusion Magnetic Resonance Imaging; Disease Progression; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neoplasm Staging; Neoplastic Cells, Circulating; Positron-Emission Tomography; Prognosis; Treatment Outcome | 2014 |
The use of PET-MRI in the follow-up after radiofrequency- and microwave ablation of colorectal liver metastases.
Topics: Catheter Ablation; Colorectal Neoplasms; Early Detection of Cancer; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Liver Neoplasms; Magnetic Resonance Imaging; Multimodal Imaging; Observer Variation; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals | 2014 |
A phase I monotherapy study of RG7212, a first-in-class monoclonal antibody targeting TWEAK signaling in patients with advanced cancers.
Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Agents; Colorectal Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Male; Maximum Tolerated Dose; Melanoma; Middle Aged; Radionuclide Imaging; Radiopharmaceuticals; Treatment Outcome | 2015 |
Regorafenib assessment in refractory advanced colorectal cancer: RegARd-C study protocol.
Topics: Adenocarcinoma; Antineoplastic Agents; Colorectal Neoplasms; Epigenesis, Genetic; Fluorodeoxyglucose F18; Humans; Multimodal Imaging; Patient Selection; Phenylurea Compounds; Positron-Emission Tomography; Prospective Studies; Pyridines; Research Design; Retreatment; Survival Rate; Tomography, X-Ray | 2015 |
Prospective evaluation of 18F-fluorodeoxyglucose positron emission tomography in patients receiving hepatic arterial and systemic chemotherapy for unresectable colorectal liver metastases.
Topics: Antineoplastic Combined Chemotherapy Protocols; Colorectal Neoplasms; Disease Progression; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Humans; Kaplan-Meier Estimate; Liver Neoplasms; Male; Middle Aged; Multimodal Imaging; New York City; Positron-Emission Tomography; Predictive Value of Tests; Proportional Hazards Models; Prospective Studies; Radiopharmaceuticals; Risk Factors; Time Factors; Tomography, X-Ray Computed; Treatment Outcome | 2015 |
Colorectal liver metastatic disease: efficacy of irreversible electroporation--a single-arm phase II clinical trial (COLDFIRE-2 trial).
Topics: Ablation Techniques; Aged; Colorectal Neoplasms; Electroporation; Female; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Male; Middle Aged; Survival Analysis; Tomography, X-Ray Computed | 2015 |
Monitoring metabolic response using FDG PET-CT during targeted therapy for metastatic colorectal cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Capecitabine; Colorectal Neoplasms; Drug Monitoring; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Molecular Targeted Therapy; Niacinamide; Phenylurea Compounds; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Sorafenib; Treatment Outcome | 2016 |
Total lesion glycolysis (TLG) as an imaging biomarker in metastatic colorectal cancer patients treated with regorafenib.
Topics: Adult; Aged; Biomarkers, Tumor; Colorectal Neoplasms; Female; Fluorodeoxyglucose F18; Glycolysis; Humans; Male; Middle Aged; Neoplasm Metastasis; Phenylurea Compounds; Positron Emission Tomography Computed Tomography; Prospective Studies; Pyridines; Treatment Outcome | 2017 |
Early prediction of response to first-line chemotherapy by sequential [18F]-2-fluoro-2-deoxy-D-glucose positron emission tomography in patients with advanced colorectal cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Colorectal Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Irinotecan; Male; Middle Aged; Positron-Emission Tomography; Predictive Value of Tests; Prognosis; Prospective Studies; Radiopharmaceuticals | 2009 |
Evaluation of different normalization procedures for the calculation of the standardized uptake value in therapy response monitoring studies.
Topics: Adult; Aged; Analysis of Variance; Carcinoma, Non-Small-Cell Lung; Colorectal Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Positron-Emission Tomography; Prospective Studies; Regression Analysis; Survival Rate; Treatment Outcome | 2009 |
Improved selection of patients for hepatic surgery of colorectal liver metastases with (18)F-FDG PET: a randomized study.
Topics: Adult; Aged; Colorectal Neoplasms; Female; Fluorodeoxyglucose F18; Hepatectomy; Humans; Liver Neoplasms; Male; Middle Aged; Netherlands; Patient Selection; Positron-Emission Tomography; Prognosis; Radiography; Radiopharmaceuticals; Survival Analysis; Survival Rate; Treatment Outcome | 2009 |
Detection of colorectal cancer using ¹⁸F-FLT PET: comparison with ¹⁸F-FDG PET.
Topics: Adult; Aged; Aged, 80 and over; Cell Proliferation; Colorectal Neoplasms; Dideoxynucleosides; Feasibility Studies; Female; Fluorodeoxyglucose F18; Humans; Immunohistochemistry; Male; Middle Aged; Positron-Emission Tomography; Prospective Studies | 2009 |
Chemotherapy response monitoring of colorectal liver metastases by dynamic Gd-DTPA-enhanced MRI perfusion parameters and 18F-FDG PET metabolic rate.
Topics: Aged; Antineoplastic Agents; Colorectal Neoplasms; Disease Progression; Female; Fluorodeoxyglucose F18; Gadolinium DTPA; Humans; Liver Neoplasms; Magnetic Resonance Imaging; Male; Middle Aged; Radionuclide Imaging; Survival Rate; Treatment Outcome | 2009 |
Unsuspected hibernating myocardium detected by routine oncology (18)F-FDG PET/CT.
Topics: Colorectal Neoplasms; Fluorodeoxyglucose F18; Humans; Incidental Findings; Male; Middle Aged; Myocardial Stunning; Positron-Emission Tomography; Radiopharmaceuticals; Subtraction Technique; Tomography, X-Ray Computed | 2010 |
Added value of positron emission tomography imaging in the surgical treatment of colorectal liver metastases.
Topics: Adult; Aged; Aged, 80 and over; Colorectal Neoplasms; Costs and Cost Analysis; Female; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Male; Middle Aged; Positron-Emission Tomography; Quality-Adjusted Life Years; Sensitivity and Specificity; Treatment Outcome | 2010 |
Detection of incidental colorectal tumours with 18F-labelled 2-fluoro-2-deoxyglucose positron emission tomography/computed tomography scans: results of a prospective study.
Topics: Adenocarcinoma; Adenoma; Adult; Aged; Aged, 80 and over; Biopsy; Colonic Polyps; Colonoscopy; Colorectal Neoplasms; False Positive Reactions; Female; Fluorodeoxyglucose F18; Humans; Incidental Findings; Lymphoma; Male; Middle Aged; Multimodal Imaging; Multivariate Analysis; Positron-Emission Tomography; Proportional Hazards Models; Prospective Studies; Tomography, X-Ray Computed; Young Adult | 2011 |
Response to intra-arterial oncolytic virotherapy with the herpes virus NV1020 evaluated by [18F]fluorodeoxyglucose positron emission tomography and computed tomography.
Topics: Adult; Aged; Antineoplastic Agents; Biomarkers, Tumor; Colorectal Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Male; Multimodal Imaging; Oncolytic Virotherapy; Oncolytic Viruses; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Simplexvirus; Tomography, X-Ray Computed; Treatment Outcome | 2012 |
A phase II study for metabolic in vivo response monitoring with sequential 18FDG-PET-CT during treatment with the EGFR-monoclonal-antibody cetuximab in metastatic colorectal cancer: the Heidelberg REMOTUX trial.
Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Agents; Cetuximab; Colorectal Neoplasms; ErbB Receptors; Female; Fluorodeoxyglucose F18; Humans; Male; Positron-Emission Tomography; Predictive Value of Tests; Prospective Studies; Radiopharmaceuticals | 2012 |
The flow-metabolic phenotype of primary colorectal cancer: assessment by integrated 18F-FDG PET/perfusion CT with histopathologic correlation.
Topics: Aged; Aged, 80 and over; Cell Hypoxia; Colorectal Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Multimodal Imaging; Neovascularization, Pathologic; Perfusion Imaging; Phenotype; Positron-Emission Tomography; Regional Blood Flow; Tomography, X-Ray Computed | 2012 |
Value of DCE-MRI and FDG-PET/CT in the prediction of response to preoperative chemotherapy with bevacizumab for colorectal liver metastases.
Topics: Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Bevacizumab; Camptothecin; Colorectal Neoplasms; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Fluorouracil; Humans; Leucovorin; Liver Neoplasms; Magnetic Resonance Imaging; Male; Middle Aged; Multimodal Imaging; Neoadjuvant Therapy; Organoplatinum Compounds; Positron-Emission Tomography; Tomography, X-Ray Computed | 2012 |
Yttrium-90 microsphere-selective internal radiation therapy with chemotherapy (chemo-SIRT) for colorectal cancer liver metastases: an in vivo double-arm-controlled phase II trial.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Brachytherapy; Camptothecin; Chemoradiotherapy; Colorectal Neoplasms; Female; Fluorodeoxyglucose F18; Fluorouracil; Follow-Up Studies; Humans; Irinotecan; Leucovorin; Liver Neoplasms; Male; Microspheres; Middle Aged; Neoplasm Staging; Organoplatinum Compounds; Oxaliplatin; Positron-Emission Tomography; Prognosis; Prospective Studies; Radiopharmaceuticals; Tomography, X-Ray Computed; Yttrium Radioisotopes | 2013 |
The usefulness of 18F-FDG PET images obtained 2 hours after intravenous injection in liver tumor.
Topics: Aged; Aged, 80 and over; Carcinoma, Hepatocellular; Colorectal Neoplasms; Esophageal Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Injections, Intravenous; Liver Neoplasms; Male; Middle Aged; Radionuclide Imaging; Radiopharmaceuticals; Sensitivity and Specificity; Time Factors | 2002 |
FDG-PET improves the management of patients with suspected recurrence of colorectal cancer.
Topics: Abdomen; Adult; Carcinoembryonic Antigen; Colorectal Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Male; Middle Aged; Neoplasm Recurrence, Local; Pain; Radionuclide Imaging; Radiopharmaceuticals; Tomography, X-Ray Computed | 2002 |
PET-FDG as predictor of therapy response in patients with colorectal carcinoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Colorectal Neoplasms; Fluorodeoxyglucose F18; Fluorouracil; Follow-Up Studies; Humans; Leucovorin; Liver Neoplasms; Lung Neoplasms; Neoplasm Recurrence, Local; Neoplasm Staging; Organoplatinum Compounds; Radiopharmaceuticals; Risk Assessment; Tomography, Emission-Computed; Treatment Outcome | 2003 |
Potential impact of [18F]3'-deoxy-3'-fluorothymidine versus [18F]fluoro-2-deoxy-D-glucose in positron emission tomography for colorectal cancer.
Topics: Aged; Aged, 80 and over; Colorectal Neoplasms; Dideoxynucleosides; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Tomography, Emission-Computed; Whole-Body Counting | 2003 |
Detection of recurrent colorectal carcinoma by 18F-FDG: comparison of the clinical performances of FDG PET and FDG CDET.
Topics: Adult; Aged; Aged, 80 and over; Colorectal Neoplasms; False Negative Reactions; False Positive Reactions; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Gamma Cameras; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Prospective Studies; Radiopharmaceuticals; Tomography, Emission-Computed | 2004 |
Prognostic aspects of 18F-FDG PET kinetics in patients with metastatic colorectal carcinoma receiving FOLFOX chemotherapy.
Topics: Algorithms; Antineoplastic Combined Chemotherapy Protocols; Colorectal Neoplasms; Disease-Free Survival; Fluorodeoxyglucose F18; Fluorouracil; Humans; Image Interpretation, Computer-Assisted; Kinetics; Leucovorin; Organoplatinum Compounds; Prognosis; Radionuclide Imaging; Radiopharmaceuticals; Reproducibility of Results; Risk Assessment; Risk Factors; Sensitivity and Specificity; Survival Analysis; Treatment Outcome | 2004 |
Metabolic response after intraarterial 90Y-glass microsphere treatment for colorectal liver metastases: comparison of quantitative and visual analyses by 18F-FDG PET.
Topics: Aged; Colorectal Neoplasms; Female; Fluorodeoxyglucose F18; Glass; Humans; Liver Function Tests; Liver Neoplasms; Male; Microspheres; Observer Variation; Radionuclide Imaging; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Trauma Severity Indices; Treatment Outcome; Yttrium Radioisotopes | 2004 |
[Evaluation of positron emission tomography by using F-18-fluorodeoxyglucose in diagnosis of recurrent colorectal cancer].
Topics: Adult; Carcinoma; Colon; Colorectal Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Magnetic Resonance Imaging; Male; Middle Aged; Neoplasm Recurrence, Local; Positron-Emission Tomography; Radiopharmaceuticals; Rectum; Retrospective Studies; Sensitivity and Specificity; Tomography, X-Ray Computed | 2004 |
Prospective evaluation of the impact of [18F]fluoro-2-deoxy-D-glucose positron emission tomography of resectable colorectal liver metastases.
Topics: Adult; Aged; Colorectal Neoplasms; Double-Blind Method; Female; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Male; Middle Aged; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Tomography, X-Ray Computed | 2005 |
Detection of residual tumor after radiofrequency ablation of liver metastasis with dual-modality PET/CT: initial results.
Topics: Aged; Catheter Ablation; Colorectal Neoplasms; Contrast Media; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Iohexol; Liver; Liver Neoplasms; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm, Residual; Observer Variation; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Tomography, X-Ray Computed | 2006 |
Imaging the pharmacokinetics of [F-18]FAU in patients with tumors: PET studies.
Topics: Arabinofuranosyluracil; Bone Marrow; Breast Neoplasms; Chromatography, High Pressure Liquid; Colorectal Neoplasms; Contrast Media; Fluorodeoxyglucose F18; Humans; Injections, Intravenous; Kidney; Liver Neoplasms; Lung Neoplasms; Lymphatic Metastasis; Pilot Projects; Positron-Emission Tomography; Time Factors; Tissue Distribution | 2006 |
90Y microsphere (TheraSphere) treatment for unresectable colorectal cancer metastases of the liver: response to treatment at targeted doses of 135-150 Gy as measured by [18F]fluorodeoxyglucose positron emission tomography and computed tomographic imaging.
Topics: Aged; Aged, 80 and over; Colorectal Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Male; Microspheres; Middle Aged; Positron-Emission Tomography; Radiography, Interventional; Radiopharmaceuticals; Radiotherapy Dosage; Tomography, X-Ray Computed; Treatment Outcome; Yttrium Radioisotopes | 2005 |
A novel iterative method for lesion delineation and volumetric quantification with FDG PET.
Topics: Aged; Calibration; Colorectal Neoplasms; Feasibility Studies; Fluorodeoxyglucose F18; Humans; Image Interpretation, Computer-Assisted; Liver Neoplasms; Middle Aged; Models, Biological; Phantoms, Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity; Tumor Burden | 2007 |
18F-FDG PET scanning correlates with tissue markers of poor prognosis and predicts mortality for patients after liver resection for colorectal metastases.
Topics: Adult; Aged; Aged, 80 and over; Biomarkers, Tumor; Colorectal Neoplasms; Female; Fluorodeoxyglucose F18; Hepatectomy; Humans; Incidence; Liver Neoplasms; Male; Middle Aged; New York; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Reproducibility of Results; Risk Assessment; Risk Factors; Sensitivity and Specificity; Survival Rate; Treatment Outcome | 2007 |
FDG-PET improves management of patients with colorectal liver metastases allocated for local treatment: a consecutive prospective study.
Topics: Adult; Aged; Colorectal Neoplasms; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Hepatectomy; Humans; Laparotomy; Liver Neoplasms; Male; Middle Aged; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Treatment Outcome | 2007 |
Early detection of recurrence by 18FDG-PET in the follow-up of patients with colorectal cancer.
Topics: Adult; Aged; Colorectal Neoplasms; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Middle Aged; Neoplasm Recurrence, Local; Positron-Emission Tomography; Prospective Studies | 2008 |
Increased metabolic activity of indolent liver metastases after resection of a primary colorectal tumor.
Topics: Aged; Colorectal Neoplasms; Female; Fluorodeoxyglucose F18; Hepatectomy; Humans; Male; Metabolic Clearance Rate; Middle Aged; Radionuclide Imaging; Radiopharmaceuticals | 2008 |
RadioimmunoPET: detection of colorectal carcinoma with positron-emitting copper-64-labeled monoclonal antibody.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Animals; Colorectal Neoplasms; Copper Radioisotopes; Deoxyglucose; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Predictive Value of Tests; Radiation Dosage; Radioimmunodetection; Rats; Rats, Sprague-Dawley; Sensitivity and Specificity; Tomography, Emission-Computed | 1995 |
Positron emission tomography to stage suspected metastatic colorectal carcinoma to the liver.
Topics: Colorectal Neoplasms; Deoxyglucose; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Liver Neoplasms; Male; Middle Aged; Neoplasm Staging; Sensitivity and Specificity; Tomography, Emission-Computed; Tomography, X-Ray Computed | 1996 |
The role of whole-body positron emission tomography with [18F]fluorodeoxyglucose in identifying operable colorectal cancer metastases to the liver.
Topics: Colorectal Neoplasms; Deoxyglucose; Double-Blind Method; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Neoplasm Recurrence, Local; Radiography; Tomography, Emission-Computed | 1996 |
Possible role of FDG-PET in the early prediction of therapy outcome in liver metastases of colorectal cancer.
Topics: Adenocarcinoma; Aged; Animals; Antimetabolites, Antineoplastic; Colorectal Neoplasms; Feasibility Studies; Female; Fluorodeoxyglucose F18; Fluorouracil; Humans; Leucovorin; Liver Neoplasms; Male; Middle Aged; Predictive Value of Tests; Radiopharmaceuticals; Tomography, Emission-Computed; Treatment Outcome | 1999 |
Whole-body PET imaging with [18F]fluorodeoxyglucose in management of recurrent colorectal cancer.
Topics: Adult; Aged; Aged, 80 and over; Carcinoembryonic Antigen; Colorectal Neoplasms; Female; Fluorodeoxyglucose F18; Health Care Costs; Humans; Male; Middle Aged; Neoplasm Metastasis; Prospective Studies; Radiopharmaceuticals; Retrospective Studies; Single-Blind Method; Tomography, Emission-Computed | 1999 |
Survival of patients evaluated by FDG-PET before hepatic resection for metastatic colorectal carcinoma: a prospective database study.
Topics: Aged; Carcinoma; Colorectal Neoplasms; Databases, Factual; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Male; Middle Aged; Missouri; Neoplasm Staging; Prospective Studies; Radiopharmaceuticals; Sensitivity and Specificity; Survival Rate; Tomography, Emission-Computed | 2001 |
Value of positron emission tomography with [F-18]fluorodeoxyglucose in patients with colorectal liver metastases: a prospective study.
Topics: Adult; Aged; Colorectal Neoplasms; Decision Making; Diagnosis, Differential; False Negative Reactions; Female; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Lung Neoplasms; Male; Middle Aged; Neoplasm Staging; Patient Care Planning; Preoperative Care; Prospective Studies; Radiopharmaceuticals; Tomography, Emission-Computed | 2002 |
Evaluating 90Y-glass microsphere treatment response of unresectable colorectal liver metastases by [18F]FDG PET: a comparison with CT or MRI.
Topics: Aged; Aged, 80 and over; Biomarkers, Tumor; Carcinoembryonic Antigen; Colorectal Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Lung Neoplasms; Lymphatic Metastasis; Magnetic Resonance Imaging; Male; Microspheres; Middle Aged; Prospective Studies; Radionuclide Imaging; Radiopharmaceuticals; Severity of Illness Index; Tomography, X-Ray Computed; Treatment Outcome; Yttrium Radioisotopes | 2002 |
460 other study(ies) available for fluorodeoxyglucose f18 and Colorectal Neoplasms
Article | Year |
---|---|
Investigating ultra-low-dose total-body [18F]-FDG PET/CT in colorectal cancer: initial experience.
Topics: Adult; Aged; Aged, 80 and over; China; Colorectal Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Tomography, X-Ray Computed | 2022 |
Diagnostic performance of the FDG-PET/CT in patients with resected mucinous colorectal liver metastases.
Topics: Colorectal Neoplasms; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity | 2021 |
Clinically significant findings in patients with focal incidental colorectal abnormalities on positron emission tomography-CT scans.
Topics: Adenoma; Colorectal Neoplasms; Fluorodeoxyglucose F18; Humans; Incidental Findings; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies | 2022 |
Elevated CEA with negative PET scan on surveillance of colorectal cancers-a role of CEA kinetics.
Topics: Carcinoembryonic Antigen; Colorectal Neoplasms; Fluorodeoxyglucose F18; Humans; Kinetics; Neoplasm Recurrence, Local; Positron-Emission Tomography; Retrospective Studies | 2022 |
Different prognostic impact of glucose uptake in visceral adipose tissue according to sex in patients with colorectal cancer.
Topics: Aged; Blood Glucose; Colorectal Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Intra-Abdominal Fat; Kaplan-Meier Estimate; Male; Middle Aged; Multivariate Analysis; Positron Emission Tomography Computed Tomography; Prognosis; Retrospective Studies; Sex Factors; Subcutaneous Fat | 2021 |
Correlation between incidental focal colorectal FDG uptake on PET/CT and colonoscopic and histopathological results.
Topics: Colonoscopy; Colorectal Neoplasms; Fluorodeoxyglucose F18; Humans; Incidental Findings; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies | 2022 |
Prognostic significance of imaging features of peritumoral adipose tissue in FDG PET/CT of patients with colorectal cancer.
Topics: Adipose Tissue; Colorectal Neoplasms; Fluorodeoxyglucose F18; Humans; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies | 2021 |
Survival after liver resection and liver transplantation for colorectal liver metastases: a comparative analysis stratified by metabolic tumor volume assessed by
Topics: Colorectal Neoplasms; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Liver Transplantation; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Retrospective Studies; Tumor Burden | 2022 |
Angiopoietin-like 4 promotes glucose metabolism by regulating glucose transporter expression in colorectal cancer.
Topics: Angiopoietin-Like Protein 4; Angiopoietins; Animals; Colorectal Neoplasms; Fluorodeoxyglucose F18; Glucose; Glucose Transport Proteins, Facilitative; Humans; Mice; Phosphatidylinositol 3-Kinases; Positron Emission Tomography Computed Tomography; Proto-Oncogene Proteins c-akt | 2022 |
The value of
Topics: Colorectal Neoplasms; Fluorodeoxyglucose F18; Humans; Nomograms; Positron Emission Tomography Computed Tomography; Retrospective Studies | 2022 |
Imaging Characteristics and Prognostic Value of Isolated Pulmonary Metastasis from Colorectal Cancer Demonstrated with
Topics: Colorectal Neoplasms; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Positron Emission Tomography Computed Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies | 2022 |
Selective thyroid hormone receptor beta agonist, GC-1, is capable to reduce growth of colorectal tumor in syngeneic mouse models.
Topics: Acetates; Animals; Colorectal Neoplasms; Disease Models, Animal; Fluorodeoxyglucose F18; Glucose; Mice; Phenols; Thyroid Hormone Receptors beta; Thyroid Hormones | 2022 |
Half-dose versus full-dose 18 F-FDG total-body PET/CT in patients with colorectal cancer.
Topics: Colorectal Neoplasms; Fluorodeoxyglucose F18; Humans; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals | 2022 |
Efficacy of PET/CT in diagnosis of regional lymph node metastases in patients with colorectal cancer: retrospective cohort study.
Topics: Colorectal Neoplasms; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Retrospective Studies | 2022 |
Extrauterine Endometrial Stromal Sarcoma Mimicking Colorectal Cancer With Metastases.
Topics: Colorectal Neoplasms; Endometrial Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Positron Emission Tomography Computed Tomography; Sarcoma, Endometrial Stromal | 2022 |
FDG metabolic parameter-based models for predicting recurrence after upfront surgery in synchronous colorectal cancer liver metastasis.
Topics: Colorectal Neoplasms; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Male; Positron Emission Tomography Computed Tomography; Prognosis; Retrospective Studies | 2023 |
Clinical Value of PET.CT Based on Big Data in Colorectal and Peritoneal Metastatic Cancer.
Topics: alpha-Fetoproteins; Big Data; Colorectal Neoplasms; Fluorodeoxyglucose F18; Humans; Peritoneal Neoplasms; Positron Emission Tomography Computed Tomography; Tomography, X-Ray Computed | 2022 |
Relationship between [
Topics: Colorectal Neoplasms; Fluorodeoxyglucose F18; Glucose; Humans; Metabolomics; Positron Emission Tomography Computed Tomography | 2022 |
Diagnostic performance and impact on patient management of [68Ga]Ga-DOTA-TOC PET/CT in colorectal neuroendocrine tumors derived from hindgut.
Topics: Colorectal Neoplasms; Fluorodeoxyglucose F18; Humans; Neuroendocrine Tumors; Positron Emission Tomography Computed Tomography; Retrospective Studies | 2022 |
Increased FDG Uptake in Skin Rashes Caused by EGFR Inhibitors.
Topics: Colorectal Neoplasms; Exanthema; Fluorodeoxyglucose F18; Humans; Prognosis; Protein Kinase Inhibitors | 2023 |
Clinical value of fluorine-18-fluorodeoxyglucose PET/MRI for liver metastasis in colorectal cancer: a prospective study.
Topics: Colorectal Neoplasms; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Magnetic Resonance Imaging; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Prospective Studies; Sensitivity and Specificity | 2023 |
Disappearing colorectal liver metastases in the era of state-of-the-art triple-modality diagnostic imaging.
Topics: Colorectal Neoplasms; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Magnetic Resonance Imaging; Retrospective Studies; Tomography, X-Ray Computed | 2023 |
Diagnostic performance of Ga-68 FAPI 04 PET/CT in colorectal malignancies.
Topics: Colorectal Neoplasms; Fluorodeoxyglucose F18; Gallium Radioisotopes; Humans; Positron Emission Tomography Computed Tomography; Quinolines | 2023 |
Comparison of 18 F-FDG and 68 Ga-FAPI-04 Uptake in Postoperative Re-evaluation of Gastric, Duodenal, and Colorectal Cancers.
Topics: Colorectal Neoplasms; Fluorodeoxyglucose F18; Gallium Radioisotopes; Humans; Middle Aged; Neoplasm Recurrence, Local; Positron Emission Tomography Computed Tomography; Retrospective Studies | 2023 |
Economic evaluation of 18F-FDG PET/CT, MRI and CE-CT in selection of colorectal liver metastases eligible for ablation - A cost-effectiveness analysis.
Topics: Colorectal Neoplasms; Cost-Benefit Analysis; Cost-Effectiveness Analysis; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Magnetic Resonance Imaging; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Tomography, X-Ray Computed | 2023 |
Prediction of Microsatellite Instability in Colorectal Cancer Using a Machine Learning Model Based on PET/CT Radiomics.
Topics: Colorectal Neoplasms; Fluorodeoxyglucose F18; Humans; Machine Learning; Microsatellite Instability; Positron Emission Tomography Computed Tomography; Retrospective Studies | 2023 |
The potential role of 68Ga-FAPI-04 PET/CT for screening malignancy in suspected colonic lesions.
Topics: Adenoma; Colorectal Neoplasms; Fluorodeoxyglucose F18; Gallium Radioisotopes; Humans; Positron Emission Tomography Computed Tomography; Quinolines; Radiopharmaceuticals; Retrospective Studies; Tomography, X-Ray Computed | 2023 |
A novel objective method for discriminating pathological and physiological colorectal uptake in the lower abdominal region using whole-body dynamic
Topics: Colorectal Neoplasms; Fluorodeoxyglucose F18; Humans; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies | 2023 |
PET/CT imaging fibroblast activation protein in initial colorectal cancer: compared to 18 F-FDG PET/CT.
Topics: Colorectal Neoplasms; Fibroblasts; Fluorodeoxyglucose F18; Gallium Radioisotopes; Humans; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Quinolines | 2023 |
Colonoscopy following the positron emission tomography/computed tomography scan in patients with incidental colorectal uptake: what is the most effective management?
Topics: Colonoscopy; Colorectal Neoplasms; Fluorodeoxyglucose F18; Humans; Positron Emission Tomography Computed Tomography; Retrospective Studies; Tomography, X-Ray Computed | 2023 |
Evaluation of patients via colonoscopy who underwent positron emission tomography/computerized tomography due to colon involvement.
Topics: Colon; Colonoscopy; Colorectal Neoplasms; Fluorodeoxyglucose F18; Humans; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Retrospective Studies | 2023 |
Yield of endoscopy in cases of abnormalities detected via radiological examination.
Topics: Colon; Colonic Polyps; Colonoscopy; Colorectal Neoplasms; Diverticulum, Colon; False Negative Reactions; False Positive Reactions; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Rectum; Tomography, X-Ray Computed | 2019 |
FDG-PET reflects tumor viability on SUV in colorectal cancer liver metastasis.
Topics: Adult; Aged; Aged, 80 and over; Biomarkers, Tumor; Carrier Proteins; Colorectal Neoplasms; Female; Fluorodeoxyglucose F18; Glucose Transporter Type 1; Hepatectomy; Humans; Hypoxia-Inducible Factor 1, alpha Subunit; Immunohistochemistry; Ki-67 Antigen; Liver Neoplasms; Male; Membrane Proteins; Middle Aged; Neoplasm Recurrence, Local; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies; Thyroid Hormone-Binding Proteins; Thyroid Hormones | 2020 |
Can [
Topics: Colorectal Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Peritoneal Neoplasms; Positron Emission Tomography Computed Tomography; Preoperative Period; Radiation Dosage; Radiopharmaceuticals; Retrospective Studies | 2020 |
A novel in vivo Cerenkov luminescence image-guided surgery on primary and metastatic colorectal cancer.
Topics: Animals; Colorectal Neoplasms; Fluorodeoxyglucose F18; Luminescence; Luminescent Measurements; Mice; Surgery, Computer-Assisted; Swine | 2020 |
A prospective comparative study of contrast-enhanced CT, contrast-enhanced MRI and 18F-FDG PET/CT in the preoperative staging of colorectal cancer patients.
Topics: Aged; Colorectal Neoplasms; Contrast Media; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, X-Ray Computed | 2020 |
Complete Metabolic Response Assessed by FDG PET/CT to FOLFOXIRI-Bevacizumab in First-Line Treatment of BRAFV600E Mutated Metastatic Colorectal Cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bevacizumab; Camptothecin; Cetuximab; Colorectal Neoplasms; Female; Fluorodeoxyglucose F18; Fluorouracil; Humans; Leucovorin; Middle Aged; Mutation; Neoplasm Metastasis; Organoplatinum Compounds; Positron Emission Tomography Computed Tomography; Proto-Oncogene Proteins B-raf; Treatment Outcome | 2020 |
Preoperative 18F-FDG PET/computed tomography predicts survival following resection for colorectal liver metastases.
Topics: Aged; Aged, 80 and over; Colorectal Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Kaplan-Meier Estimate; Liver Neoplasms; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Preoperative Period; Retrospective Studies | 2020 |
Promising clinical performance of pretargeted immuno-PET with anti-CEA bispecific antibody and gallium-68-labelled IMP-288 peptide for imaging colorectal cancer metastases: a pilot study.
Topics: Antibodies, Monoclonal; Carcinoembryonic Antigen; Colorectal Neoplasms; Fluorodeoxyglucose F18; Gallium Radioisotopes; Heterocyclic Compounds, 1-Ring; Humans; Oligopeptides; Pilot Projects; Positron-Emission Tomography | 2021 |
18F-FDG simultaneous PET/MR monitoring treatment response of a Turcot syndrome case.
Topics: Brain Neoplasms; Colorectal Neoplasms; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Neoplastic Syndromes, Hereditary; Positron-Emission Tomography; Radiopharmaceuticals | 2021 |
Prevalence of hypoxia and correlation with glycolytic metabolism and angiogenic biomarkers in metastatic colorectal carcinoma.
Topics: Biomarkers; Colorectal Neoplasms; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Hypoxia; Misonidazole; Positron-Emission Tomography; Prevalence; Radiopharmaceuticals | 2021 |
Prognostic value of pretreatment F-18 fluorodeoxyglucose PET/CT in colorectal cancer with unresectable metastasis.
Topics: Adult; Aged; Aged, 80 and over; Colorectal Neoplasms; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Prognosis; Retrospective Studies | 2021 |
Screening of radiotracer for diagnosis of colorectal cancer liver metastasis based on MACC1-SPON2.
Topics: Animals; Colorectal Neoplasms; Early Detection of Cancer; Fluorodeoxyglucose F18; Liver Neoplasms; Mice; Mice, Nude; Positron-Emission Tomography; Radiopharmaceuticals | 2021 |
Micro-positron emission tomography imaging of angiogenesis based on
Topics: Animals; Colorectal Neoplasms; Fluorodeoxyglucose F18; Ki-67 Antigen; Liver Neoplasms; Mice; Neovascularization, Pathologic; Oligopeptides; Positron-Emission Tomography; Radiopharmaceuticals; Tumor Microenvironment; Vascular Endothelial Growth Factor A | 2021 |
FDG-PET/CT in colorectal cancer: potential for vascular-metabolic imaging to provide markers of prognosis.
Topics: Aged; Colorectal Neoplasms; Female; Fluorodeoxyglucose F18; Glycolysis; Humans; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies; Tumor Burden | 2021 |
18F-FDG PET/CT metabolic parameters and HER2 expression in colorectal cancer.
Topics: Colorectal Neoplasms; Fluorodeoxyglucose F18; Humans; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Receptor, ErbB-2; Retrospective Studies | 2021 |
Atypical presentation of colorectal carcinoma with sole multiple osteolytic bone metastases: a case report.
Topics: Adenocarcinoma; Bone Neoplasms; Colorectal Neoplasms; Delayed Diagnosis; Fluorodeoxyglucose F18; Humans; Male; Middle Aged | 2021 |
The additional diagnostic impact of positron emission tomography-computed tomography for lymph node metastasis from colorectal cancer: A prospective lymph node level analysis.
Topics: Adenocarcinoma; Aged; Colorectal Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Predictive Value of Tests; Prospective Studies; Radiopharmaceuticals; Sensitivity and Specificity | 2021 |
Microenvironment-triggered multimodal precision diagnostics.
Topics: Acidosis; Animals; Colorectal Neoplasms; Disease Progression; Female; Fluorodeoxyglucose F18; Mice; Mice, Inbred BALB C; Multimodal Imaging; Positron-Emission Tomography; Precision Medicine; Tumor Microenvironment | 2021 |
Implication of FDG-PET/CT without synchronous colonic lesion in patients with stenotic left-sided colorectal cancer.
Topics: Adenoma; Aged; Case-Control Studies; Cohort Studies; Colon; Colonoscopy; Colorectal Neoplasms; Constriction, Pathologic; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Predictive Value of Tests; Republic of Korea; Retrospective Studies | 2021 |
Identifying an early indicator of drug efficacy in patients with metastatic colorectal cancer-a prospective evaluation of circulating tumor cells, 18F-fluorodeoxyglucose positron-emission tomography and the RECIST criteria.
Topics: Aged; Antineoplastic Agents; Colorectal Neoplasms; Disease Progression; Disease-Free Survival; Endpoint Determination; Female; Fluorodeoxyglucose F18; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Multidetector Computed Tomography; Neoplasm Metastasis; Neoplastic Cells, Circulating; Positron Emission Tomography Computed Tomography; Predictive Value of Tests; Proportional Hazards Models; Prospective Studies; Radiopharmaceuticals; Response Evaluation Criteria in Solid Tumors; Risk Factors; Time Factors; Treatment Outcome | 2017 |
Early Postoperative FDG-PET-CT Imaging Results in a Relevant Upstaging in the pN2 Subgroup of Stage III Colorectal Cancer Patients.
Topics: Adult; Aged; Cohort Studies; Colorectal Neoplasms; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Postoperative Period | 2017 |
Response to: "Consideration of KRAS Mutation Status May Enhance the Prognostic Impact of Indeterminate Extrahepatic Disease in the Lungs, as Identified by 18FDG-PET, in Patients With Colorectal Liver Metastases".
Topics: Colorectal Neoplasms; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Mutation; Positron-Emission Tomography; Prognosis; Proto-Oncogene Proteins p21(ras); Retrospective Studies | 2018 |
Carcinoembryonic antigen directed PET-CECT scanning for postoperative surveillance of colorectal cancer.
Topics: Adult; Aged; Carcinoembryonic Antigen; Colectomy; Colorectal Neoplasms; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Positron Emission Tomography Computed Tomography; Postoperative Complications; Postoperative Period; Predictive Value of Tests; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Young Adult | 2017 |
Consideration of KRAS Mutational Status May Enhance the Prognostic Impact of Indeterminate Extrahepatic Disease in the Lungs, as Identified by 18FDG-PET Scan, in Patients With Colorectal Liver Metastases.
Topics: Colorectal Neoplasms; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Positron-Emission Tomography; Prognosis; Proto-Oncogene Proteins p21(ras); Retrospective Studies | 2018 |
Percutaneous radiofrequency ablation of lung metastases from colorectal carcinoma under C-arm cone beam CT guidance.
Topics: Aged; Aged, 80 and over; Catheter Ablation; Colorectal Neoplasms; Cone-Beam Computed Tomography; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Prospective Studies; Radiography, Interventional; Radiopharmaceuticals | 2017 |
Concurrent focal fat sparing and peritumoral fat sparing in diffuse fatty liver identified on 18F-FDG PETCT and multiparametric magnetic resonance imaging.
Topics: Aged; Colorectal Neoplasms; Fatty Liver; Female; Fluorodeoxyglucose F18; Humans; Liver; Magnetic Resonance Imaging; Positron Emission Tomography Computed Tomography | 2017 |
18 F-FDG PET/MR imaging in patients with suspected liver lesions: Value of liver-specific contrast agent Gadobenate dimeglumine.
Topics: Adult; Aged; Breast Neoplasms; Carcinoma, Hepatocellular; Cholangiocarcinoma; Colorectal Neoplasms; Contrast Media; Female; Fluorodeoxyglucose F18; Humans; Liver; Liver Neoplasms; Magnetic Resonance Imaging; Male; Meglumine; Melanoma; Middle Aged; Organometallic Compounds; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Sensitivity and Specificity | 2017 |
Low Accuracy of Computed Tomography and Positron Emission Tomography to Detect Lung and Lymph Node Metastases of Colorectal Cancer.
Topics: Aged; Colorectal Neoplasms; Diagnostic Errors; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Tomography, X-Ray Computed | 2017 |
A pilot study for texture analysis of
Topics: Adult; Aged; Aged, 80 and over; Colorectal Neoplasms; Dideoxynucleosides; Female; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Male; Middle Aged; Pilot Projects; Positron Emission Tomography Computed Tomography; Prognosis; Recurrence; Retrospective Studies; Survival Analysis | 2017 |
Regarding "Survival Outcomes in Asymptomatic Patients with Normal Conventional Imaging but Raised Carcinoembryonic Antigen Levels in Colorectal Cancer Following Positron Emission Tomography-Computed Tomography Imaging".
Topics: Carcinoembryonic Antigen; Colorectal Neoplasms; Fluorodeoxyglucose F18; Humans; Neoplasm Recurrence, Local; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, X-Ray Computed | 2017 |
Fluorine-18-fluorodeoxyglucose positron emission tomography as an objective substitute for CT morphologic response criteria in patients undergoing chemotherapy for colorectal liver metastases.
Topics: Adult; Aged; Aged, 80 and over; Colorectal Neoplasms; Databases, Factual; Female; Fluorodeoxyglucose F18; Humans; Liver; Liver Neoplasms; Male; Middle Aged; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Reproducibility of Results; Tomography, X-Ray Computed | 2018 |
Incidental detection of colorectal lesions by FDG PET/CT scans in melanoma patients.
Topics: Australia; Colonoscopy; Colorectal Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Incidental Findings; Male; Melanoma; Middle Aged; Positron Emission Tomography Computed Tomography; Prevalence; Radiopharmaceuticals; Retrospective Studies; Skin Neoplasms; Survival Rate | 2017 |
Fluorine-18-fluorodeoxyglucose uptake of bone marrow on PET/CT can predict prognosis in patients with colorectal cancer after curative surgical resection.
Topics: Adult; Aged; Aged, 80 and over; Bone Marrow; C-Reactive Protein; Colorectal Neoplasms; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Lymphatic Vessels; Lymphocyte Count; Male; Middle Aged; Neoplasm Invasiveness; Neoplasm Staging; Neoplasm, Residual; Neutrophils; Platelet Count; Positron Emission Tomography Computed Tomography; Predictive Value of Tests; Radiopharmaceuticals; Survival Rate; Tumor Burden | 2018 |
The relationship between
Topics: Aged; Biomarkers, Tumor; Colorectal Neoplasms; Databases, Factual; Female; Fluorodeoxyglucose F18; Glycolysis; Humans; Inflammation; Male; Middle Aged; Neoplasm Recurrence, Local; Positron Emission Tomography Computed Tomography; Postoperative Period; Prognosis; Prospective Studies; Radiopharmaceuticals; Tumor Burden | 2018 |
Endoscopic and histopathological analysis of incidental focal colorectal
Topics: Adenoma; Aged; Aged, 80 and over; Carcinoma; Colonoscopy; Colorectal Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Incidental Findings; Male; Melanoma; Middle Aged; Positron Emission Tomography Computed Tomography; Precancerous Conditions; Radiopharmaceuticals; Retrospective Studies | 2018 |
Usefulness of metabolic activity of adipose tissue in FDG PET/CT of colorectal cancer.
Topics: Adipose Tissue; Aged; Colorectal Neoplasms; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Male; Middle Aged; Patient Outcome Assessment; Positron Emission Tomography Computed Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies | 2018 |
High CEA levels in a case of resected colorectal cancer: delayed diagnosis of metachronous medullary thyroid cancer.
Topics: Biomarkers, Tumor; Carcinoembryonic Antigen; Carcinoma, Neuroendocrine; Colorectal Neoplasms; Delayed Diagnosis; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Thyroid Neoplasms; Thyroidectomy | 2017 |
Discussion of: Endoscopic and histopathological analysis of incidental focal colorectal
Topics: Colonoscopy; Colorectal Neoplasms; Fluorodeoxyglucose F18; Humans; Incidental Findings; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed | 2018 |
New intra-abdominal mass after operation for colorectal cancer: desmoid tumor versus peritoneal seeding.
Topics: Adult; Aged; Colorectal Neoplasms; Diagnosis, Differential; Female; Fibromatosis, Abdominal; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neoplasm Seeding; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Radiographic Image Interpretation, Computer-Assisted; Radiopharmaceuticals; Retrospective Studies; Whole Body Imaging | 2018 |
Prediction of tumor biological characteristics in different colorectal cancer liver metastasis animal models using
Topics: Adenocarcinoma; Animals; Cell Line, Tumor; Colorectal Neoplasms; Dideoxynucleosides; Feasibility Studies; Fluorodeoxyglucose F18; Humans; Hyaluronan Receptors; Immunohistochemistry; Ki-67 Antigen; Linear Models; Liver Neoplasms; Mice, Nude; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Time Factors; Vascular Endothelial Growth Factor A | 2018 |
Propofol Disrupts Aerobic Glycolysis in Colorectal Cancer Cells via Inactivation of the NMDAR-CAMKII-ERK Pathway.
Topics: Animals; Calcium-Calmodulin-Dependent Protein Kinase Type 2; Cell Line, Tumor; Colorectal Neoplasms; Dizocilpine Maleate; Down-Regulation; Extracellular Signal-Regulated MAP Kinases; Female; Fluorodeoxyglucose F18; Glucose Transporter Type 1; Glycolysis; HT29 Cells; Human Umbilical Vein Endothelial Cells; Humans; Mice; Mice, Inbred BALB C; Oligopeptides; Phosphoglycerate Kinase; Prognosis; Propofol; Receptors, N-Methyl-D-Aspartate; Signal Transduction | 2018 |
Preoperative CT-based predictive factors for resectability and medium-term overall survival in patients with peritoneal carcinomatosis from colorectal cancer.
Topics: Adult; Aged; Colorectal Neoplasms; Combined Modality Therapy; Cytoreduction Surgical Procedures; Female; Fluorodeoxyglucose F18; Humans; Hyperthermia, Induced; Male; Middle Aged; Peritoneal Neoplasms; Positron Emission Tomography Computed Tomography; Predictive Value of Tests; Radiopharmaceuticals; Reproducibility of Results; Retrospective Studies; Risk Factors; Survival Rate; Tomography, X-Ray Computed | 2018 |
Importance of 18F-FDG PET/CT to select patients with nonresectable colorectal liver metastases for liver transplantation.
Topics: Adult; Colorectal Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Liver Transplantation; Male; Middle Aged; Patient Selection; Positron Emission Tomography Computed Tomography; Survival Analysis | 2018 |
Predictive value of dual-time
Topics: Adenocarcinoma; Adenocarcinoma of Lung; Colorectal Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Retrospective Studies; Solitary Pulmonary Nodule; Tomography, X-Ray Computed | 2018 |
Diagnostic accuracy of CE-CT, MRI and FDG PET/CT for detecting colorectal cancer liver metastases in patients considered eligible for hepatic resection and/or local ablation.
Topics: Adult; Aged; Aged, 80 and over; Colorectal Neoplasms; Contrast Media; Female; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Magnetic Resonance Imaging; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Prospective Studies; ROC Curve; Sensitivity and Specificity; Tomography, X-Ray Computed | 2018 |
Microwave Ablation in the Management of Colorectal Cancer Pulmonary Metastases.
Topics: Adult; Aged; Catheter Ablation; Colorectal Neoplasms; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Lung Neoplasms; Male; Microwaves; Middle Aged; Positron Emission Tomography Computed Tomography; Retrospective Studies; Tomography, X-Ray Computed; Treatment Outcome | 2018 |
Klotho negatively regulated aerobic glycolysis in colorectal cancer via ERK/HIF1α axis.
Topics: Aerobiosis; Cell Proliferation; Colorectal Neoplasms; Extracellular Signal-Regulated MAP Kinases; Fluorodeoxyglucose F18; Gene Expression Regulation, Neoplastic; Glucuronidase; Glycolysis; HCT116 Cells; Humans; Hypoxia-Inducible Factor 1, alpha Subunit; Klotho Proteins; Positron Emission Tomography Computed Tomography; Signal Transduction; Transcription, Genetic | 2018 |
Metabolic Imaging Phenotype Using Radiomics of [
Topics: Adult; Aged; Aged, 80 and over; Colorectal Neoplasms; DNA Mutational Analysis; Dose-Response Relationship, Radiation; Female; Fluorodeoxyglucose F18; Humans; Male; Metabolism; Middle Aged; Mutation; Phenotype; Pilot Projects; Positron Emission Tomography Computed Tomography; Radiometry; Retrospective Studies | 2019 |
Long-term outcomes and recurrence pattern of 18F-FDG PET-CT complete metabolic response in the first-line treatment of metastatic colorectal cancer: a lesion-based and patient-based analysis.
Topics: Adult; Aged; Aged, 80 and over; Colorectal Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Kaplan-Meier Estimate; Liver Neoplasms; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Retrospective Studies; ROC Curve; Treatment Outcome | 2018 |
Efficacy of 18-fluoro deoxy glucose-positron emission tomography computed tomography for the detection of colonic neoplasia proximal to obstructing colorectal cancer.
Topics: Adult; Aged; Aged, 80 and over; Colectomy; Colon; Colonic Neoplasms; Colorectal Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Intestinal Obstruction; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Predictive Value of Tests; Preoperative Care; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Treatment Outcome | 2018 |
Relationship between KRAS mutations and dual time point
Topics: Aged; Colorectal Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Male; Middle Aged; Mutation; Positron Emission Tomography Computed Tomography; Proto-Oncogene Proteins p21(ras); Radiopharmaceuticals; Retrospective Studies | 2019 |
A new strategy based on fluorodeoxyglucose-positron emission tomography for managing liver metastasis from colorectal cancer.
Topics: Adult; Aged; Aged, 80 and over; Algorithms; Colorectal Neoplasms; Decision Support Techniques; Fluorodeoxyglucose F18; Hepatectomy; Humans; Liver Neoplasms; Middle Aged; Neoplasm Recurrence, Local; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity | 2018 |
Rectal adenocarcinoma presenting with thigh muscle metastasis as the only metastatic site.
Topics: Adenocarcinoma; Chemoradiotherapy, Adjuvant; Colorectal Neoplasms; Diagnosis, Differential; Fluorodeoxyglucose F18; Humans; Male; Metastasectomy; Middle Aged; Muscle Neoplasms; Muscle, Skeletal; Neoplasm Metastasis; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Rare Diseases; Thigh; Treatment Outcome | 2019 |
Measurement of 18F-FDG PET tumor heterogeneity improves early assessment of response to bevacizumab compared with the standard size and uptake metrics in a colorectal cancer model.
Topics: Animals; Bevacizumab; Biological Transport; Cell Transformation, Neoplastic; Colorectal Neoplasms; Disease Models, Animal; Fluorodeoxyglucose F18; Mice; Positron Emission Tomography Computed Tomography; Time Factors; Treatment Outcome; Tumor Burden | 2019 |
Comparison of PERCIST and RECIST criteria for evaluation of therapy response after yttrium-90 microsphere therapy in patients with hepatocellular carcinoma and those with metastatic colorectal carcinoma.
Topics: Aged; Aged, 80 and over; Carcinoma, Hepatocellular; Colorectal Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Male; Microspheres; Middle Aged; Positron Emission Tomography Computed Tomography; Response Evaluation Criteria in Solid Tumors; Yttrium Radioisotopes | 2019 |
Prognostic modeling for patients with colorectal liver metastases incorporating FDG PET radiomic features.
Topics: Adult; Aged; Aged, 80 and over; Colorectal Neoplasms; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Glycolysis; Humans; Liver Neoplasms; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Prognosis; Proportional Hazards Models; Retrospective Studies; Tumor Burden; Young Adult | 2019 |
Impact of free-breathing CT on quantitative measurements of static and quiescent period-gated PET Images.
Topics: Aged; Algorithms; Carcinoma, Non-Small-Cell Lung; Colorectal Neoplasms; Female; Fluorodeoxyglucose F18; Four-Dimensional Computed Tomography; Humans; Image Interpretation, Computer-Assisted; Lung Neoplasms; Male; Movement; Positron-Emission Tomography; Prospective Studies; Respiration; Respiratory-Gated Imaging Techniques | 2019 |
Complete Metabolic Response Assessed by FDG PET/CT to FOLFIRI-Aflibercept in Second-Line Treatment of Metastatic Colorectal Cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Colorectal Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Neoplasm Metastasis; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals | 2019 |
Dynamic bioenergetic alterations in colorectal adenomatous polyps and adenocarcinomas.
Topics: Adenocarcinoma; Adenomatous Polyps; Aged; Aged, 80 and over; Biomarkers; Cell Line, Tumor; Colorectal Neoplasms; DNA, Mitochondrial; Energy Metabolism; Female; Fluorodeoxyglucose F18; Humans; Intestinal Mucosa; Male; Middle Aged; Mitochondria; Monocarboxylic Acid Transporters; Muscle Proteins; Mutation; Neoplasm Staging; Oxidative Phosphorylation; Oxygen Consumption; Positron Emission Tomography Computed Tomography; Tumor Burden | 2019 |
Clinical impact of PET/MR in treated colorectal cancer patients.
Topics: Adult; Aged; Colorectal Neoplasms; Electronic Health Records; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Multimodal Imaging; Neoplasm Staging; Positron-Emission Tomography; Retrospective Studies; Treatment Outcome | 2019 |
The prognostic value of quantitative parameters of 18F-FDG PET/CT in the evaluation of response to internal radiation therapy with yttrium-90 in patients with liver metastases of colorectal cancer.
Topics: Adult; Aged; Colorectal Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Prognosis; ROC Curve; Survival Analysis; Tomography, X-Ray Computed; Treatment Outcome; Yttrium Radioisotopes | 2013 |
Invited editorial: Response to therapy assessment of colorectal liver metastasis.
Topics: Adult; Aged; Colorectal Neoplasms; Contrast Media; Female; Fluorodeoxyglucose F18; Humans; Image Enhancement; Iopamidol; Liver Neoplasms; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Spain; Tomography, X-Ray Computed; Treatment Outcome | 2013 |
Relevance of incidental colorectal FDG-PET/CT-enhanced lesions.
Topics: Aged; Aged, 80 and over; Colonoscopy; Colorectal Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Incidental Findings; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Tomography, X-Ray Computed | 2013 |
Standardized added metabolic activity (SAM) IN ¹⁸F-FDG PET assessment of treatment response in colorectal liver metastases.
Topics: Aged; Antibodies, Monoclonal, Humanized; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Bevacizumab; Camptothecin; Colorectal Neoplasms; Female; Fluorodeoxyglucose F18; Fluorouracil; Humans; Leucovorin; Liver Neoplasms; Male; Middle Aged; Multimodal Imaging; Organoplatinum Compounds; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed; Treatment Outcome | 2013 |
Evaluation of ¹⁸F-FDG and ¹⁸F-FLT for monitoring therapeutic responses of colorectal cancer cells to radiotherapy.
Topics: Apoptosis; Cell Line, Tumor; Cell Survival; Colorectal Neoplasms; Dideoxynucleosides; Dose-Response Relationship, Radiation; Fluorodeoxyglucose F18; Humans; Metabolic Clearance Rate; Radionuclide Imaging; Radiopharmaceuticals; Radiotherapy, Image-Guided; Reproducibility of Results; Sensitivity and Specificity; Treatment Outcome | 2013 |
Diagnostic performance of ¹⁸F-fluorothymidine PET/CT for primary colorectal cancer and its lymph node metastasis: comparison with ¹⁸F-fluorodeoxyglucose PET/CT.
Topics: Adult; Aged; Aged, 80 and over; Colorectal Neoplasms; Dideoxynucleosides; Female; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Lymphatic Metastasis; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed | 2013 |
Validation of several SUV-based parameters derived from 18F-FDG PET for prediction of survival after SIRT of hepatic metastases from colorectal cancer.
Topics: Colorectal Neoplasms; Embolization, Therapeutic; Female; Fluorodeoxyglucose F18; Humans; Kaplan-Meier Estimate; Liver Neoplasms; Male; Middle Aged; Positron-Emission Tomography; Prognosis; Treatment Outcome; Yttrium Radioisotopes | 2013 |
Comparing respiratory gated with delayed scans in the detection of colorectal carcinoma hepatic and pulmonary metastases with 18F-FDG PET-CT.
Topics: Aged; Colorectal Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Lung Neoplasms; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Respiratory-Gated Imaging Techniques; Time Factors; Tomography, X-Ray Computed | 2014 |
Evaluation of strategies towards harmonization of FDG PET/CT studies in multicentre trials: comparison of scanner validation phantoms and data analysis procedures.
Topics: Colorectal Neoplasms; Data Interpretation, Statistical; Esophageal Neoplasms; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Multicenter Studies as Topic; Multimodal Imaging; Phantoms, Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Tomography Scanners, X-Ray Computed; Tomography, X-Ray Computed | 2013 |
Which FDG/PET parameters of the primary tumors in colon or sigmoid cancer provide the best correlation with the pathological findings?
Topics: Adult; Aged; Aged, 80 and over; Algorithms; Biopsy; Colorectal Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Image Enhancement; Image Interpretation, Computer-Assisted; Imaging, Three-Dimensional; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Statistics as Topic; Tumor Burden | 2013 |
Incidental focal colorectal ¹⁸F-fluorodeoxyglucose uptake on positron emission tomography/computed tomography.
Topics: Adenoma; Adult; Aged; Aged, 80 and over; Area Under Curve; Carcinoma; Colonoscopy; Colorectal Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Predictive Value of Tests; Prognosis; Radiopharmaceuticals; ROC Curve; Tomography, X-Ray Computed | 2013 |
Test-retest variability of various quantitative measures to characterize tracer uptake and/or tracer uptake heterogeneity in metastasized liver for patients with colorectal carcinoma.
Topics: Area Under Curve; Colorectal Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed | 2014 |
[Influence of FDG-PET-CT on diagnostic and treatment of colorectal cancer].
Topics: Adult; Aged; Aged, 80 and over; Colon; Colorectal Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Prospective Studies; Rectum | 2011 |
F-18 FDG PET/CT in the assessment of patients with unexplained CEA rise after surgical curative resection for colorectal cancer.
Topics: Adult; Aged; Aged, 80 and over; Carcinoembryonic Antigen; Colorectal Neoplasms; Endpoint Determination; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Kaplan-Meier Estimate; Logistic Models; Male; Middle Aged; Multivariate Analysis; Positron-Emission Tomography; ROC Curve; Tomography, X-Ray Computed | 2013 |
A comparison of positron emission tomography and colonoscopy for the detection of advanced colorectal neoplasms in subjects undergoing a health check-up.
Topics: Adult; Aged; Aged, 80 and over; Colonoscopy; Colorectal Neoplasms; Early Detection of Cancer; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Reproducibility of Results; Retrospective Studies; Sensitivity and Specificity; Tomography, X-Ray Computed; Young Adult | 2013 |
Incidental detection of colorectal malignancies using FDG PET-CT.
Topics: Colorectal Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Incidental Findings; Male; Middle Aged; Multimodal Imaging; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Tomography, X-Ray Computed | 2013 |
FDG-PET-CT is effective in selecting patients with poor long term survivals for colorectal liver metastases.
Topics: Adult; Aged; Colorectal Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Interdisciplinary Communication; Kaplan-Meier Estimate; Liver; Liver Neoplasms; Male; Middle Aged; Multimodal Imaging; Neoplasm Staging; Patient Care Team; Patient Selection; Positron-Emission Tomography; Predictive Value of Tests; Prospective Studies; Radiopharmaceuticals; Registries; Retrospective Studies; Tomography, X-Ray Computed; United Kingdom | 2014 |
[Comparison of (18)F-FDG PET/CT and enhancement CT in diagnosing regional lymph node metastasis of colorectal cancer].
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Colorectal Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Lymphatic Metastasis; Male; Middle Aged; Positron-Emission Tomography; Radiographic Image Enhancement; Tomography, X-Ray Computed; Young Adult | 2013 |
(18)F-FDG PET/CT findings of obstructive colitis proximal to colorectal cancer.
Topics: Adult; Aged; Aged, 80 and over; Colitis; Colorectal Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Incidental Findings; Intestinal Obstruction; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Retrospective Studies; Tomography, X-Ray Computed | 2014 |
Preclinical FLT-PET and FDG-PET imaging of tumor response to the multi-targeted Aurora B kinase inhibitor, TAK-901.
Topics: Animals; Aurora Kinase B; Biological Transport; Biomarkers, Tumor; Carbolines; Colorectal Neoplasms; Dideoxynucleosides; Female; Fluorodeoxyglucose F18; HCT116 Cells; Humans; Mice; Positron-Emission Tomography; Protein Kinase Inhibitors; Sulfones; Treatment Outcome | 2014 |
Detection of colorectal cancer and adenomas by FDG-PET cancer screening program: results based on a nationwide Japanese survey.
Topics: Adenoma; Adult; Aged; Aged, 80 and over; Asymptomatic Diseases; Colorectal Neoplasms; Data Collection; Female; Fluorodeoxyglucose F18; Humans; Japan; Male; Mass Screening; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Tomography, X-Ray Computed; Young Adult | 2014 |
Preoperative FDG-PET-scan in patients with resectable colorectal liver metastases does not improve overall survival: a retrospective analyses stratified by clinical risk score.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Colorectal Neoplasms; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Hepatectomy; Humans; Liver Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Prognosis; Retrospective Studies; Survival Rate; Treatment Outcome | 2013 |
A comparison of diagnostic imaging modalities for colorectal liver metastases.
Topics: Adult; Aged; Aged, 80 and over; Cohort Studies; Colorectal Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Liver; Liver Neoplasms; Lymph Nodes; Magnetic Resonance Imaging; Male; Middle Aged; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Tomography, X-Ray Computed; Ultrasonography | 2014 |
Prognostic value of metabolic parameters in patients with synchronous colorectal cancer liver metastasis following curative-intent colorectal and hepatic surgery.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Colorectal Neoplasms; Endpoint Determination; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Glycolysis; Humans; Image Processing, Computer-Assisted; Kaplan-Meier Estimate; Liver Neoplasms; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasms, Multiple Primary; Prognosis; Radionuclide Imaging; Radiopharmaceuticals; Regression Analysis; Risk Factors; Survival Analysis | 2014 |
Diagnostic accuracy of ¹⁸F-FDG PET/CT for detection of advanced colorectal adenoma.
Topics: Adenoma; Adult; Aged; Aged, 80 and over; Colonic Polyps; Colonoscopy; Colorectal Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Tomography, X-Ray Computed | 2014 |
Metabolic response to preoperative chemotherapy predicts prognosis for patients undergoing surgical resection of colorectal cancer metastatic to the liver.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Colorectal Neoplasms; Combined Modality Therapy; Female; Fluorodeoxyglucose F18; Fluorouracil; Follow-Up Studies; Hepatectomy; Humans; Leucovorin; Liver Neoplasms; Male; Middle Aged; Neoplasm Staging; Organoplatinum Compounds; Oxaliplatin; Positron-Emission Tomography; Prognosis; Prospective Studies; Radiopharmaceuticals; ROC Curve; Survival Rate; Tomography, X-Ray Computed; Young Adult | 2014 |
[Diagnostic value of water enema (18)F-fluorodexyglucose positron emission tomography and computed tomography in incidental finding of hypermetabolism focus in the colorectum].
Topics: Adenoma; Colorectal Neoplasms; Diagnosis, Differential; Enema; Fluorodeoxyglucose F18; Humans; Incidental Findings; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed; Water | 2014 |
Respiratory gated and prolonged acquisition 18F-FDG PET improve preoperative assessment of colorectal liver metastases.
Topics: Aged; Aged, 80 and over; Colorectal Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Liver; Liver Neoplasms; Male; Middle Aged; Positron-Emission Tomography; Preoperative Care; Radiopharmaceuticals; Reproducibility of Results; Respiratory-Gated Imaging Techniques; Time Factors | 2015 |
Improved long-term survival after resection of colorectal liver metastases following staging with FDG positron emission tomography.
Topics: Adenocarcinoma; Aged; Chemotherapy, Adjuvant; Colorectal Neoplasms; Female; Fluorodeoxyglucose F18; Hepatectomy; Humans; Kaplan-Meier Estimate; Liver Neoplasms; Male; Middle Aged; Multimodal Imaging; Neoplasm Staging; Patient Selection; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Tomography, X-Ray Computed | 2014 |
Transposed ovary mimicking a peritoneal implant on FDG PET/CT in a patient with carcinoma of the rectum.
Topics: Adult; Carcinoma; Colorectal Neoplasms; Diagnostic Errors; Female; Fluorodeoxyglucose F18; Humans; Multimodal Imaging; Ovary; Peritoneal Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed | 2014 |
Lack of association between KRAS mutations and 18F-FDG PET/CT in Caucasian metastatic colorectal cancer patients.
Topics: Adult; Aged; Colorectal Neoplasms; DNA Mutational Analysis; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Multimodal Imaging; Mutation; Positron-Emission Tomography; Proto-Oncogene Proteins; Proto-Oncogene Proteins p21(ras); Radiopharmaceuticals; ras Proteins; Real-Time Polymerase Chain Reaction; Retrospective Studies; Tomography, X-Ray Computed | 2014 |
The influence of FDG PET-CT on the detection of extrahepatic disease in patients being considered for resection of colorectal liver metastasis.
Topics: Adult; Aged; Aged, 80 and over; Colorectal Neoplasms; False Negative Reactions; False Positive Reactions; Female; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Male; Middle Aged; Multimodal Imaging; Neoplasm Recurrence, Local; Neoplasm Staging; Positron-Emission Tomography; Precancerous Conditions; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, X-Ray Computed | 2014 |
Recent chemotherapy reduces the maximum-standardized uptake value of 18F-fluoro-deoxyglucose positron emission tomography in colorectal cancer.
Topics: Aged; Antineoplastic Agents; Chemoradiotherapy, Adjuvant; Chemotherapy, Adjuvant; Colorectal Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Male; Neoplasm Invasiveness; Neoplasm Metastasis; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies | 2014 |
Value of ¹⁸F-FDG PET-CT in surveillance of postoperative colorectal cancer patients with various carcinoembryonic antigen concentrations.
Topics: Adult; Aged; Carcinoembryonic Antigen; Colorectal Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Multimodal Imaging; Neoplasm Metastasis; Neoplasm Recurrence, Local; Positron-Emission Tomography; Postoperative Period; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Tomography, X-Ray Computed | 2014 |
Measurement of apparent diffusion coefficient with simultaneous MR/positron emission tomography in patients with peritoneal carcinomatosis: comparison with 18F-FDG-PET.
Topics: Adult; Aged; Carcinoma; Colorectal Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Multimodal Imaging; Ovarian Neoplasms; Peritoneal Neoplasms; Positron-Emission Tomography; Prospective Studies; Sensitivity and Specificity | 2014 |
Correlation of intra-tumor 18F-FDG uptake heterogeneity indices with perfusion CT derived parameters in colorectal cancer.
Topics: Colorectal Neoplasms; Female; Fluorodeoxyglucose F18; Genetic Heterogeneity; Humans; Male; Positron-Emission Tomography; Prospective Studies; Radiographic Image Enhancement; Radiopharmaceuticals; Tomography, X-Ray Computed; Tumor Burden | 2014 |
CT versus FDG-PET/CT response evaluation in patients with metastatic colorectal cancer treated with irinotecan and cetuximab.
Topics: Adult; Aged; Aged, 80 and over; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Cetuximab; Colorectal Neoplasms; Disease Progression; Female; Fluorodeoxyglucose F18; Humans; Irinotecan; Male; Middle Aged; Neoplasm Metastasis; Positron-Emission Tomography; Proto-Oncogene Proteins; Proto-Oncogene Proteins p21(ras); ras Proteins; Tomography, X-Ray Computed; Treatment Outcome | 2014 |
Correlation between PET/CT parameters and KRAS expression in colorectal cancer.
Topics: Adult; Aged; Aged, 80 and over; Biomarkers, Tumor; Colorectal Neoplasms; Data Interpretation, Statistical; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Multimodal Imaging; Mutation; Positron-Emission Tomography; Proto-Oncogene Proteins; Proto-Oncogene Proteins p21(ras); Radiopharmaceuticals; ras Proteins; Tomography, X-Ray Computed | 2014 |
Imaging in resectable colorectal liver metastasis patients with or without preoperative chemotherapy: results of the PROMETEO-01 study.
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Agents; Chemotherapy, Adjuvant; Colorectal Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Induction Chemotherapy; Liver Neoplasms; Male; Middle Aged; Positron-Emission Tomography; Preoperative Care; Prospective Studies; Radiopharmaceuticals; Sensitivity and Specificity | 2014 |
Prognostic value of 18F-FDG uptake by regional lymph nodes on pretreatment PET/CT in patients with resectable colorectal cancer.
Topics: Adult; Aged; Aged, 80 and over; Case-Control Studies; Colorectal Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Lymphatic Metastasis; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Predictive Value of Tests; Prognosis; Radiopharmaceuticals; Tomography, X-Ray Computed | 2014 |
Detection of a liver metastasis by breath-hold FDG-PET/CT not visible on standard PET/CT.
Topics: Colorectal Neoplasms; Diagnosis, Differential; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Male; Middle Aged; Positron-Emission Tomography; Tomography, X-Ray Computed | 2014 |
Positron emission tomography combined with computed tomography for diagnosis of synchronous tumors.
Topics: Aged; Carcinoma, Neuroendocrine; Colorectal Neoplasms; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Lung Neoplasms; Male; Middle Aged; Multimodal Imaging; Neoplasms, Multiple Primary; Neoplasms, Second Primary; Ovarian Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed | 2014 |
Ability of 18-fludeoxyglucose positron emission tomography/CT to detect incidental cancer.
Topics: Aged; Aged, 80 and over; Colorectal Neoplasms; Diagnostic Errors; Female; Fluorodeoxyglucose F18; Humans; Incidental Findings; Lung Neoplasms; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies | 2014 |
Value of CT, FDG PET-CT and serum tumor markers in staging recurrent colorectal cancer.
Topics: Adult; Aged; Aged, 80 and over; Biomarkers, Tumor; Colorectal Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Multimodal Imaging; Neoplasm Recurrence, Local; Neoplasm Staging; Positron-Emission Tomography; Retrospective Studies; Sensitivity and Specificity; Tomography, X-Ray Computed; Tumor Burden; Young Adult | 2015 |
Classification of Physiological 18F-fluorodeoxyglucose Uptake in the Large Intestine: a Preliminary Study.
Topics: Aged; Colonoscopy; Colorectal Neoplasms; Diagnostic Errors; False Positive Reactions; Feasibility Studies; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Intestine, Large; Male; Mass Screening; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Risk | 2014 |
Correlation between long-term aspirin use and F-fluorodeoxyglucose uptake in colorectal cancer measured by PET/CT.
Topics: Adult; Aged; Aged, 80 and over; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Case-Control Studies; Colorectal Neoplasms; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Male; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Tomography, X-Ray Computed; Tumor Burden | 2014 |
¹⁸F-FDG PET/contrast enhanced CT in the standard surveillance of high risk colorectal cancer patients.
Topics: Adult; Aged; Colorectal Neoplasms; Contrast Media; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Multimodal Imaging; Neoplasm Recurrence, Local; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Reproducibility of Results; Tomography, X-Ray Computed | 2014 |
Early post-treatment FDG PET predicts survival after 90Y microsphere radioembolization in liver-dominant metastatic colorectal cancer.
Topics: Aged; Aged, 80 and over; Colorectal Neoplasms; Embolization, Therapeutic; Female; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Male; Microspheres; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Survival Analysis; Tomography, X-Ray Computed; Yttrium Radioisotopes | 2015 |
The potential usefulness of (18)F-FDG PET/CT for detecting colorectal carcinoma and adenoma in asymptomatic adults.
Topics: Adenoma; Asymptomatic Diseases; Colorectal Neoplasms; Endoscopy, Gastrointestinal; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Retrospective Studies; ROC Curve; Tomography, X-Ray Computed | 2015 |
Regulation of 18F-FDG accumulation in colorectal cancer cells with mutated KRAS.
Topics: Animals; Cell Hypoxia; Cell Line, Tumor; Colorectal Neoplasms; Fluorodeoxyglucose F18; Glucose; Humans; Mice; Mutation; Neoplasm Transplantation; Positron-Emission Tomography; Proto-Oncogene Proteins; Proto-Oncogene Proteins p21(ras); Radiopharmaceuticals; ras Proteins | 2014 |
PET scans as a predictive marker of survival in advanced colorectal cancer.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Colorectal Neoplasms; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Male; Middle Aged; Neoplasm Metastasis; Positron-Emission Tomography; Retrospective Studies; Survival Rate; Treatment Outcome | 2015 |
The performance of contrast-enhanced FDG PET/CT for the differential diagnosis of unexpected ovarian mass lesions in patients with nongynecologic cancer.
Topics: Adult; Aged; Aged, 80 and over; Breast Neoplasms; Case-Control Studies; Colorectal Neoplasms; Contrast Media; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Multimodal Imaging; Ovarian Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Tomography, X-Ray Computed | 2015 |
Early postoperative 18F-FDG PET/CT in high-risk stage III colorectal cancer.
Topics: Adult; Aged; Aged, 80 and over; Colorectal Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Multimodal Imaging; Neoplasm Staging; Positron-Emission Tomography; Postoperative Period; Prospective Studies; Radiopharmaceuticals; Tomography, X-Ray Computed | 2015 |
Early prediction by 18F-FDG PET/CT for progression-free survival and overall survival in patients with metastatic colorectal cancer receiving third-line cetuximab-based therapy.
Topics: Adult; Aged; Antibodies, Monoclonal, Humanized; Antineoplastic Agents; Cetuximab; Colorectal Neoplasms; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Multimodal Imaging; Neoplasm Metastasis; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed; Treatment Outcome | 2015 |
[False-positive local recurrences on FDG-PET/CT due to postoperative infection - a case report].
Topics: Abdominal Abscess; Aged; Colorectal Neoplasms; Diagnosis, Differential; Fluorodeoxyglucose F18; Humans; Male; Neoplasm Recurrence, Local; Positron-Emission Tomography; Tomography, X-Ray Computed | 2014 |
The role of routine clinical pretreatment 18F-FDG PET/CT in predicting outcome of colorectal liver metastasis.
Topics: Adult; Aged; Aged, 80 and over; Colorectal Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed | 2015 |
[Correlation of ¹⁸F-FDG PET-CT maximum standard uptake value and T/N ratio with the prognosis of postoperative colorectal cancer].
Topics: Colorectal Neoplasms; Disease-Free Survival; Fluorodeoxyglucose F18; Humans; Multimodal Imaging; Neoplasm Staging; Positron-Emission Tomography; Postoperative Period; Prognosis; Proportional Hazards Models; Retrospective Studies; ROC Curve; Tomography, X-Ray Computed | 2015 |
[Diagnostic value of ¹⁸F-fluorodexyglucose positron emission tomography combined with contrast enhanced computed tomography in colorectal cancer liver metastasis].
Topics: Colorectal Neoplasms; Contrast Media; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Multimodal Imaging; Positron-Emission Tomography; Retrospective Studies; Tomography, X-Ray Computed | 2015 |
Impact of FDG-PET findings on decisions regarding patient management strategies: a multicenter trial in patients with lung cancer and other types of cancer.
Topics: Adult; Aged; Aged, 80 and over; Brain Neoplasms; Breast Neoplasms; Colorectal Neoplasms; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Image Interpretation, Computer-Assisted; Lung Neoplasms; Lymphoma; Male; Melanoma; Middle Aged; Pancreatic Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Young Adult | 2015 |
Multimodality imaging to predict response to systemic treatment in patients with advanced colorectal cancer.
Topics: Adult; Aged; Colorectal Neoplasms; Diffusion Magnetic Resonance Imaging; Female; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Predictive Value of Tests; Treatment Outcome | 2015 |
Subcutaneous and muscular metastasis of the colorectal cancer on F-18 FDG PET/CT.
Topics: Adult; Aged; Aged, 80 and over; Colorectal Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Multimodal Imaging; Muscle Neoplasms; Neoplasm Metastasis; Positron-Emission Tomography; Retrospective Studies; Skin Neoplasms; Tomography, X-Ray Computed | 2015 |
Endotracheal metastasis from colorectal cancer.
Topics: Colorectal Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed; Tracheal Neoplasms | 2015 |
F-18 FDG PET/CT findings of metastatic ovarian tumors from gastrointestinal tract origin.
Topics: Colorectal Neoplasms; Female; Fluorodeoxyglucose F18; Gastrointestinal Tract; Humans; Middle Aged; Neoplasm Metastasis; Ovarian Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Stomach Neoplasms; Tomography, X-Ray Computed | 2015 |
PET scan findings can be false positive.
Topics: Colorectal Neoplasms; False Positive Reactions; Fluorodeoxyglucose F18; Gastrointestinal Tract; Humans; Positron-Emission Tomography; Radiopharmaceuticals | 2015 |
¹⁸F-FDG PET/CT and Colorectal Cancer: Value of Fourth and Subsequent Posttherapy Follow-up Scans for Patient Management.
Topics: Aged; Biopsy; Colorectal Neoplasms; Electronic Health Records; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Neoplasm Metastasis; Positron-Emission Tomography; Prognosis; Proportional Hazards Models; Recurrence; Registries; Retrospective Studies; Time Factors; Tomography, X-Ray Computed; Treatment Outcome | 2015 |
Clinical Performance of Whole-Body 18F-FDG PET/Dixon-VIBE, T1-Weighted, and T2-Weighted MRI Protocol in Colorectal Cancer.
Topics: Aged; Aged, 80 and over; Colorectal Neoplasms; Diffusion Magnetic Resonance Imaging; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Whole Body Imaging | 2015 |
Genetic Alterations in Colorectal Cancer Have Different Patterns on 18F-FDG PET/CT.
Topics: Adult; Aged; Aged, 80 and over; Biomarkers, Tumor; Colorectal Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Multimodal Imaging; Mutation; Positron-Emission Tomography; Proto-Oncogene Proteins; Proto-Oncogene Proteins p21(ras); Radiopharmaceuticals; ras Proteins; Tomography, X-Ray Computed; Tumor Suppressor Protein p53 | 2015 |
Prognostic Value of Total Lesion Glycolysis Measured by 18F-FDG-PET/CT in Patients with Colorectal Cancer.
Topics: Adult; Aged; Aged, 80 and over; Colorectal Neoplasms; Female; Fluorodeoxyglucose F18; Glycolysis; Humans; Male; Middle Aged; Multimodal Imaging; Neoplasm Staging; Positron-Emission Tomography; Prognosis; Proportional Hazards Models; Survival Analysis; Tomography, X-Ray Computed | 2015 |
Comparison of hybrid FDG PET/MRI compared with PET/CT in colorectal cancer staging and restaging: a pilot study.
Topics: Aged; Colon; Colorectal Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Multimodal Imaging; Neoplasm Staging; Pilot Projects; Positron-Emission Tomography; Radiopharmaceuticals; Rectum; Reproducibility of Results; Tomography, X-Ray Computed | 2015 |
Pitfalls and mimickers on (18)F-FDG-PET/CT in peritoneal carcinomatosis from colorectal cancer: An analysis from 37 patients.
Topics: Adenocarcinoma; Adult; Aged; Colorectal Neoplasms; Cytoreduction Surgical Procedures; False Positive Reactions; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Multimodal Imaging; Peritoneal Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Tomography, X-Ray Computed | 2015 |
Relationship Between 18F-FDG PET/CT Scans and KRAS Mutations in Metastatic Colorectal Cancer.
Topics: Adult; Aged; Aged, 80 and over; Colorectal Neoplasms; Fluorodeoxyglucose F18; Genetic Markers; Humans; Lymphatic Metastasis; Middle Aged; Multimodal Imaging; Mutation; Polymorphism, Single Nucleotide; Positron-Emission Tomography; Proto-Oncogene Proteins; Proto-Oncogene Proteins p21(ras); Radiopharmaceuticals; ras Proteins; Reproducibility of Results; Risk Assessment; Sensitivity and Specificity; Tomography, X-Ray Computed | 2015 |
Does a novel penalized likelihood reconstruction of 18F-FDG PET-CT improve signal-to-background in colorectal liver metastases?
Topics: Adult; Algorithms; Artifacts; Bayes Theorem; Colorectal Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Likelihood Functions; Liver Neoplasms; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Signal-To-Noise Ratio; Tomography, X-Ray Computed | 2015 |
A General Cutoff Level Combined With Personalized Dynamic Change of Serum Carcinoembryonic Antigen Can Suggest Timely Use of FDG PET for Early Detection of Recurrent Colorectal Cancer.
Topics: Adult; Aged; Biomarkers, Tumor; Carcinoembryonic Antigen; Colorectal Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Positron-Emission Tomography; Precision Medicine; Radiopharmaceuticals | 2015 |
Assessment of metastatic colorectal cancer with hybrid imaging: comparison of reading performance using different combinations of anatomical and functional imaging techniques in PET/MRI and PET/CT in a short case series.
Topics: Adolescent; Adult; Child; Colorectal Neoplasms; Diffusion Magnetic Resonance Imaging; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Multimodal Imaging; Neoplasm Metastasis; Positron-Emission Tomography; Retrospective Studies; Tomography, X-Ray Computed; Young Adult | 2016 |
The Synergistic Effect of Selumetinib/Docetaxel Combination Therapy Monitored by [(18)F]FDG/[(18)F]FLT PET and Diffusion-Weighted Magnetic Resonance Imaging in a Colorectal Tumor Xenograft Model.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Benzimidazoles; Cell Proliferation; Colorectal Neoplasms; Dideoxynucleosides; Diffusion Magnetic Resonance Imaging; Docetaxel; Drug Synergism; Fluorodeoxyglucose F18; HCT116 Cells; Humans; Immunohistochemistry; Mice; Positron-Emission Tomography; Taxoids; Xenograft Model Antitumor Assays | 2016 |
Performance of tumor growth kinetics as an imaging biomarker for response assessment in colorectal liver metastases: correlation with FDG PET.
Topics: Adult; Aged; Angiogenesis Inhibitors; Bevacizumab; Biomarkers; Colorectal Neoplasms; Fluorodeoxyglucose F18; Humans; Liver; Liver Neoplasms; Male; Middle Aged; Multidetector Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals; Treatment Outcome | 2015 |
Standardized Added Metabolic Activity Predicts Survival After Intra-arterial Resin-Based 90Y Radioembolization Therapy in Unresectable Chemorefractory Metastatic Colorectal Cancer to the Liver.
Topics: Adult; Aged; Aged, 80 and over; Colorectal Neoplasms; Embolization, Therapeutic; Female; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Yttrium Radioisotopes | 2016 |
[Correlation between metabolic tumor volume (MTV) and microvessel density (MVD) and blood-borne metastasis in colorectal carcinoma].
Topics: Colorectal Neoplasms; Fluorodeoxyglucose F18; Humans; Microvessels; Multimodal Imaging; Neoplasm Staging; Neoplastic Cells, Circulating; Positron-Emission Tomography; Radiopharmaceuticals; ROC Curve; Sensitivity and Specificity; Tomography, X-Ray Computed | 2015 |
Comparison of (18)F-fluorodeoxyglucose PET/CT findings with vascular endothelial growth factors and receptors in colorectal cancer.
Topics: Aged; Colorectal Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neoplasm Metastasis; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Receptors, Vascular Endothelial Growth Factor; Retrospective Studies; ROC Curve; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factor D; Vascular Endothelial Growth Factor Receptor-3 | 2016 |
A 79-Year-Old Man With Interstitial Lung Disease and Cryptic Area of High 18 Fluorodeoxyglucose Uptake in Left Upper Lobe.
Topics: Adenocarcinoma; Aged; Carcinoembryonic Antigen; Colectomy; Colorectal Neoplasms; Fluorodeoxyglucose F18; Humans; Lung Diseases, Interstitial; Lung Neoplasms; Male; Monitoring, Physiologic; Neoplasms, Second Primary; Pneumonectomy; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed; Treatment Outcome | 2015 |
Diagnostic performance of CT, MRI and PET/CT in patients with suspected colorectal liver metastases: the superiority of MRI.
Topics: Adult; Aged; Aged, 80 and over; Colorectal Neoplasms; Contrast Media; Diffusion Magnetic Resonance Imaging; Female; Fluorodeoxyglucose F18; Gadolinium DTPA; Humans; Liver Neoplasms; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Prospective Studies; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, X-Ray Computed | 2016 |
Relationship between Preoperative ¹⁸F-Fluorodeoxyglucose Uptake and Epidermal Growth Factor Receptor Status in Primary Colorectal Cancer.
Topics: Adult; Aged; Aged, 80 and over; Colorectal Neoplasms; ErbB Receptors; Female; Fluorodeoxyglucose F18; Humans; Immunohistochemistry; Male; Middle Aged; Multimodal Imaging; Neoplasm Staging; Positron-Emission Tomography; Predictive Value of Tests; Prognosis; Radiography; Radiopharmaceuticals; ROC Curve; Sensitivity and Specificity | 2016 |
The preoperative SUVmax for (18)F-FDG uptake predicts survival in patients with colorectal cancer.
Topics: Adult; Aged; Colorectal Neoplasms; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Predictive Value of Tests; Prognosis; Radiopharmaceuticals; Retrospective Studies; ROC Curve; Sensitivity and Specificity; Tomography, X-Ray Computed | 2015 |
Added Value of Integrated Whole-Body PET/MRI for Evaluation of Colorectal Cancer: Comparison With Contrast-Enhanced MDCT.
Topics: Adult; Aged; Colorectal Neoplasms; Contrast Media; Fluorodeoxyglucose F18; Humans; Image Interpretation, Computer-Assisted; Magnetic Resonance Imaging; Middle Aged; Multidetector Computed Tomography; Multimodal Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Whole Body Imaging | 2016 |
Relationship Between 18F-Fluorodeoxyglucose Uptake and V-Ki-Ras2 Kirsten Rat Sarcoma Viral Oncogene Homolog Mutation in Colorectal Cancer Patients: Variability Depending on C-Reactive Protein Level.
Topics: Aged; C-Reactive Protein; Colorectal Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Multimodal Imaging; Mutation; Polymerase Chain Reaction; Positron-Emission Tomography; Proto-Oncogene Proteins p21(ras); Radiopharmaceuticals; Sarcoma; Tomography, X-Ray Computed | 2016 |
Focal colorectal uptake in (18)FDG-PET/CT: maximum standard uptake value as a trigger in a semi-automated screening setting.
Topics: Adult; Aged; Aged, 80 and over; Colon; Colonoscopy; Colorectal Neoplasms; Early Detection of Cancer; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Reproducibility of Results; Retrospective Studies; Sensitivity and Specificity; Tomography, X-Ray Computed | 2016 |
Trends in the Use of (18)F-Fluorodeoxyglucose PET Imaging in Surveillance of Non-Small-Cell Lung and Colorectal Cancer.
Topics: Aged; Carcinoma, Non-Small-Cell Lung; Colorectal Neoplasms; Decision Making; Evidence-Based Medicine; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Medicare; Neoplasm Staging; Population Surveillance; Positron-Emission Tomography; Radiopharmaceuticals; SEER Program; United States | 2016 |
Predictive Role of Functional Visceral Fat Activity Assessed by Preoperative F-18 FDG PET/CT for Regional Lymph Node or Distant Metastasis in Patients with Colorectal Cancer.
Topics: Adenocarcinoma; Aged; C-Reactive Protein; Colorectal Neoplasms; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Inflammation; Intra-Abdominal Fat; Lymphatic Metastasis; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Subcutaneous Fat; Tomography, X-Ray Computed | 2016 |
Clinicopathological Features of Second Primary Colorectal Cancer Incidentally Identified by 18F-FDG-PET.
Topics: Aged; Asymptomatic Diseases; Colorectal Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Incidental Findings; Male; Neoplasm Staging; Neoplasms, Second Primary; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Retrospective Studies; Tumor Burden | 2015 |
Visual and quantitative comparison of (18)F-fluorodeoxyglucose PET/CT findings in the detection of pelvic tumor recurrence in colorectal cancer.
Topics: Adult; Aged; Aged, 80 and over; Colorectal Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Pelvic Neoplasms; Positron Emission Tomography Computed Tomography; Recurrence; Retrospective Studies; ROC Curve | 2016 |
Sensitivity of 2-[
Topics: Adult; Aged; Aged, 80 and over; Colonoscopy; Colorectal Neoplasms; Early Detection of Cancer; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neoplasm Invasiveness; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Sensitivity and Specificity; Single-Blind Method | 2016 |
Clinical value of intratumoral metabolic heterogeneity in [18F]FDG PET/CT for prediction of recurrence in patients with locally advanced colorectal cancer.
Topics: Colorectal Neoplasms; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Recurrence; Retrospective Studies | 2018 |
Colorectal Cancer Liver Metastases: Diagnostic Performance and Prognostic Value of PET/MR Imaging.
Topics: Adult; Aged; Aged, 80 and over; Colorectal Neoplasms; Contrast Media; Female; Fluorodeoxyglucose F18; Gadolinium DTPA; Humans; Liver Neoplasms; Magnetic Resonance Imaging; Male; Middle Aged; Multidetector Computed Tomography; Multimodal Imaging; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies; Survival Rate; Whole Body Imaging | 2016 |
Clinical evaluation of (18)F-fludeoxyglucose positron emission tomography/CT using point spread function reconstruction for nodal staging of colorectal cancer.
Topics: Algorithms; Colorectal Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Image Interpretation, Computer-Assisted; Image Processing, Computer-Assisted; Lymph Nodes; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Reproducibility of Results; Retrospective Studies; Signal-To-Noise Ratio | 2016 |
Metabolic tumor volume and total lesion glycolysis on FDG-PET/CT can predict overall survival after (90)Y radioembolization of colorectal liver metastases: A comparison with SUVmax, SUVpeak, and RECIST 1.0.
Topics: Adult; Aged; Aged, 80 and over; Brachytherapy; Colorectal Neoplasms; Female; Fluorodeoxyglucose F18; Glycolysis; Humans; Liver; Liver Neoplasms; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Predictive Value of Tests; Radiopharmaceuticals; Response Evaluation Criteria in Solid Tumors; Retrospective Studies; Survival Analysis; Tumor Burden; Yttrium Radioisotopes | 2016 |
Early 18F-FDG PET/CT Evaluation Shows Heterogeneous Metabolic Responses to Anti-EGFR Therapy in Patients with Metastatic Colorectal Cancer.
Topics: Adenocarcinoma; Aged; Algorithms; Antineoplastic Agents; Biomarkers; Cetuximab; Colorectal Neoplasms; ErbB Receptors; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Multimodal Imaging; Neoplasm Metastasis; Pilot Projects; Positron Emission Tomography Computed Tomography; Proto-Oncogene Proteins p21(ras); Treatment Outcome | 2016 |
Surrogate Imaging Biomarkers of Response of Colorectal Liver Metastases After Salvage Radioembolization Using 90Y-Loaded Resin Microspheres.
Topics: Adult; Aged; Aged, 80 and over; Biomarkers, Tumor; Colorectal Neoplasms; Contrast Media; Female; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Male; Microspheres; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Response Evaluation Criteria in Solid Tumors; Retrospective Studies; Salvage Therapy; Sensitivity and Specificity; Survival Rate; Tomography, X-Ray Computed; Yttrium Radioisotopes | 2016 |
Fluoro-2-deoxy-d-glucose positron emission tomography/computed tomography for the detection of proximal synchronous lesions in patients with obstructive colorectal cancer.
Topics: Adenoma; Aged; Colectomy; Colon; Colonoscopy; Colorectal Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Intestinal Obstruction; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Predictive Value of Tests; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity | 2017 |
JOURNAL CLUB: Value of Quantitative FDG PET/CT Volumetric Biomarkers in Recurrent Colorectal Cancer Patient Survival.
Topics: Aged; Biopsy; Colorectal Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Radiographic Image Interpretation, Computer-Assisted; Radiopharmaceuticals; Retrospective Studies; Survival Analysis; Tumor Burden | 2016 |
The prognostic value of fluorodeoxyglucose positron emission tomography metabolic tumor volume in solitary colorectal liver metastasis.
Topics: Adult; Aged; Aged, 80 and over; Colorectal Neoplasms; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Male; Middle Aged; Positron-Emission Tomography; Prognosis; Retrospective Studies; Survival Rate; Treatment Outcome; Tumor Burden | 2017 |
Impact of Fluorine-18 2-Fluoro-2-Deoxy-D-Glucose Uptake on Preoperative Positron Emission Tomography/Computed Tomography in the Lymph Nodes of Patients with Primary Colorectal Cancer.
Topics: Adult; Aged; Aged, 80 and over; Colorectal Neoplasms; Contrast Media; Disease Progression; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Predictive Value of Tests; Prognosis; Radiopharmaceuticals; Retrospective Studies; Survival Rate; Tomography, X-Ray Computed; Young Adult | 2017 |
Background Colonic 18F-Fluoro-2-Deoxy-D-Glucose Uptake on Positron Emission Tomography Is Associated with the Presence of Colorectal Adenoma.
Topics: Adenoma; Adult; Aged; Colonoscopy; Colorectal Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies | 2016 |
Correlation of Ki-67 proliferation index and 18-fluorodeoxyglucose uptake in colorectal incidental lesions detected by positron emission tomography-computed tomography.
Topics: Cell Proliferation; Colorectal Neoplasms; Fluorodeoxyglucose F18; Humans; Multimodal Imaging; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Tomography, X-Ray Computed | 2016 |
Can positron emission tomography detect colorectal adenomas and cancers?
Topics: Adenoma; Adult; Aged; Aged, 80 and over; Colonoscopy; Colorectal Neoplasms; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Multivariate Analysis; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity; Young Adult | 2017 |
Metabolic Tumor Volume and Total Lesion Glycolysis in PET/CT Correlate With the Pathological Findings of Colorectal Cancer and Allow Its Accurate Staging.
Topics: Adult; Aged; Aged, 80 and over; Area Under Curve; Colorectal Neoplasms; Female; Fluorodeoxyglucose F18; Glycolysis; Humans; Male; Middle Aged; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Prognosis; Retrospective Studies; ROC Curve; Tumor Burden | 2016 |
Diagnostic accuracy of 18F-FDG PET/CT for detecting synchronous advanced colorectal neoplasia in patients with gastric cancer.
Topics: Adult; Aged; Aged, 80 and over; Colorectal Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neoplasms, Multiple Primary; Positron Emission Tomography Computed Tomography; Predictive Value of Tests; Retrospective Studies; Stomach Neoplasms | 2016 |
Survival Outcomes in Asymptomatic Patients With Normal Conventional Imaging but Raised Carcinoembryonic Antigen Levels in Colorectal Cancer Following Positron Emission Tomography-Computed Tomography Imaging.
Topics: Adult; Aged; Aged, 80 and over; Carcinoembryonic Antigen; Colorectal Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Retrospective Studies | 2016 |
Positron Emission Tomography-Computed Tomography for Patients with Recurrent Colorectal Liver Metastases: Impact on Restaging and Treatment Planning.
Topics: Bone Neoplasms; Colorectal Neoplasms; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Lung Neoplasms; Lymph Nodes; Lymphatic Metastasis; Magnetic Resonance Imaging; Neoplasm Staging; Patient Care Planning; Peritoneal Neoplasms; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Recurrence; Sensitivity and Specificity; Survival Rate | 2017 |
Prognostic Importance of the Presence of Early Metabolic Response and Absence of Extrahepatic Metastasis After Selective Internal Radiation Therapy in Colorectal Cancer Liver Metastasis.
Topics: Colorectal Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Male; Middle Aged; Neoplasm Metastasis; Positron Emission Tomography Computed Tomography; Prognosis; Survival Analysis | 2016 |
Effect of chemotherapy on the impact of FDG-PET/CT in selection of patients for surgical resection of colorectal liver metastases: single center analysis of PET-CAM randomized trial.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Colorectal Neoplasms; Combined Modality Therapy; Female; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Young Adult | 2017 |
Clinicopathological analysis and risk factors of advanced colorectal neoplasms incidentally detected by 18F-FDG PET-CT.
Topics: Adult; Aged; Aged, 80 and over; Colonoscopy; Colorectal Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Incidental Findings; Male; Middle Aged; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Retrospective Studies; Risk Factors; ROC Curve | 2017 |
[Surgery of colorectal lung metastases : Results of a survey in Germany].
Topics: Colorectal Neoplasms; Contraindications; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Lung Neoplasms; Metastasectomy; Pneumonectomy; Positron-Emission Tomography; Prognosis; Surveys and Questionnaires; Tomography, X-Ray Computed; United Kingdom | 2017 |
Preoperative localization of distal colorectal tumours.
Topics: Aged; Colonoscopy; Colorectal Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Male; Positron Emission Tomography Computed Tomography; Preoperative Care; Radiopharmaceuticals; Retrospective Studies; Tomography, X-Ray Computed | 2016 |
Methylglyoxal-Mediated Stress Correlates with High Metabolic Activity and Promotes Tumor Growth in Colorectal Cancer.
Topics: Adult; Aged; Animals; Carnosine; Cell Line, Tumor; Cell Proliferation; Chickens; Cohort Studies; Colorectal Neoplasms; Fluorodeoxyglucose F18; Glycolysis; Humans; Lactoylglutathione Lyase; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Pyrimidines; Pyruvaldehyde; Stress, Physiological | 2017 |
Detection and Viability of Colorectal Liver Metastases After Neoadjuvant Chemotherapy: A Multiparametric PET/CT-MRI Study.
Topics: Aged; Colorectal Neoplasms; Contrast Media; Female; Fluorodeoxyglucose F18; Gadolinium DTPA; Humans; Liver Neoplasms; Magnetic Resonance Imaging; Male; Middle Aged; Neoadjuvant Therapy; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals | 2017 |
Survival Outcomes for Patients With Indeterminate 18FDG-PET Scan for Extrahepatic Disease Before Liver Resection for Metastatic Colorectal Cancer: A Retrospective Cohort Study Using a Prospectively Maintained Database to Analyze Survival Outcomes for Pati
Topics: Colorectal Neoplasms; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Hepatectomy; Humans; Liver; Liver Neoplasms; Male; Middle Aged; Neoplasm Staging; Peritoneal Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; South Australia; Survival Rate | 2018 |
Accuracy of FDG-PET/CT in Colorectal Peritoneal Carcinomatosis: Potential Tool for Evaluation of Chemotherapeutic Response.
Topics: Adult; Aged; Aged, 80 and over; Colorectal Neoplasms; Drug Therapy; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neoadjuvant Therapy; Outcome Assessment, Health Care; Peritoneal Neoplasms; Positron Emission Tomography Computed Tomography; Reproducibility of Results; Retrospective Studies; Sensitivity and Specificity | 2017 |
Mucosa-associated lymphoid tissue lymphoma with unusual
Topics: Adenocarcinoma; Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Chemoradiotherapy, Adjuvant; Colectomy; Colon, Sigmoid; Colonoscopy; Colorectal Neoplasms; Cyclophosphamide; Fluorodeoxyglucose F18; Humans; Lymphoma, B-Cell, Marginal Zone; Male; Neoplasm Recurrence, Local; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Prednisone; Remission Induction; Rituximab; Sigmoid Neoplasms; Vincristine | 2017 |
Comparison of Contrast-Enhanced CT and [
Topics: Adult; Aged; Aged, 80 and over; Colorectal Neoplasms; Contrast Media; Female; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Staging; Positron Emission Tomography Computed Tomography | 2017 |
Safety and efficacy of microwave ablation for medically inoperable colorectal pulmonary metastases: Single-centre experience.
Topics: Aged; Catheter Ablation; Colorectal Neoplasms; Contrast Media; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Microwaves; Positron Emission Tomography Computed Tomography; Radiography, Interventional; Radiopharmaceuticals; Retrospective Studies; Treatment Outcome | 2017 |
Clinical case report and literature review: metachronous colorectal splenic metastases.
Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Carcinoembryonic Antigen; Colorectal Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Middle Aged; Positron-Emission Tomography; Splenectomy; Splenic Neoplasms | 2008 |
Colorectal tumor cells treated with 5-FU, oxaliplatin, irinotecan, and cetuximab exhibit changes in 18F-FDG incorporation corresponding to hexokinase activity and glucose transport.
Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Agents; Biological Transport; Camptothecin; Cell Line, Tumor; Cell Survival; Cetuximab; Colorectal Neoplasms; Drug Interactions; Fluorodeoxyglucose F18; Fluorouracil; Glucose; Hexokinase; Humans; Irinotecan; Organoplatinum Compounds; Oxaliplatin; Radiopharmaceuticals | 2008 |
Impact of angiogenesis-related gene expression on the tracer kinetics of 18F-FDG in colorectal tumors.
Topics: Angiopoietin-2; Colorectal Neoplasms; Fluorodeoxyglucose F18; Gene Expression Profiling; Humans; Neovascularization, Pathologic; Oligonucleotide Array Sequence Analysis; Positron-Emission Tomography; Radiopharmaceuticals; Vascular Endothelial Growth Factor A | 2008 |
Improvement of the diagnostic accuracy of lymph node metastases of colorectal cancer in 18F-FDG-PET/CT by optimizing the iteration number for the image reconstruction.
Topics: Algorithms; Colorectal Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Image Enhancement; Image Interpretation, Computer-Assisted; Lymph Nodes; Lymphatic Metastasis; Male; Middle Aged; Phantoms, Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Subtraction Technique; Tomography, X-Ray Computed | 2008 |
Comparison of MRI (including SS SE-EPI and SPIO-enhanced MRI) and FDG-PET/CT for the detection of colorectal liver metastases.
Topics: Aged; Colorectal Neoplasms; Contrast Media; Dextrans; Female; Ferric Compounds; Ferrosoferric Oxide; Fluorodeoxyglucose F18; Humans; Iron; Liver; Magnetic Resonance Imaging; Magnetite Nanoparticles; Male; Middle Aged; Neoplasm Metastasis; Oxides; Positron-Emission Tomography; Tomography, X-Ray Computed | 2009 |
Protocol considerations for positron emission tomography-computed tomography of the abdomen and pelvis.
Topics: Abdominal Neoplasms; Colorectal Neoplasms; Contrast Media; Female; Fluorodeoxyglucose F18; Gastrointestinal Stromal Tumors; Genital Neoplasms, Female; Humans; Lymphoma; Lymphoproliferative Disorders; Pancreatic Neoplasms; Pelvic Neoplasms; Positron-Emission Tomography; Sarcoma; Stomach Neoplasms; Tomography, X-Ray Computed | 2008 |
Unique site- and time-specific patterns of recurrence following resection of colorectal carcinoma hepatic metastases in patients staged by FDG-PET.
Topics: Adult; Aged; Aged, 80 and over; Colorectal Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Male; Middle Aged; Neoplasm Recurrence, Local; Positron-Emission Tomography; Preoperative Care; Radiopharmaceuticals; Time Factors; Young Adult | 2008 |
FDG-PET demonstration of asymptomatic skeletal muscle metastasis from colorectal carcinoma.
Topics: Carcinoma; Colorectal Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Muscle Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals | 2008 |
Focal fat spared area in the liver masquerading as hepatic metastasis on F-18 FDG PET imaging.
Topics: Biopsy; Colorectal Neoplasms; False Positive Reactions; Fluorodeoxyglucose F18; Humans; Intra-Abdominal Fat; Liver Neoplasms; Male; Middle Aged; Positron-Emission Tomography; Tomography, X-Ray Computed; Whole Body Imaging | 2008 |
Role of IV iodinated contrast material in 18F-FDG PET/CT of liver metastases.
Topics: Colorectal Neoplasms; Contrast Media; Fluorodeoxyglucose F18; Image Enhancement; Iopamidol; Liver Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Tomography, X-Ray Computed | 2008 |
Multimodality imaging can predict the metabolic response of unresectable colorectal liver metastases to radioembolization therapy with Yttrium-90 labeled resin microspheres.
Topics: Aged; Clinical Trials, Phase III as Topic; Colorectal Neoplasms; Embolization, Therapeutic; Fluorodeoxyglucose F18; Fluorouracil; Glycolysis; Humans; Liver Neoplasms; Microspheres; Middle Aged; Models, Biological; Positron-Emission Tomography; Radiation Dosage; Reproducibility of Results; Tomography, Emission-Computed, Single-Photon; Tomography, X-Ray Computed; Treatment Outcome; Yttrium Radioisotopes | 2008 |
Metastatic colorectal cancer to a primary thyroid cancer.
Topics: Colorectal Neoplasms; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Positron-Emission Tomography; Thyroid Neoplasms | 2008 |
Trends in nontherapeutic laparotomy rates in patients undergoing surgical therapy for hepatic colorectal metastases.
Topics: Adult; Aged; Aged, 80 and over; Carcinoembryonic Antigen; Catheter Ablation; Cohort Studies; Colorectal Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Laparotomy; Liver Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Invasiveness; Neoplasm Staging; Positron-Emission Tomography; Preoperative Care; Prognosis; Radiography; Radiopharmaceuticals; Survival Rate; Treatment Outcome; Young Adult | 2009 |
Increased metabolic activity of indolent liver metastases after resection of a primary colorectal tumor.
Topics: Colorectal Neoplasms; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Positron-Emission Tomography | 2009 |
Comparison of diffusion-weighted MRI and 2-[fluorine-18]-fluoro-2-deoxy-D-glucose positron emission tomography (FDG-PET) for detecting primary colorectal cancer and regional lymph node metastases.
Topics: Aged; Aged, 80 and over; Colorectal Neoplasms; Diffusion Magnetic Resonance Imaging; Female; Fluorodeoxyglucose F18; Humans; Image Interpretation, Computer-Assisted; Lymphatic Metastasis; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Tomography, X-Ray Computed; Ultrasonography | 2009 |
Whole-body MRI at 1.5 T and 3 T compared with FDG-PET-CT for the detection of tumour recurrence in patients with colorectal cancer.
Topics: Aged; Aged, 80 and over; Colorectal Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Neoplasm Recurrence, Local; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Tomography, X-Ray Computed; Whole Body Imaging | 2009 |
Performance of integrated FDG-PET/contrast-enhanced CT in the staging and restaging of colorectal cancer: comparison with PET and enhanced CT.
Topics: Aged; Aged, 80 and over; Colorectal Neoplasms; Contrast Media; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Systems Integration; Tomography, X-Ray Computed | 2010 |
Diagnostic accuracy of serial CT/magnetic resonance imaging review vs. positron emission tomography/CT in colorectal cancer patients with suspected and known recurrence.
Topics: Carcinoembryonic Antigen; Colorectal Neoplasms; False Negative Reactions; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Neoplasm Metastasis; Neoplasm Recurrence, Local; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, X-Ray Computed | 2009 |
Early effects of FOLFOX treatment of colorectal tumour in an animal model: assessment of changes in gene expression and FDG kinetics.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Cell Line, Tumor; Colorectal Neoplasms; Disease Models, Animal; Fluorodeoxyglucose F18; Fluorouracil; Gene Expression Regulation, Neoplastic; Humans; Kinetics; Leucovorin; Mice; Mice, Nude; Neoplasm Transplantation; Organoplatinum Compounds; Positron-Emission Tomography | 2009 |
[Evaluation of the primary lesion detection in colorectal carcinoma with (18)F-FDG PET-CT].
Topics: Aged; Colorectal Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Staging; Positron-Emission Tomography | 2009 |
Performance of integrated FDG PET/contrast-enhanced CT in the diagnosis of recurrent colorectal cancer: Comparison with integrated FDG PET/non-contrast-enhanced CT and enhanced CT.
Topics: Adult; Aged; Aged, 80 and over; Colorectal Neoplasms; Contrast Media; Fluorodeoxyglucose F18; Humans; Middle Aged; Neoplasm Metastasis; Neoplasm Recurrence, Local; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed | 2009 |
Role of PET/CT in the detection of liver metastases from colorectal cancer.
Topics: Aged; Carcinoma; Colorectal Neoplasms; Female; Fluorodeoxyglucose F18; Hepatectomy; Humans; Liver Neoplasms; Male; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Tomography, X-Ray Computed; Treatment Outcome | 2009 |
FDG-PET: for early prediction of response to the first-line chemotherapy in metastatic colorectal cancer?
Topics: Antineoplastic Agents; Colorectal Neoplasms; Fluorodeoxyglucose F18; Humans; Positron-Emission Tomography; Predictive Value of Tests; Prognosis; Radiopharmaceuticals | 2009 |
Detection of colo-rectal liver metastases: prospective comparison of contrast enhanced US, multidetector CT, PET/CT, and 1.5 Tesla MR with extracellular and reticulo-endothelial cell specific contrast agents.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Colorectal Neoplasms; Contrast Media; Dextrans; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Gadolinium DTPA; Humans; Iohexol; Liver Neoplasms; Magnetic Resonance Imaging; Magnetite Nanoparticles; Male; Middle Aged; Positron-Emission Tomography; Predictive Value of Tests; Prospective Studies; Radiopharmaceuticals; ROC Curve; Sensitivity and Specificity; Tomography, X-Ray Computed; Ultrasonography | 2010 |
Resection of liver metastases from colorectal cancer: does preoperative chemotherapy affect the accuracy of PET in preoperative planning?
Topics: Antineoplastic Combined Chemotherapy Protocols; Chi-Square Distribution; Colorectal Neoplasms; False Negative Reactions; False Positive Reactions; Female; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Male; Middle Aged; Patient Care Planning; Preoperative Care; Prospective Studies; Radiopharmaceuticals; Tomography, Emission-Computed; Tomography, X-Ray Computed | 2009 |
Chemotherapy response evaluation in metastatic colorectal cancer with FDG PET/CT and CT scans.
Topics: Adult; Aged; Antineoplastic Agents; Colorectal Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neoplasm Metastasis; Positron-Emission Tomography; Tomography, X-Ray Computed | 2009 |
Comparison of 18F-FDG positron emission tomography and computed tomography in patients with colorectal carcinoma and lymphoma: our initial clinical experience.
Topics: Adenocarcinoma; Adult; Aged; Colorectal Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Lymphoma; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed; Young Adult | 2009 |
Positron emission tomography for the detection of colorectal adenomas.
Topics: Adenoma; Adult; Aged; Aged, 80 and over; Colonoscopy; Colorectal Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Positron-Emission Tomography; Retrospective Studies; Sensitivity and Specificity | 2010 |
18F-FLT and 18F-FDG PET to measure response to radiotherapy combined with celecoxib in two colorectal xenograft models.
Topics: Animals; Celecoxib; Cell Line, Tumor; Colorectal Neoplasms; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Dideoxynucleosides; Female; Fluorodeoxyglucose F18; Gene Expression Regulation, Neoplastic; Humans; Mice; Positron-Emission Tomography; Pyrazoles; Sulfonamides; Treatment Outcome; Xenograft Model Antitumor Assays | 2009 |
Using dual-tracer PET to predict the biologic behavior of human colorectal cancer.
Topics: Animals; Biological Transport; Blotting, Western; Cell Line, Tumor; Colorectal Neoplasms; Dideoxynucleosides; Fluorodeoxyglucose F18; Humans; Immunohistochemistry; Linear Models; Male; Mice; Mice, Inbred BALB C; Neoplasm Metastasis; Positron-Emission Tomography; Radioactive Tracers; Tomography, X-Ray Computed | 2009 |
Computer-aided detection (CAD) and assessment of malignant lesions in the liver and lung using a novel PET/CT software tool: initial results.
Topics: Adult; Aged; Carcinoma, Non-Small-Cell Lung; Colorectal Neoplasms; Diagnosis, Computer-Assisted; Female; Fluorodeoxyglucose F18; Humans; Image Interpretation, Computer-Assisted; Imaging, Three-Dimensional; Liver; Liver Neoplasms; Lung; Lung Neoplasms; Male; Middle Aged; Molecular Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Software; Tomography, X-Ray Computed; Tumor Burden | 2010 |
Value of combined PET/CT for radiation planning in CT-guided percutaneous interstitial high-dose-rate single-fraction brachytherapy for colorectal liver metastases.
Topics: Aged; Aged, 80 and over; Brachytherapy; Colorectal Neoplasms; Disease Progression; Female; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Male; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Radiotherapy Planning, Computer-Assisted; Retrospective Studies; Tomography, X-Ray Computed; Tumor Burden | 2010 |
FDG uptake in cutaneous and subcutaneous metastases from colorectal adenocarcinoma.
Topics: Adenocarcinoma; Aged; Colorectal Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Positron-Emission Tomography; Skin Neoplasms; Subcutaneous Tissue; Tomography, X-Ray Computed | 2010 |
Resected colorectal cancer among Medicare beneficiaries:adoption of FDG PET.
Topics: Aged; Colorectal Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Male; Medicare; Positron-Emission Tomography; Radiopharmaceuticals; Regression Analysis; Retrospective Studies; SEER Program; United States | 2010 |
PET/CT pattern analysis for surgical staple line recurrence in patients with colorectal cancer.
Topics: Adult; Aged; Aged, 80 and over; Colorectal Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Sutures; Tomography, X-Ray Computed | 2010 |
The value of 18-FDG PET/CT imaging in a patient with atypical metastatic colorectal cancer--case report: 18-FDG PET/CT in colorectal cancer.
Topics: Adult; Colorectal Neoplasms; Fluorodeoxyglucose F18; Humans; Male; Muscle Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed | 2009 |
Assessment of tumor recurrence in patients with colorectal cancer and elevated carcinoembryonic antigen level: FDG PET/CT versus contrast-enhanced 64-MDCT of the chest and abdomen.
Topics: Adult; Aged; Aged, 80 and over; Carcinoembryonic Antigen; Colorectal Neoplasms; Contrast Media; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neoplasm Metastasis; Neoplasm Recurrence, Local; Radiographic Image Interpretation, Computer-Assisted; Radiography, Abdominal; Radiography, Thoracic; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, Emission-Computed; Tomography, X-Ray Computed | 2010 |
Using 18F-FDG positron emission tomography/computed tomography to judge benign or malignant colorectal hypermetabolic lesions.
Topics: Adenocarcinoma; Adenomatous Polyps; Colorectal Neoplasms; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Lymphoma, Large B-Cell, Diffuse; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Tomography, X-Ray Computed | 2010 |
PET and PET/CT in the clinical management of colorectal cancer.
Topics: Colorectal Neoplasms; Fluorodeoxyglucose F18; Humans; Incidence; Multimodal Imaging; Neoplasm Staging; Positron-Emission Tomography; Tomography, X-Ray Computed | 2009 |
Performance of FDG PET/CT in postoperative colorectal cancer patients with a suspected recurrence and a normal CEA level.
Topics: Adult; Aged; Aged, 80 and over; Carcinoembryonic Antigen; Colorectal Neoplasms; Endoscopy; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Physical Examination; Positron-Emission Tomography; Postoperative Period; Recurrence; Retrospective Studies; Tomography, X-Ray Computed | 2010 |
Role of FDG-PET/CT in detection of recurrent disease in colorectal cancer.
Topics: Adult; Aged; Aged, 80 and over; Colorectal Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Positron-Emission Tomography; Recurrence; Tomography, X-Ray Computed; Young Adult | 2010 |
Synchronous adenocarcinoma of the appendix demonstrated on F-18 FDG PET/CT.
Topics: Adenocarcinoma; Appendiceal Neoplasms; Colorectal Neoplasms; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neoplasms, Multiple Primary; Positron-Emission Tomography; Radiopharmaceuticals; Subtraction Technique; Tomography, X-Ray Computed | 2010 |
Subcutaneous metastases of colorectal cancer detected with PET/CT.
Topics: Adenocarcinoma; Colorectal Neoplasms; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Skin Neoplasms; Subtraction Technique; Tomography, X-Ray Computed | 2010 |
Ability of 18F-FDG PET/CT to diagnose recurrent colorectal cancer in patients with elevated CEA concentrations.
Topics: Adult; Aged; Aged, 80 and over; Carcinoembryonic Antigen; Colorectal Neoplasms; False Negative Reactions; False Positive Reactions; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Positron-Emission Tomography; Recurrence; Retrospective Studies; Tomography, X-Ray Computed; Tumor Burden | 2010 |
The role of 18FDG-PET in the detection of early cancers and precancerous polyps in colorectum.
Topics: Colonic Polyps; Colorectal Neoplasms; Early Detection of Cancer; Fluorodeoxyglucose F18; Neoplasm Staging; Positron-Emission Tomography | 2010 |
Fluoro-2-deoxy-D-glucose positron emission tomography/computed tomography predicts extrahepatic metastatic potential of colorectal metastasis: a practical guide for yttrium-90 microsphere liver-directed therapy.
Topics: Colorectal Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Lymphatic Metastasis; Male; Microspheres; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Tissue Distribution; Tomography, X-Ray Computed; Tumor Cells, Cultured; Yttrium Radioisotopes | 2010 |
The role of ¹⁸F-FDG-PET in the detection of early cancers and precancerous polyps in colorectum.
Topics: Colorectal Neoplasms; Early Detection of Cancer; Fluorodeoxyglucose F18; Humans; Intestinal Polyps; Positron-Emission Tomography; Precancerous Conditions | 2009 |
Assessment of liver metastases from colorectal adenocarcinoma following chemotherapy: SPIO-MRI versus FDG-PET/CT.
Topics: Adenocarcinoma; Adult; Aged; Colorectal Neoplasms; Contrast Media; Dermatitis, Contact; Female; Ferrosoferric Oxide; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Magnetic Resonance Imaging; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed | 2010 |
Differentiation between peri-anastomotic inflammatory changes and local recurrence following neoadjuvant radiochemotherapy surgery for colorectal cancer using visual and semiquantitative analysis of PET-CT data.
Topics: Aged; Colorectal Neoplasms; Diagnosis, Differential; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Inflammation; Male; Middle Aged; Neoadjuvant Therapy; Neoplasm Recurrence, Local; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Tomography, X-Ray Computed | 2010 |
Management of local recurrence of colorectal cancer: the role of PET/CT.
Topics: Adult; Aged; Colorectal Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Neoplasm Recurrence, Local; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, X-Ray Computed; Whole Body Imaging | 2011 |
Detection of hepatic metastases using dual-time-point FDG PET/CT scans in patients with colorectal cancer.
Topics: Adult; Aged; Aged, 80 and over; Colorectal Neoplasms; Contrast Media; Female; Fluorodeoxyglucose F18; Humans; Liver; Liver Neoplasms; Male; Middle Aged; Positron-Emission Tomography; ROC Curve; Time Factors; Tomography, X-Ray Computed | 2011 |
Embolization of hepatic arterial branches to simplify hepatic blood flow before yttrium 90 radioembolization: a useful technique in the presence of challenging anatomy.
Topics: Adult; Aged; Breast Neoplasms; Cholangiocarcinoma; Colorectal Neoplasms; Embolization, Therapeutic; Female; Fluorodeoxyglucose F18; Hepatic Artery; Humans; Liver Circulation; Liver Neoplasms; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Treatment Outcome; Yttrium Radioisotopes | 2011 |
Early PET/CT after radiofrequency ablation in colorectal cancer liver metastases: is it useful?
Topics: Adult; Aged; Aged, 80 and over; Catheter Ablation; Colorectal Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Male; Middle Aged; Positron-Emission Tomography; Tomography, X-Ray Computed | 2010 |
Use of molecular imaging to differentiate liver metastasis of colorectal cancer metastasis from neuroendocrine tumor origin.
Topics: Biopsy; Colorectal Neoplasms; Diagnosis, Differential; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Male; Middle Aged; Neoplasms, Multiple Primary; Neuroendocrine Tumors; Organometallic Compounds; Pancreatic Neoplasms; Positron-Emission Tomography | 2011 |
Application of (18)F-fluorodeoxyglucose positron emission tomography to detection of proximal lesions of obstructive colorectal cancer.
Topics: Aged; Aged, 80 and over; Colorectal Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Intestinal Obstruction; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Statistics, Nonparametric | 2010 |
Monitoring early responses to irradiation with dual-tracer micro-PET in dual-tumor bearing mice.
Topics: Adenocarcinoma; Animals; Cell Cycle; Cell Line, Tumor; Colorectal Neoplasms; Disease Models, Animal; Dose-Response Relationship, Radiation; Fluorodeoxyglucose F18; Male; Mice; Mice, Inbred BALB C; Mice, Nude; Monitoring, Physiologic; Positron-Emission Tomography; Radiotherapy; Transplantation, Heterologous | 2010 |
Impact of cell-proliferation-associated gene expression on 2-deoxy-2-[(18)f]fluoro-D-glucose (FDG) kinetics as measured by dynamic positron emission tomography (dPET) in colorectal tumors.
Topics: Biological Transport; Blood Volume; Cell Proliferation; Colorectal Neoplasms; Cyclin D2; Cyclin-Dependent Kinase 2; Fluorodeoxyglucose F18; Fractals; Gene Expression Regulation, Neoplastic; Genes, Neoplasm; Humans; Linear Models; Positron-Emission Tomography | 2011 |
FDG PET/CT evaluation of treatment response in patients with recurrent colorectal cancer.
Topics: Adult; Aged; Aged, 80 and over; Colorectal Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Positron-Emission Tomography; Recurrence; Tomography, X-Ray Computed; Treatment Outcome | 2011 |
[PET/CT in colorectal cancer].
Topics: Colorectal Neoplasms; Fluorodeoxyglucose F18; Humans; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed | 2010 |
Adjuvant radioimmunotherapy after radiofrequency ablation of colorectal liver metastases in an experimental model.
Topics: Analysis of Variance; Animals; Antibodies, Monoclonal; Catheter Ablation; Colorectal Neoplasms; Contrast Media; Disease Models, Animal; Fluorodeoxyglucose F18; Liver Neoplasms; Lutetium; Male; Octreotide; Positron-Emission Tomography; Radioimmunotherapy; Radioisotopes; Radiopharmaceuticals; Rats; Reproducibility of Results; Statistics, Nonparametric; Survival Rate; Tomography, X-Ray Computed; Triiodobenzoic Acids | 2011 |
Case 166: Metastatic left pulmonary artery sarcoma.
Topics: Colorectal Neoplasms; Fluorodeoxyglucose F18; Humans; Iohexol; Male; Middle Aged; Positron-Emission Tomography; Pulmonary Artery; Radiopharmaceuticals; Sarcoma; Tomography, X-Ray Computed; Vascular Neoplasms | 2011 |
Clinical value of (18)F-FDG PET/CT in postoperative monitoring for patients with colorectal carcinoma.
Topics: Adolescent; Adult; Aged; Bone Neoplasms; Colorectal Neoplasms; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Liver Neoplasms; Lung Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Monitoring, Physiologic; Neoplasm Recurrence, Local; Peritoneal Neoplasms; Positron-Emission Tomography; Postoperative Care; Prognosis; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, X-Ray Computed; Young Adult | 2011 |
Clinical impact of fluorodeoxyglucose-positron emission tomography scan/computed tomography in comparison with computed tomography on the detection of colorectal cancer recurrence.
Topics: Adult; Aged; Aged, 80 and over; Colorectal Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Recurrence, Local; Ovarian Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Tomography, X-Ray Computed | 2011 |
Total abdominal 18F-FDG uptake reflects intestinal adenoma burden in Apc mutant mice.
Topics: Abdomen; Adenoma; Animals; Colorectal Neoplasms; Fluorodeoxyglucose F18; Genes, APC; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Mice, Mutant Strains; Radionuclide Imaging; Radiopharmaceuticals; Tissue Distribution | 2011 |
FDG PET and PET/CT for colorectal cancer.
Topics: Carcinoma; Colorectal Neoplasms; Fluorodeoxyglucose F18; Humans; Neoplasm Recurrence, Local; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, Emission-Computed | 2011 |
Detection and characterization of tumor changes in 18F-FDG PET patient monitoring using parametric imaging.
Topics: Adult; Aged; Aged, 80 and over; Algorithms; Carcinoma; Colorectal Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Image Enhancement; Image Interpretation, Computer-Assisted; Male; Middle Aged; Pattern Recognition, Automated; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Young Adult | 2011 |
A role of 18F-fluorodeoxyglucose positron emission/computed tomography in a strategy for abdominal wall metastasis of colorectal mucinous adenocarcinoma developed after laparoscopic surgery.
Topics: Abdominal Wall; Adenocarcinoma, Mucinous; Cecal Neoplasms; Colorectal Neoplasms; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Tomography, Emission-Computed | 2011 |
Use of laxative-augmented contrast medium in the evaluation of colorectal foci at FDG PET.
Topics: Adult; Aged; Aged, 80 and over; Citric Acid; Colonoscopy; Colorectal Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Image Interpretation, Computer-Assisted; Iothalamate Meglumine; Laxatives; Male; Middle Aged; Neoplasm Staging; Organometallic Compounds; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Reference Standards; Tomography, X-Ray Computed | 2011 |
18F-5-fluorouracil dynamic positron emission tomography/computed tomography shows decreased tracer activity after bevacizumab in colorectal metastases.
Topics: Adult; Aged; Aged, 80 and over; Angiogenesis Inhibitors; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Area Under Curve; Bevacizumab; Colorectal Neoplasms; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Fluorouracil; Humans; Male; Middle Aged; Pilot Projects; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, Emission-Computed | 2011 |
Preoperative staging of patients with liver metastases of colorectal carcinoma. Does PET/CT really add something to multidetector CT?
Topics: Colorectal Neoplasms; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Liver Neoplasms; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Positron-Emission Tomography; Preoperative Care; Prognosis; Prospective Studies; Radiopharmaceuticals; Sensitivity and Specificity; Survival Rate; Tomography, X-Ray Computed | 2011 |
Colorectal cancer and 18FDG-PET/CT: what about adding the T to the N parameter in loco-regional staging?
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Chi-Square Distribution; Colorectal Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Logistic Models; Male; Middle Aged; Neoplasm Invasiveness; Neoplasm Staging; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Tomography, X-Ray Computed | 2011 |
Gadoxetate disodium-enhanced magnetic resonance imaging versus contrast-enhanced 18F-fluorodeoxyglucose positron emission tomography/computed tomography for the detection of colorectal liver metastases.
Topics: Adult; Aged; Aged, 80 and over; Colorectal Neoplasms; Contrast Media; Female; Fluorodeoxyglucose F18; Gadolinium DTPA; Humans; Liver Neoplasms; Magnetic Resonance Imaging; Male; Middle Aged; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Retrospective Studies; ROC Curve; Sensitivity and Specificity; Statistics as Topic; Tomography, X-Ray Computed | 2011 |
Vascular and metabolic response to bevacizumab-containing regimens in two patients with colorectal liver metastases measured by dynamic contrast-enhanced MRI and dynamic 18F-FDG-PET.
Topics: Angiogenesis Inhibitors; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Bevacizumab; Colorectal Neoplasms; Drug Monitoring; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Magnetic Resonance Imaging; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals | 2011 |
18F-FDG PET-CT in evaluation of postoperative colorectal cancer patients with rising CEA level.
Topics: Adult; Aged; Aged, 80 and over; Carcinoembryonic Antigen; Colorectal Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Positron-Emission Tomography; Postoperative Period; Retrospective Studies; Systems Integration; Tomography, X-Ray Computed | 2011 |
Clinical impact of FDG PET-CT in patients with potentially operable metastatic colorectal cancer.
Topics: Adult; Aged; Aged, 80 and over; Cohort Studies; Colorectal Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Lung Neoplasms; Male; Middle Aged; Multimodal Imaging; Neoplasm Staging; Neoplasms, Unknown Primary; Peritoneal Neoplasms; Positron-Emission Tomography; Preoperative Care; Radiopharmaceuticals; Retrospective Studies; Tomography, X-Ray Computed; Unnecessary Procedures | 2011 |
Detectability of colorectal neoplasia with fluorine-18-2-fluoro-2-deoxy-D-glucose positron emission tomography and computed tomography (FDG-PET/CT).
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Child; Colonoscopy; Colorectal Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Tomography, X-Ray Computed; Young Adult | 2012 |
Molecular mechanism underlying the detection of colorectal cancer by 18F-2-fluoro-2-deoxy-D-glucose positron emission tomography.
Topics: Aged; Aged, 80 and over; Biomarkers, Tumor; Colorectal Neoplasms; Female; Fluorodeoxyglucose F18; Glucose; Glucose Transporter Type 1; Hexokinase; Humans; Hypoxia; Hypoxia-Inducible Factor 1, alpha Subunit; Male; Positron-Emission Tomography; Proliferating Cell Nuclear Antigen; Radiopharmaceuticals; Reverse Transcriptase Polymerase Chain Reaction | 2012 |
Serial FDG-PET/CT for early outcome prediction in patients with metastatic colorectal cancer undergoing chemotherapy.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Colorectal Neoplasms; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Multimodal Imaging; Multivariate Analysis; Neoplasm Metastasis; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, X-Ray Computed; Treatment Outcome; Whole Body Imaging; Young Adult | 2012 |
The role of 18FDG PET/CT in the management of colorectal liver metastases.
Topics: Adult; Aged; Colorectal Neoplasms; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Hepatectomy; Humans; Liver Neoplasms; Male; Middle Aged; Multimodal Imaging; Neoplasm Metastasis; Neoplasm Staging; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Tomography, X-Ray Computed | 2012 |
Pharmacodynamic evaluation of irinotecan therapy by FDG and FLT PET/CT imaging in a colorectal cancer xenograft model.
Topics: Animals; Camptothecin; Cell Line, Tumor; Colorectal Neoplasms; Dideoxynucleosides; Female; Fluorodeoxyglucose F18; Humans; Immunohistochemistry; Irinotecan; Mice; Mice, SCID; Multimodal Imaging; Positron-Emission Tomography; Tomography, X-Ray Computed; Tumor Burden; Xenograft Model Antitumor Assays | 2012 |
¹⁸F-fluoro-2-deoxyglucose uptake on PET CT and glucose transporter 1 expression in colorectal adenocarcinoma.
Topics: Adenocarcinoma; Aged; Colorectal Neoplasms; Female; Fluorodeoxyglucose F18; Glucose Transporter Type 1; Humans; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed | 2012 |
The method and efficacy of 18F-fluorodeoxyglucose positron emission tomography/computed tomography for diagnosing the lymphatic metastasis of colorectal carcinoma.
Topics: Adult; Aged; Carcinoma; Colorectal Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Statistics as Topic; Subtraction Technique; Tomography, X-Ray Computed | 2012 |
Imaging features of colorectal liver metastasis in FDG PET-CT: a retrospective correlative analysis between CT attenuation and FDG uptake.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Colorectal Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Tomography, X-Ray Computed; Young Adult | 2012 |
Relationship between 18F-fluorodeoxyglucose accumulation and KRAS/BRAF mutations in colorectal cancer.
Topics: Adult; Aged; Aged, 80 and over; Colorectal Neoplasms; Female; Fluorodeoxyglucose F18; Glucose Transporter Type 1; Humans; Male; Middle Aged; Mutation; Positron-Emission Tomography; Proto-Oncogene Proteins; Proto-Oncogene Proteins B-raf; Proto-Oncogene Proteins p21(ras); Radiopharmaceuticals; ras Proteins | 2012 |
Quantitative assessment of heterogeneity in tumor metabolism using FDG-PET.
Topics: Adult; Aged; Blood Volume; Breast Neoplasms; Carcinoma, Non-Small-Cell Lung; Colorectal Neoplasms; Female; Fluorodeoxyglucose F18; Glucose; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasms; Phosphorylation; Positron-Emission Tomography; Radiopharmaceuticals | 2012 |
The role of 18F-FDG PET/CT in detecting colorectal cancer recurrence in patients with elevated CEA levels.
Topics: Aged; Carcinoembryonic Antigen; Colorectal Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Multimodal Imaging; Neoplasm Recurrence, Local; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Tomography, X-Ray Computed; Whole Body Imaging | 2012 |
In vitro 2-deoxy-2-[18F]fluoro-D-glucose uptake: practical considerations.
Topics: Brain Neoplasms; Carcinoma, Hepatocellular; Cell Count; Cell Proliferation; Colorectal Neoplasms; Culture Media; Fluorodeoxyglucose F18; Glucose Transporter Type 1; Hexokinase; Humans; Immunoenzyme Techniques; Liver Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Time Factors; Tumor Cells, Cultured | 2012 |
Improved imaging of intrahepatic colorectal metastases with 18F-fluorodeoxyglucose respiratory-gated positron emission tomography.
Topics: Adult; Aged; Aged, 80 and over; Colorectal Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Reproducibility of Results; Respiratory-Gated Imaging Techniques; Sensitivity and Specificity; Tomography, X-Ray Computed | 2012 |
Correlations between SUVmax and expression of GLUT1 and growth factors inducing lymphangiogenesis.
Topics: Aged; Carcinoma; Colorectal Neoplasms; Female; Fluorodeoxyglucose F18; Glucose Transporter Type 1; Humans; Image Enhancement; Image Interpretation, Computer-Assisted; Intercellular Signaling Peptides and Proteins; Lymphangiogenesis; Lymphatic Metastasis; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Statistics as Topic; Subtraction Technique; Tomography, X-Ray Computed | 2012 |
18F-2-deoxy-2-fluoro-D-glucose positron emission tomography, computed tomography, and magnetic resonance imaging for the detection of experimental colorectal liver metastases.
Topics: Animals; Artifacts; Colorectal Neoplasms; Fluorodeoxyglucose F18; Image Processing, Computer-Assisted; Liver Neoplasms; Magnetic Resonance Imaging; Male; Positron-Emission Tomography; Rats; Sensitivity and Specificity; Tomography, X-Ray Computed | 2012 |
Dual-time-point 18F-FDG PET/CT in patients with colorectal cancer: clinical value of early delayed scanning.
Topics: Adult; Aged; Aged, 80 and over; Biological Transport; Colorectal Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Multimodal Imaging; Neoplasm Staging; Positron-Emission Tomography; Retrospective Studies; Time Factors; Tomography, X-Ray Computed; Young Adult | 2012 |
Diagnostic value of FDG-PET/CT for lymph node metastasis of colorectal cancer.
Topics: Adult; Aged; Aged, 80 and over; Chi-Square Distribution; Colorectal Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Image Interpretation, Computer-Assisted; Lymphatic Metastasis; Male; Middle Aged; Multimodal Imaging; Neoplasm Staging; Positron-Emission Tomography; Predictive Value of Tests; Prognosis; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Tomography, X-Ray Computed | 2012 |
Assessment of the metabolic flow phenotype of primary colorectal cancer: correlations with microvessel density are influenced by the histological scoring method.
Topics: Aged; Aged, 80 and over; Algorithms; Antigens, CD; Colorectal Neoplasms; Endoglin; Female; Fluorodeoxyglucose F18; Humans; Immunohistochemistry; Male; Microcirculation; Middle Aged; Neoplasm Metastasis; Perfusion; Phenotype; Positron-Emission Tomography; Receptors, Cell Surface | 2012 |
Colorectal liver metastasis after 90Y radioembolization therapy: pilot study of change in MDCT attenuation as a surrogate marker for future FDG PET response.
Topics: Adult; Aged; Aged, 80 and over; Colorectal Neoplasms; Contrast Media; Female; Fluorodeoxyglucose F18; Humans; Iohexol; Liver Neoplasms; Male; Microspheres; Middle Aged; Pilot Projects; Positron-Emission Tomography; Radiographic Image Interpretation, Computer-Assisted; Radiopharmaceuticals; Radiotherapy Dosage; Retrospective Studies; ROC Curve; Tomography, X-Ray Computed; Treatment Outcome; Yttrium Radioisotopes | 2012 |
Predictors of initial 18F-fluorodeoxyglucose-positron emission tomography indication among patients with colorectal cancer.
Topics: Aged; Colorectal Neoplasms; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Treatment Outcome | 2012 |
Colorectal cancer: translation of biological pathways into molecular imaging.
Topics: Antineoplastic Protocols; Biomarkers; Colorectal Neoplasms; Fluorodeoxyglucose F18; Humans; Molecular Imaging; Multimodal Imaging; Mutation; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed | 2012 |
Early FDG/PET scanning as a pharmacodynamic marker of anti-EGFR antibody activity in colorectal cancer.
Topics: Adult; Antibodies, Monoclonal; Antineoplastic Agents; Colorectal Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Panitumumab; Positron-Emission Tomography; Treatment Outcome | 2012 |
[Importance of PET/CT for imaging of colorectal cancer].
Topics: Colorectal Neoplasms; Fluorodeoxyglucose F18; Humans; Multimodal Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed | 2012 |
The utility of FDG-PET/CT as an effective tool for detecting recurrent colorectal cancer regardless of serum CEA levels.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Carcinoembryonic Antigen; Colorectal Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Recurrence; Retrospective Studies; Tomography, X-Ray Computed; Young Adult | 2012 |
The role of early ¹⁸F-FDG PET/CT in prediction of progression-free survival after ⁹⁰Y radioembolization: comparison with RECIST and tumour density criteria.
Topics: Adult; Aged; Biomarkers, Tumor; Colorectal Neoplasms; Contrast Media; Disease-Free Survival; Embolization, Therapeutic; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Male; Middle Aged; Multimodal Imaging; Neoplasm Metastasis; Positron-Emission Tomography; Retrospective Studies; Time Factors; Tomography, X-Ray Computed; Treatment Outcome; Tumor Burden; Yttrium Radioisotopes | 2012 |
Lesion-based detection of early chemosensitivity using serial static FDG PET/CT in metastatic colorectal cancer.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Colorectal Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Multimodal Imaging; Neoplasm Metastasis; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed; Treatment Outcome | 2012 |
Role of the standardized uptake value of 18-fluorodeoxyglucose positron emission tomography-computed tomography in detecting the primary tumor and lymph node metastasis in colorectal cancers.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Colorectal Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Male; Middle Aged; Multidetector Computed Tomography; Multimodal Imaging; Neoplasm Grading; Neoplasm Invasiveness; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, X-Ray Computed; Tumor Burden | 2012 |
CT- versus coregistered FDG-PET/CT-based radiation therapy plans for conformal radiotherapy in colorectal liver metastases: a dosimetric comparison.
Topics: Adult; Aged; Algorithms; Colorectal Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Radiotherapy Dosage; Radiotherapy, Conformal; Tomography, X-Ray Computed; Treatment Outcome | 2012 |
Prognostic ability of 18F-FDG PET/CT in the assessment of colorectal liver metastases.
Topics: Adult; Aged; Aged, 80 and over; Biological Transport; Colorectal Neoplasms; Fluorodeoxyglucose F18; Glycolysis; Humans; Liver Neoplasms; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Prognosis; Retrospective Studies; ROC Curve; Survival Analysis; Tomography, X-Ray Computed; Tumor Burden | 2012 |
Serum carcinoembryonic antigen measurement, abdominal contrast-enhanced computed tomography, and fluorine-18 fluorodeoxyglucose positron emission tomography/computed tomography in the detection of colorectal cancer recurrence: a correlative study.
Topics: Carcinoembryonic Antigen; Colorectal Neoplasms; Contrast Media; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Radiography, Abdominal; Recurrence; Retrospective Studies; Tomography, X-Ray Computed | 2012 |
[Value of dual-time-point (18)F-fluorodeoxyglucose integrated positron emission and computed tomography in differentiation of malignant from benign gastrointestinal diseases].
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Colitis; Colorectal Neoplasms; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Gastritis; Gastrointestinal Diseases; Gastrointestinal Neoplasms; Humans; Male; Middle Aged; Positron-Emission Tomography; Predictive Value of Tests; Proctitis; Proctocolitis; Radiopharmaceuticals; ROC Curve; Sensitivity and Specificity; Stomach Neoplasms; Tomography, X-Ray Computed | 2012 |
PET-CT accurately predicts the pre-operative characteristics of colorectal hepatic metastases.
Topics: Colectomy; Colorectal Neoplasms; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Hepatectomy; Humans; Liver Neoplasms; Male; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Predictive Value of Tests; Preoperative Period; Radiopharmaceuticals; Reproducibility of Results; Retrospective Studies | 2012 |
Reproducibility of functional volume and activity concentration in 18F-FDG PET/CT of liver metastases in colorectal cancer.
Topics: Antigens, CD34; Antigens, Neoplasm; Bayes Theorem; Carbonic Anhydrase IX; Carbonic Anhydrases; Colorectal Neoplasms; Fluorodeoxyglucose F18; Gene Expression Regulation, Neoplastic; Glucose Transporter Type 1; Humans; Liver Neoplasms; Multimodal Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Tomography, X-Ray Computed | 2012 |
Utility of 18-fluorodeoxyglucose positron emission/computed tomography in the management of recurrent colorectal cancer.
Topics: Carcinoembryonic Antigen; Colorectal Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Multimodal Imaging; Neoplasm Recurrence, Local; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Tomography, X-Ray Computed | 2012 |
Prognostic value of 18-fluorodeoxyglucose positron emission tomography-computed tomography in resectable colorectal cancer.
Topics: Adult; Aged; Aged, 80 and over; Colorectal Neoplasms; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Multimodal Imaging; Neoplasm Recurrence, Local; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies; Tomography, X-Ray Computed | 2012 |
Utility of low dose (18)F-FDG PET-CT in patients with suspected colorectal carcinoma recurrence in conventional diagnostic methods.
Topics: Adenocarcinoma; Aged; Biomarkers, Tumor; Brain Neoplasms; Carcinoembryonic Antigen; Chemoradiotherapy; Colorectal Neoplasms; Combined Modality Therapy; Female; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Lung Neoplasms; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Tomography, Spiral Computed; Tomography, X-Ray Computed | 2012 |
Integrated (18)F-FDG PET/CT and perfusion CT of primary colorectal cancer: effect of inter- and intraobserver agreement on metabolic-vascular parameters.
Topics: Adenocarcinoma; Aged; Colorectal Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Multimodal Imaging; Neoplasm Staging; Observer Variation; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed | 2012 |
Added value of FDG-PET imaging in the diagnostic workup for yttrium-90 radioembolisation in patients with colorectal cancer liver metastases.
Topics: Adult; Aged; Aged, 80 and over; Colorectal Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Treatment Outcome; Yttrium Radioisotopes | 2013 |
Correlation between therapy response assessment using FDG PET/CT and histopathologic tumor regression grade in hepatic metastasis of colorectal carcinoma after neoadjuvant therapy.
Topics: Biological Transport; Colorectal Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Male; Middle Aged; Multimodal Imaging; Neoadjuvant Therapy; Neoplasm Grading; Positron-Emission Tomography; ROC Curve; Tomography, X-Ray Computed; Treatment Outcome | 2013 |
Monitoring the effects of bevacizumab beyond progression in a murine colorectal cancer model: a functional imaging approach.
Topics: Animals; Antibodies, Monoclonal, Humanized; Bevacizumab; Colorectal Neoplasms; Disease Models, Animal; Disease Progression; Female; Fluorodeoxyglucose F18; Ki-67 Antigen; Magnetic Resonance Imaging; Mice; Mice, Inbred BALB C; Positron-Emission Tomography; Tumor Burden | 2013 |
FDG-PET improves the staging and selection of patients with recurrent colorectal cancer.
Topics: Colorectal Neoplasms; Endoscopy; False Negative Reactions; False Positive Reactions; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Lung Neoplasms; Magnetic Resonance Imaging; Neoplasm Recurrence, Local; Neoplasm Staging; Patient Selection; Radionuclide Imaging; Radiopharmaceuticals; Reproducibility of Results; Retrospective Studies; Sensitivity and Specificity; Tomography, X-Ray Computed; Whole-Body Counting | 2002 |
[F-18 fluorodeoxyglucose positron emission tomography in colorectal carcinoma].
Topics: Colorectal Neoplasms; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Liver Neoplasms; Lung Neoplasms; Neoplasm Recurrence, Local; Neoplasm Staging; Sensitivity and Specificity; Tomography, Emission-Computed; Treatment Outcome | 2002 |
The role of F-18 FDG positron emission tomography in preoperative assessment of the liver in patients being considered for curative resection of hepatic metastases from colorectal cancer.
Topics: Adult; Aged; Colorectal Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Male; Middle Aged; Preoperative Care; Radiopharmaceuticals; Reference Standards; Retrospective Studies; Sensitivity and Specificity; Single-Blind Method; Tomography, Emission-Computed; Ultrasonography | 2002 |
Incidental colonic fluorodeoxyglucose uptake: correlation with colonoscopic and histopathologic findings.
Topics: Adult; Aged; Aged, 80 and over; Colitis; Colon; Colonoscopy; Colorectal Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Intestinal Absorption; Male; Middle Aged; Retrospective Studies; Tomography, Emission-Computed | 2002 |
Intraoperative sonography still the standard technique in hepatic surgery.
Topics: Colorectal Neoplasms; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Monitoring, Intraoperative; Radiopharmaceuticals; Tomography, Emission-Computed; Ultrasonography | 2002 |
Usefulness of FDG-positron emission tomography in diagnosing peritoneal recurrence of colorectal cancer.
Topics: Aged; Colorectal Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Peritoneal Neoplasms; Radiopharmaceuticals; Reproducibility of Results; Retrospective Studies; Sensitivity and Specificity; Tomography, Emission-Computed; Tomography, X-Ray Computed | 2002 |
A combined PET/CT scanner: the path to true image fusion.
Topics: Aged; Colonography, Computed Tomographic; Colorectal Neoplasms; Equipment Design; Female; Fluorodeoxyglucose F18; Forecasting; Humans; Image Processing, Computer-Assisted; Lymphatic Metastasis; Male; Middle Aged; Radiopharmaceuticals; Tomography Scanners, X-Ray Computed; Tomography, Emission-Computed; Uterine Cervical Neoplasms | 2002 |
Performance evaluation of principal component analysis in dynamic FDG-PET studies of recurrent colorectal cancer.
Topics: Colorectal Neoplasms; Data Interpretation, Statistical; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Neoplasm Recurrence, Local; Radiopharmaceuticals; Tomography, Emission-Computed | 2003 |
FGD-PET in the follow-up of recurrent colorectal cancer.
Topics: Adult; Aged; Colorectal Neoplasms; False Positive Reactions; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Predictive Value of Tests; Sensitivity and Specificity; Tomography, Emission-Computed; Treatment Outcome | 2003 |
[18F-Fluorodeoxyglucose positron emission tomography in restaging of colorectal cancer].
Topics: Colorectal Neoplasms; Cost-Benefit Analysis; Evidence-Based Medicine; Fluorodeoxyglucose F18; Germany; Humans; Neoplasm Staging; Radiopharmaceuticals; Recurrence; Reproducibility of Results; Tomography, Emission-Computed | 2003 |
Sacral fractures: a potential pitfall of FDG positron emission tomography.
Topics: Aged; Bone Neoplasms; Colorectal Neoplasms; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Fractures, Bone; Humans; Prospective Studies; Radiopharmaceuticals; Sacrum; Tomography, Emission-Computed | 2003 |
Routine (18)F-FDG PET preoperative staging of colorectal cancer: comparison with conventional staging and its impact on treatment decision making.
Topics: Adult; Aged; Colorectal Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Male; Middle Aged; Neoplasm Staging; Tomography, Emission-Computed; Tomography, X-Ray Computed | 2003 |
Direct comparison of (18)F-FDG PET and PET/CT in patients with colorectal carcinoma.
Topics: Adult; Aged; Aged, 80 and over; Colorectal Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Tomography, Emission-Computed; Tomography, X-Ray Computed | 2003 |
PET/CT in Colorectal Cancer.
Topics: Colorectal Neoplasms; Fluorodeoxyglucose F18; Humans; Tomography, Emission-Computed; Tomography, X-Ray Computed | 2003 |
High predictive value of F-18 FDG PET patterns of the spine for metastases or benign lesions with good agreement between readers.
Topics: Breast Neoplasms; Colorectal Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Observer Variation; Radiopharmaceuticals; Reproducibility of Results; Retrospective Studies; Sensitivity and Specificity; Spinal Neoplasms; Tomography, Emission-Computed | 2003 |
The clinical impact of camera-based positron emission tomography imaging in patients with recurrent colorectal cancer.
Topics: Adult; Aged; Aged, 80 and over; Colorectal Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Radiopharmaceuticals; Tomography, Emission-Computed | 2004 |
Impact of positron emission tomography on strategy in liver resection for primary and secondary liver tumors.
Topics: Adenoma, Liver Cell; Breast Neoplasms; Carcinoma, Hepatocellular; Colorectal Neoplasms; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Liver Neoplasms; Male; Neoplasm Staging; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, Emission-Computed | 2004 |
FDG-PET for the pre-operative evaluation of colorectal liver metastases.
Topics: Adult; Aged; Aged, 80 and over; Colorectal Neoplasms; Female; Fluorodeoxyglucose F18; Hepatectomy; Humans; Liver Neoplasms; Male; Middle Aged; Neoplasm Staging; Preoperative Care; Prospective Studies; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Tomography, Emission-Computed; Tomography, Spiral Computed | 2004 |
Assessment of recurrent colorectal cancer following 5-fluorouracil chemotherapy using both 18FDG and 18FLT PET.
Topics: Antineoplastic Agents; Colorectal Neoplasms; Dideoxynucleosides; Fluorodeoxyglucose F18; Fluorouracil; Humans; Neoplasm Recurrence, Local; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Treatment Outcome | 2004 |
Glucose-based total parenteral nutrition does not stimulate glucose uptake by humans tumours.
Topics: Adult; Aged; Blood Glucose; Colorectal Neoplasms; Fasting; Female; Fluorodeoxyglucose F18; Glucose; Humans; Liver Neoplasms; Male; Middle Aged; Parenteral Nutrition, Total; Radiopharmaceuticals; Tomography, Emission-Computed | 2004 |
Diffuse bone marrow uptake on whole-body F-18 fluorodeoxyglucose positron emission tomography in a patient taking recombinant erythropoietin.
Topics: Aged; Artifacts; Bone Marrow; Bone Marrow Neoplasms; Colorectal Neoplasms; Diagnosis, Differential; Erythropoietin; Fluorodeoxyglucose F18; Humans; Radiopharmaceuticals; Recombinant Proteins; Tomography, Emission-Computed; Whole-Body Counting | 2004 |
Role of FDG-PET in surgical management of patients with colorectal liver metastases.
Topics: Aged; Carcinoembryonic Antigen; Colorectal Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Treatment Outcome | 2004 |
Colorectal cancer patients before resection of hepatic metastases. Impact of (18)F-FDG PET on detecting extrahepatic disease.
Topics: Adult; Aged; Aged, 80 and over; Colorectal Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Male; Middle Aged; Neoplasm Staging; Radiopharmaceuticals; Reproducibility of Results; Tissue Distribution; Tomography, Emission-Computed | 2004 |
Five-year survival after resection of hepatic metastases from colorectal cancer in patients screened by positron emission tomography with F-18 fluorodeoxyglucose (FDG-PET).
Topics: Adult; Aged; Aged, 80 and over; Carcinoma; Colorectal Neoplasms; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Hepatectomy; Humans; Liver Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Multivariate Analysis; Prognosis; Radiopharmaceuticals; Risk Factors; Survival Rate; Tomography, Emission-Computed | 2004 |
18F-FDG PET in evaluating patients treated for metastatic colorectal cancer: can we predict prognosis?
Topics: Algorithms; Colorectal Neoplasms; Disease-Free Survival; Fluorodeoxyglucose F18; Humans; Image Interpretation, Computer-Assisted; Prognosis; Radionuclide Imaging; Radiopharmaceuticals; Risk Assessment; Risk Factors; Survival Analysis; Treatment Outcome | 2004 |
[PET/CT for colorectal and hepatic tumors].
Topics: Adult; Aged; Colon; Colorectal Neoplasms; Disease Progression; Equipment Design; Female; Fluorodeoxyglucose F18; Humans; Image Enhancement; Image Processing, Computer-Assisted; Liver; Liver Neoplasms; Male; Middle Aged; Neoplasm Invasiveness; Neoplasm Recurrence, Local; Positron-Emission Tomography; Prognosis; Rectum; Sensitivity and Specificity; Tomography, X-Ray Computed | 2004 |
Does the novel PET/CT imaging modality impact on the treatment of patients with metastatic colorectal cancer of the liver?
Topics: Colorectal Neoplasms; Contrast Media; Databases, Factual; Female; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Male; Middle Aged; Neoplasm Recurrence, Local; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, X-Ray Computed; Triiodobenzoic Acids | 2004 |
Sequential FDG PET/CT in 90Y microsphere treatment of unresectable colorectal liver metastases.
Topics: Colorectal Neoplasms; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Microspheres; Positron-Emission Tomography; Radiopharmaceuticals; Subtraction Technique; Tomography, X-Ray Computed; Treatment Outcome; Yttrium Radioisotopes | 2005 |
Cesium attenuation correction of the liver dome revealing hepatic lesion missed with computed tomography attenuation correction because of the respiratory motion artifact.
Topics: Aged; Artifacts; Cesium; Colorectal Neoplasms; False Negative Reactions; Fluorodeoxyglucose F18; Humans; Image Enhancement; Liver Neoplasms; Lung Neoplasms; Male; Movement; Positron-Emission Tomography; Radiopharmaceuticals; Respiratory Mechanics; Subtraction Technique; Tomography, X-Ray Computed | 2005 |
Detection of stomach peritoneal infiltration in colorectal cancer using PET-FDG.
Topics: Aged; Carcinoma; Colorectal Neoplasms; Fatal Outcome; Female; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Neoplasm Invasiveness; Peritoneal Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Stomach Neoplasms | 2005 |
Decrease in circulating anti-angiogenic factors (angiostatin and endostatin) after surgical removal of primary colorectal carcinoma coincides with increased metabolic activity of liver metastases.
Topics: Aged; Angiostatins; Colorectal Neoplasms; Endostatins; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals | 2005 |
Feasibility study of the use of similarity maps in the evaluation of oncological dynamic positron emission tomography images.
Topics: Colorectal Neoplasms; Feasibility Studies; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Neoplasm Recurrence, Local; Neoplasms; Phantoms, Imaging; Positron-Emission Tomography; Radiopharmaceuticals | 2005 |
Incidental ovarian 18F-FDG accumulation on PET: correlation with the menstrual cycle.
Topics: Adult; Breast Neoplasms; Colorectal Neoplasms; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Image Processing, Computer-Assisted; Magnetic Resonance Spectroscopy; Menopause; Menstrual Cycle; Middle Aged; Neoplasm Metastasis; Neoplasms; Ovarian Neoplasms; Ovary; Positron-Emission Tomography; Radiopharmaceuticals; Time Factors; Uterine Cervical Neoplasms | 2005 |
Comparison between 18F-FDG PET, in-line PET/CT, and software fusion for restaging of recurrent colorectal cancer.
Topics: Algorithms; Colorectal Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Image Interpretation, Computer-Assisted; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Retrospective Studies; Sensitivity and Specificity; Software; Subtraction Technique; Tomography, X-Ray Computed | 2005 |
Correlation between serum CEA level and metabolic volume as determined by FDG PET in postoperative patients with recurrent colorectal cancer.
Topics: Biomarkers, Tumor; Carcinoembryonic Antigen; Colorectal Neoplasms; Fluorodeoxyglucose F18; Humans; Image Interpretation, Computer-Assisted; Neoplasm Recurrence, Local; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Retrospective Studies; Sensitivity and Specificity; Severity of Illness Index; Statistics as Topic; Tissue Distribution | 2005 |
[Prognostic factors in the evaluation of colorectal liver metastases].
Topics: Colorectal Neoplasms; Fluorodeoxyglucose F18; Hepatectomy; Humans; Liver; Liver Neoplasms; Neoplasm Staging; Neoplastic Cells, Circulating; Positron-Emission Tomography; Predictive Value of Tests; Prognosis; Survival Analysis | 2005 |
Utility of 2-fluoro-2-deoxy-D-glucose positron emission tomography in managing patients of colorectal cancer with unexplained carcinoembryonic antigen elevation at different levels.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Biomarkers, Tumor; Carcinoembryonic Antigen; Colorectal Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neoplasm Metastasis; Neoplasm Recurrence, Local; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Reference Values; Retrospective Studies | 2005 |
FDG uptake in colonic villous adenomas.
Topics: Adenoma, Villous; Aged; Aged, 80 and over; Colorectal Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Retrospective Studies; Sensitivity and Specificity | 2005 |
The economic impact of 18FDG positron emission tomography in the surgical management of colorectal cancer with hepatic metastases.
Topics: Colorectal Neoplasms; Cost-Benefit Analysis; Decision Trees; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Neoplasm Metastasis; Positron-Emission Tomography; Radiopharmaceuticals; Radiotherapy; Tomography, X-Ray Computed | 2005 |
[Combined FDG PET/CT imaging for restaging of colorectal cancer patients: impact of image fusion on staging accuracy].
Topics: Aged; Colorectal Neoplasms; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Metastasis; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Tomography, X-Ray Computed | 2005 |
PET/CT F-18 FDG scan accurately identifies osteoporotic fractures in a patient with known metastatic colorectal cancer.
Topics: Bone Neoplasms; Carcinoma; Colorectal Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Incidental Findings; Lumbar Vertebrae; Middle Aged; Osteoporosis; Positron-Emission Tomography; Radiopharmaceuticals; Spinal Fractures; Subtraction Technique; Tomography, X-Ray Computed | 2005 |
Can the relation between gadopentetate dimeglumine and FDG uptake in colorectal liver metastases be used clinically?
Topics: Colorectal Neoplasms; Contrast Media; Fluorodeoxyglucose F18; Gadolinium DTPA; Humans; Liver Neoplasms; Radiography; Radiopharmaceuticals | 2005 |
Gadopentetate dimeglumine and FDG uptake in liver metastases of colorectal carcinoma as determined with MR imaging and PET.
Topics: Adult; Aged; Cell Hypoxia; Colorectal Neoplasms; Contrast Media; Female; Fluorodeoxyglucose F18; Gadolinium DTPA; Humans; Liver Neoplasms; Magnetic Resonance Imaging; Male; Middle Aged; Nitroimidazoles; Positron-Emission Tomography; Radiopharmaceuticals | 2005 |
Recent chemotherapy reduces the sensitivity of [18F]fluorodeoxyglucose positron emission tomography in the detection of colorectal metastases.
Topics: Adult; Aged; Antimetabolites, Antineoplastic; Colorectal Neoplasms; Combined Modality Therapy; Digestive System Surgical Procedures; Female; Fluorodeoxyglucose F18; Fluorouracil; Humans; Liver; Liver Neoplasms; Male; Middle Aged; Multivariate Analysis; Positron-Emission Tomography; Prospective Studies; Regression Analysis; Reproducibility of Results; Sensitivity and Specificity; Treatment Outcome | 2005 |
Use of a decision analysis model to assess the cost-effectiveness of 18F-FDG PET in the management of metachronous liver metastases of colorectal cancer.
Topics: Colorectal Neoplasms; Cost-Benefit Analysis; Decision Support Techniques; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Neoplasm Metastasis; Neoplasm Staging; Neoplasms; Positron-Emission Tomography; Sensitivity and Specificity; Time Factors; Tomography, X-Ray Computed; Treatment Outcome | 2005 |
Positron emission tomography scanning is not superior to whole body multidetector helical computed tomography in the preoperative staging of colorectal cancer.
Topics: Adult; Aged; Aged, 80 and over; Colorectal Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Male; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, Spiral Computed; Whole Body Imaging | 2006 |
Abdominal positron-emission tomography lesions with increased standardized uptake values correlate with intraoperative findings.
Topics: Abdomen; Adult; Aged; Colorectal Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Surgical Procedures, Operative | 2006 |
PET/CT in the evaluation of response to treatment of liver metastases from colorectal cancer with bevacizumab and irinotecan.
Topics: Adult; Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Bevacizumab; Camptothecin; Colorectal Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Irinotecan; Liver Neoplasms; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed; Treatment Outcome | 2006 |
PET/CT detects abdominal wall and port site metastases of colorectal carcinoma.
Topics: Abdominal Wall; Adult; Aged; Colonoscopy; Colorectal Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Muscle Neoplasms; Neoplasm Seeding; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies | 2006 |
Efficacy of PET/CT in the accurate evaluation of primary colorectal carcinoma.
Topics: Adult; Aged; Aged, 80 and over; Chi-Square Distribution; Colorectal Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neoplasm Metastasis; Prospective Studies; Radiopharmaceuticals; Tomography, Emission-Computed; Tomography, X-Ray Computed | 2006 |
FDG-PET for prediction of survival of patients with metastatic colorectal carcinoma.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma; Colorectal Neoplasms; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Neoplasm Metastasis; Positron-Emission Tomography; Proportional Hazards Models | 2006 |
Evaluation of patients with liver metastases from colorectal cancer for locally ablative treatment with laser induced thermotherapy. Impact of PET with 18F-fluorodeoxyglucose on therapeutic decisions.
Topics: Colorectal Neoplasms; Fluorodeoxyglucose F18; Humans; Hyperthermia, Induced; Lasers; Liver Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Tomography, X-Ray Computed | 2006 |
Correlation of GLUT-1 overexpression, tumor size, and depth of invasion with 18F-2-fluoro-2-deoxy-D-glucose uptake by positron emission tomography in colorectal cancer.
Topics: Adenocarcinoma; Aged; Biomarkers, Tumor; Colorectal Neoplasms; Disease Progression; Female; Fluorodeoxyglucose F18; Gene Expression Regulation, Neoplastic; Glucose Transporter Type 1; Humans; Liver Neoplasms; Male; Middle Aged; Neoplasm Invasiveness; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Sensitivity and Specificity | 2006 |
The role of FDG-PET in the selection of patients with colorectal liver metastases.
Topics: Adult; Aged; Aged, 80 and over; Colorectal Neoplasms; Female; Fluorodeoxyglucose F18; Hepatectomy; Humans; Liver Neoplasms; Male; Middle Aged; Patient Selection; Positron-Emission Tomography; Radiopharmaceuticals; Survival Analysis | 2007 |
PET/CT: will it change the way that we use CT in cancer imaging?
Topics: Adenocarcinoma; Biomarkers, Tumor; Carcinoembryonic Antigen; Case Management; Colorectal Neoplasms; Diagnostic Errors; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Liver Neoplasms; Lymphatic Metastasis; Neoplasm Metastasis; Neoplasm Staging; Neoplasms; Positron-Emission Tomography; Predictive Value of Tests; Prevalence; Probability; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, X-Ray Computed | 2006 |
FDG-PET in colorectal cancer.
Topics: Adenocarcinoma; Antimetabolites, Antineoplastic; Biomarkers, Tumor; Carcinoembryonic Antigen; Clinical Trials as Topic; Colorectal Neoplasms; Combined Modality Therapy; Cost-Benefit Analysis; Fluorodeoxyglucose F18; Fluorouracil; Humans; Liver Neoplasms; Neoadjuvant Therapy; Neoplasm Recurrence, Local; Neoplasm Staging; Positron-Emission Tomography; Preoperative Care; Prognosis; Radiopharmaceuticals; Sensitivity and Specificity; Treatment Outcome | 2006 |
Comparison of multiphase CT, FDG-PET and intra-operative ultrasound in patients with colorectal liver metastases selected for surgery.
Topics: Adult; Aged; Aged, 80 and over; Colorectal Neoplasms; Female; Fluorodeoxyglucose F18; Hepatectomy; Humans; Intraoperative Period; Liver Neoplasms; Male; Middle Aged; Positron-Emission Tomography; Preoperative Care; Radiopharmaceuticals; Tomography, X-Ray Computed; Ultrasonography | 2007 |
Assessment of response to treatment of unresectable liver tumours with 90Y microspheres: value of FDG PET versus computed tomography.
Topics: Adult; Colorectal Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Male; Microspheres; Middle Aged; Neoplasm Metastasis; Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed; Treatment Outcome; Yttrium Radioisotopes | 2007 |
Clinical value of manual fusion of PET and CT images in patients with suspected recurrent colorectal cancer.
Topics: Adult; Aged; Aged, 80 and over; Colorectal Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Image Enhancement; Image Interpretation, Computer-Assisted; Male; Middle Aged; Neoplasm Recurrence, Local; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Subtraction Technique; Tomography, X-Ray Computed | 2007 |
Fluorine-18 fluorodeoxyglucose PET in the preoperative staging of colorectal cancer.
Topics: Adult; Aged; Aged, 80 and over; Colorectal Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neoplasm Metastasis; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Tomography, X-Ray Computed | 2007 |
Assessment of quantitative FDG PET data in primary colorectal tumours: which parameters are important with respect to tumour detection?
Topics: Algorithms; Cell Differentiation; Colorectal Neoplasms; Decision Support Techniques; Fluorodeoxyglucose F18; Humans; Kinetics; Liver; Models, Statistical; Models, Theoretical; Neoplasm Metastasis; Positron-Emission Tomography; Probability; Radiopharmaceuticals; Software | 2007 |
A surgical perspective on positron emission tomography.
Topics: Breast Neoplasms; Colorectal Neoplasms; Female; Fluorodeoxyglucose F18; Glucose Transporter Type 1; Humans; Image Enhancement; Melanoma; Neoplasm Staging; Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity; Sentinel Lymph Node Biopsy; Thyroid Neoplasms; Tomography, X-Ray Computed | 2007 |
Calyceal rupture secondary to ureteric obstruction by recurrent colorectal carcinoma.
Topics: Aged; Colorectal Neoplasms; Extravasation of Diagnostic and Therapeutic Materials; Fluorodeoxyglucose F18; Humans; Kidney Diseases; Male; Neoplasm Recurrence, Local; Radionuclide Imaging; Radiopharmaceuticals; Rupture; Tomography, X-Ray Computed; Ureteral Obstruction | 2007 |
FDG PET in preoperative assessment of colorectal liver metastases combining "evidence-based practice" and "technology assessment" methods to develop departmental imaging protocols: should FDG PET be routinely used in the preoperative assessment of patient
Topics: Colorectal Neoplasms; Evidence-Based Medicine; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Neoplasm Staging; Positron-Emission Tomography; Preoperative Care; Radiopharmaceuticals; Technology Assessment, Biomedical | 2007 |
The role and limitations of 18-fluoro-2-deoxy-D-glucose positron emission tomography (FDG-PET) scan and computerized tomography (CT) in restaging patients with hepatic colorectal metastases following neoadjuvant chemotherapy: comparison with operative and
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Colorectal Neoplasms; Female; Fluorodeoxyglucose F18; Hepatectomy; Humans; Liver Neoplasms; Male; Middle Aged; Neoadjuvant Therapy; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, X-Ray Computed | 2007 |
NCCN task force report: positron emission tomography (PET)/computed tomography (CT) scanning in cancer.
Topics: Breast Neoplasms; Carcinoma, Non-Small-Cell Lung; Colorectal Neoplasms; Fluorodeoxyglucose F18; Humans; Lymphoma; Neoplasm Staging; Neoplasms; Positron-Emission Tomography; Prognosis; Tomography, X-Ray Computed | 2007 |
FDG-PET/CT in restaging of patients with recurrent breast cancer: possible impact on staging and therapy.
Topics: Adult; Aged; Aged, 80 and over; Breast Neoplasms; Colorectal Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity; Stomach Neoplasms; Tomography, X-Ray Computed | 2007 |
FDG-PET scan in patients with clinically and/or radiologically suspicious colorectal cancer recurrence but normal CEA.
Topics: Adult; Aged; Aged, 80 and over; Carcinoembryonic Antigen; Colorectal Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neoplasm Metastasis; Neoplasm Recurrence, Local; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity | 2007 |
Preoperative imaging for metastasectomy.
Topics: Adrenal Gland Neoplasms; Bone Neoplasms; Carcinoma; Colorectal Neoplasms; Contrast Media; Diagnostic Imaging; Digestive System Neoplasms; Enteroendocrine Cells; Fluorodeoxyglucose F18; Humans; Intraoperative Care; Liver Neoplasms; Lung Neoplasms; Magnetic Resonance Imaging; Neoplasm Metastasis; Peritoneal Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Sarcoma; Soft Tissue Neoplasms; Tomography, X-Ray Computed | 2007 |
Colorectal tubulovillous adenomas identified on fluoro-2-deoxy-d-glucose positron emission tomography/computed tomography scans.
Topics: Adenoma, Villous; Adenomatous Polyps; Aged; Aged, 80 and over; Colorectal Neoplasms; Female; Fluorodeoxyglucose F18; Gastrointestinal Neoplasms; Head and Neck Neoplasms; Humans; Incidental Findings; Lung Neoplasms; Male; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Retrospective Studies; Tomography, X-Ray Computed | 2008 |
Combined use of preoperative 18F FDG-PET imaging and intraoperative gamma probe detection for accurate assessment of tumor recurrence in patients with colorectal cancer.
Topics: Adult; Aged; Carcinoembryonic Antigen; Colorectal Neoplasms; Female; Fluorodeoxyglucose F18; Gamma Cameras; Humans; Intraoperative Period; Male; Middle Aged; Neoplasm Metastasis; Positron-Emission Tomography; Radiation Dosage; Radiopharmaceuticals | 2007 |
Utility of 18F-FDG PET and contrast-enhanced CT scan in the assessment of residual liver metastasis from colorectal cancer following adjuvant chemotherapy.
Topics: Adult; Aged; Antineoplastic Agents; Chemotherapy, Adjuvant; Colorectal Neoplasms; Contrast Media; Female; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Male; Middle Aged; Neoadjuvant Therapy; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Tomography, X-Ray Computed | 2007 |
Radioimmunoguided surgery (RIGS), PET/CT image-guided surgery, and fluorescence image-guided surgery: past, present, and future.
Topics: Antibodies, Monoclonal; Antibodies, Neoplasm; Antigens, Neoplasm; Colorectal Neoplasms; Fluorescence; Fluorodeoxyglucose F18; Forecasting; Gamma Cameras; Glycoproteins; Humans; Iodine Radioisotopes; Neoplasm Staging; Positron-Emission Tomography; Radioimmunodetection; Radiopharmaceuticals; Surgery, Computer-Assisted; Survival Analysis; Tomography, X-Ray Computed | 2007 |
(18)F-DG PET/CT in detection of recurrence and metastasis of colorectal cancer.
Topics: Adult; Aged; Carcinoembryonic Antigen; Colorectal Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neoplasm Metastasis; Neoplasm Recurrence, Local; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Tomography, X-Ray Computed | 2007 |
Assessment of local control after laser-induced thermotherapy of liver metastases from colorectal cancer: contribution of FDG-PET in patients with clinical suspicion of progressive disease.
Topics: Adult; Aged; Catheter Ablation; Colorectal Neoplasms; Diagnostic Errors; Disease Progression; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Hyperthermia, Induced; Laser Therapy; Liver Neoplasms; Male; Middle Aged; Neoplasm, Residual; Positron-Emission Tomography; ROC Curve; Sensitivity and Specificity | 2007 |
Intraoperative sonography in patients with colorectal cancer and resectable liver metastases on preoperative FDG-PET-CT.
Topics: Aged; Aged, 80 and over; Colorectal Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Intraoperative Care; Liver Neoplasms; Male; Middle Aged; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Retrospective Studies; Tomography, X-Ray Computed; Ultrasonography | 2008 |
Chemotherapy response evaluation with FDG-PET in patients with colorectal cancer.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Colorectal Neoplasms; Combined Modality Therapy; Disease-Free Survival; Evaluation Studies as Topic; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Neoplasm Invasiveness; Neoplasm Staging; Positron-Emission Tomography; Predictive Value of Tests; Probability; Prospective Studies; Risk Assessment; Sensitivity and Specificity; Survival Analysis; Treatment Outcome | 2008 |
F18-FDG-PET evaluation of patients for resection of colorectal liver metastases.
Topics: Adult; Aged; Aged, 80 and over; Colorectal Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Magnetic Resonance Imaging; Male; Medical Oncology; Middle Aged; Neoplasm Metastasis; Neoplasm Staging; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, X-Ray Computed; Treatment Outcome; Whole Body Imaging | 2007 |
Systemic disseminated tuberculosis mimicking malignancy on F-18 FDG PET-CT.
Topics: Colorectal Neoplasms; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed; Tuberculosis | 2008 |
Comparison of FDG-PET, PET/CT and MRI for follow-up of colorectal liver metastases treated with radiofrequency ablation: initial results.
Topics: Adult; Aged; Catheter Ablation; Colorectal Neoplasms; Contrast Media; Female; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Liver Neoplasms; Magnetic Resonance Imaging; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed; Treatment Outcome | 2008 |
Planning transarterial radioembolization of colorectal liver metastases with Yttrium 90 microspheres: evaluation of a sequential diagnostic approach using radiologic and nuclear medicine imaging techniques.
Topics: Algorithms; Colorectal Neoplasms; Contrast Media; Female; Fluorodeoxyglucose F18; Gadolinium DTPA; Humans; Liver Neoplasms; Magnetic Resonance Imaging; Male; Middle Aged; Neoplasm Staging; Radiopharmaceuticals; Radiotherapy Planning, Computer-Assisted; Technetium Tc 99m Aggregated Albumin; Tomography, Emission-Computed, Single-Photon; Tomography, X-Ray Computed; Treatment Outcome; Yttrium Radioisotopes | 2008 |
Diagnosis supporting algorithm for lymph node metastases from colorectal carcinoma on 18F-FDG PET/CT.
Topics: Algorithms; Colorectal Neoplasms; Data Interpretation, Statistical; Female; Fluorodeoxyglucose F18; Humans; Image Enhancement; Image Interpretation, Computer-Assisted; Lymph Nodes; Lymphatic Metastasis; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Subtraction Technique; Tomography, X-Ray Computed | 2008 |
Staging pathways in recurrent colorectal carcinoma: is contrast-enhanced 18F-FDG PET/CT the diagnostic tool of choice?
Topics: Colorectal Neoplasms; Contrast Media; Female; Fluorodeoxyglucose F18; Humans; Image Enhancement; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Tomography, X-Ray Computed | 2008 |
PET/CT colonography for the preoperative evaluation of the colon proximal to the obstructive colorectal cancer.
Topics: Aged; Colonography, Computed Tomographic; Colonoscopy; Colorectal Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Image Interpretation, Computer-Assisted; Intestinal Obstruction; Male; Middle Aged; Neoplasm Staging; Neoplasms, Multiple Primary; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Treatment Outcome; Whole Body Imaging | 2008 |
The use of 18F-FDG PET/CT in colorectal liver metastases--comparison with CT and liver MRI.
Topics: Aged; Colorectal Neoplasms; Contrast Media; Edetic Acid; False Positive Reactions; Female; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Magnetic Resonance Imaging; Male; Middle Aged; Positron-Emission Tomography; Predictive Value of Tests; Pyridoxal Phosphate; Radiopharmaceuticals; Retrospective Studies; Tomography, X-Ray Computed | 2008 |
Where there is no PET/CT.
Topics: Adult; Aged; Catheter Ablation; Colorectal Neoplasms; Contrast Media; Female; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Liver Neoplasms; Magnetic Resonance Imaging; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed; Treatment Outcome | 2009 |
Where there is no PET/CT.
Topics: Adult; Aged; Catheter Ablation; Colorectal Neoplasms; Contrast Media; Female; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Liver Neoplasms; Magnetic Resonance Imaging; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed; Treatment Outcome | 2008 |
Preoperative diagnosis of lymph node metastases of colorectal cancer by FDG-PET/CT.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma; Colonic Neoplasms; Colorectal Neoplasms; Contrast Media; Female; Fluorodeoxyglucose F18; Humans; Image Interpretation, Computer-Assisted; Lymph Nodes; Lymphatic Metastasis; Male; Middle Aged; Positron-Emission Tomography; Preoperative Care; Radiopharmaceuticals; Rectal Neoplasms; ROC Curve; Sensitivity and Specificity; Tomography, X-Ray Computed | 2008 |
A prognostic system applicable to patients with resectable liver metastasis from colorectal carcinoma staged by positron emission tomography with [18F]fluoro-2-deoxy-D-glucose: role of primary tumor variables.
Topics: Adult; Aged; Aged, 80 and over; Colorectal Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Male; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Viloxazine | 2008 |
Krukenberg tumor and lung metastases from colon carcinoma diagnosed with F-18 FDG PET.
Topics: Carcinoembryonic Antigen; Colorectal Neoplasms; Deoxyglucose; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Krukenberg Tumor; Liver Neoplasms; Lung Neoplasms; Middle Aged; Ovarian Neoplasms; Tomography, Emission-Computed | 1995 |
Indium-111 OncoScint CR/OV and F-18 FDG in colorectal and ovarian carcinoma recurrences. Early observations.
Topics: Aged; Antibodies, Monoclonal; Colorectal Neoplasms; Deoxyglucose; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Indium Radioisotopes; Liver Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Recurrence, Local; Oligopeptides; Ovarian Neoplasms; Pentetic Acid; Tomography, Emission-Computed | 1995 |
Clinical value of whole-body positron emission tomography with [18F]fluorodeoxyglucose in recurrent colorectal cancer.
Topics: Aged; Colorectal Neoplasms; Deoxyglucose; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Lung Neoplasms; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Prospective Studies; Sensitivity and Specificity; Tomography, Emission-Computed; Tomography, X-Ray Computed | 1994 |
Fluorodeoxyglucose PET of abdominal and pelvic neoplasms: potential role in oncologic imaging.
Topics: Abdominal Neoplasms; Carcinoma, Hepatocellular; Colorectal Neoplasms; Deoxyglucose; Fluorodeoxyglucose F18; Hemangioma, Cavernous; Humans; Liver Neoplasms; Lymphoma, Non-Hodgkin; Pelvic Neoplasms; Tomography, Emission-Computed | 1993 |
Positron emission tomography in the clinical evaluation of metastatic cancer.
Topics: Colorectal Neoplasms; Deoxyglucose; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Glucose; Humans; Liver Neoplasms; Models, Biological; Tomography, Emission-Computed | 1996 |
Noninvasive monitoring of tumor metabolism using fluorodeoxyglucose and positron emission tomography in colorectal cancer liver metastases: correlation with tumor response to fluorouracil.
Topics: Antimetabolites, Antineoplastic; Antineoplastic Agents; Body Weight; Colorectal Neoplasms; Deoxyglucose; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Fluorouracil; Humans; Interferon alpha-2; Interferon-alpha; Liver Neoplasms; Recombinant Proteins; Tomography, Emission-Computed | 1996 |
Role of positron emission tomography scanning in evaluating gastrointestinal neoplasms.
Topics: Colorectal Neoplasms; Deoxyglucose; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Gastrointestinal Neoplasms; Humans; Pancreatic Neoplasms; Sensitivity and Specificity; Tomography, Emission-Computed | 1996 |
1996 SNM annual meeting: medical problem solving.
Topics: Artifacts; ATP Binding Cassette Transporter, Subfamily B, Member 1; Breast Neoplasms; Colorectal Neoplasms; Contrast Media; Dementia; Deoxyglucose; Eye Neoplasms; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Genetic Therapy; Head and Neck Neoplasms; Humans; Lung Neoplasms; Male; Melanoma; Neoplasms; Radioisotopes; Radiotherapy; Rhenium; Societies, Medical; Technetium; Tomography, Emission-Computed; Tomography, Emission-Computed, Single-Photon | 1996 |
Positron emission tomography with F-18-fluorodeoxyglucose to evaluate the results of hepatic chemoembolization.
Topics: Adenocarcinoma; Chemoembolization, Therapeutic; Colorectal Neoplasms; Deoxyglucose; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Male; Middle Aged; Tomography, Emission-Computed | 1996 |
Staging recurrent metastatic colorectal carcinoma with PET.
Topics: Adenocarcinoma; Algorithms; Colorectal Neoplasms; Deoxyglucose; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Male; Middle Aged; Neoplasm Staging; Portography; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, Emission-Computed; Tomography, X-Ray Computed | 1997 |
Fluorodeoxyglucose whole-body positron emission tomography in colorectal cancer patients studied in routine daily practice.
Topics: Adult; Aged; Aged, 80 and over; Colorectal Neoplasms; False Positive Reactions; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neoplasm Metastasis; Neoplasm Recurrence, Local; Sensitivity and Specificity; Tomography, Emission-Computed | 1997 |
Comparison of positron emission tomography and computed tomography in detection of recurrent and metastatic colorectal cancer.
Topics: Colorectal Neoplasms; Fluorodeoxyglucose F18; Humans; Radiopharmaceuticals; Tomography, Emission-Computed; Tomography, X-Ray Computed | 1997 |
Detection of recurrent and metastatic colorectal cancer: comparison of positron emission tomography and computed tomography.
Topics: Adult; Aged; Aged, 80 and over; Colorectal Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Male; Middle Aged; Neoplasm Metastasis; Neoplasm Recurrence, Local; Prognosis; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Tomography, Emission-Computed; Tomography, X-Ray Computed | 1997 |
Staging of primary colorectal carcinomas with fluorine-18 fluorodeoxyglucose whole-body PET: correlation with histopathologic and CT findings.
Topics: Adenocarcinoma; Aged; Colorectal Neoplasms; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Lymphatic Metastasis; Male; Neoplasm Staging; Predictive Value of Tests; Sensitivity and Specificity; Tomography, Emission-Computed; Tomography, X-Ray Computed | 1998 |
Utility of FDG-PET for investigating unexplained plasma CEA elevation in patients with colorectal cancer.
Topics: Adult; Aged; Aged, 80 and over; Animals; Carcinoembryonic Antigen; Colorectal Neoplasms; False Positive Reactions; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Male; Middle Aged; Neoplasm Metastasis; Neoplasm Recurrence, Local; Predictive Value of Tests; Retrospective Studies; Tomography, Emission-Computed | 1998 |
Intravenous and intra-arterial oxygen-15-labeled water and fluorine-18-labeled fluorouracil in patients with liver metastases from colorectal carcinoma.
Topics: Antimetabolites, Antineoplastic; Colorectal Neoplasms; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Fluorouracil; Humans; Injections, Intra-Arterial; Injections, Intravenous; Liver Neoplasms; Oxygen Radioisotopes; Radiopharmaceuticals; Time Factors; Tomography, Emission-Computed; Water | 1998 |
Fluorine-18-fluorodeoxyglucose dual-head gamma camera coincidence imaging of recurrent colorectal carcinoma.
Topics: Adenocarcinoma; Aged; Colorectal Neoplasms; Fluorodeoxyglucose F18; Gamma Cameras; Humans; Lymphatic Metastasis; Male; Neoplasm Invasiveness; Neoplasm Recurrence, Local; Radionuclide Imaging; Radiopharmaceuticals; Urinary Bladder Neoplasms | 1998 |
18F-labeled fluorouracil positron emission tomography and the prognoses of colorectal carcinoma patients with metastases to the liver treated with 5-fluorouracil.
Topics: Aged; Antidotes; Antimetabolites, Antineoplastic; Carcinoma; Colorectal Neoplasms; Drug Interactions; Female; Fluorodeoxyglucose F18; Fluorouracil; Humans; Leucovorin; Liver; Liver Neoplasms; Male; Middle Aged; Prognosis; Radiopharmaceuticals; Tomography, Emission-Computed | 1998 |
Nuclear medicine: the road to smart medicine and surgery.
Topics: Brain Diseases; Colorectal Neoplasms; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Heart Diseases; Humans; Lung Neoplasms; Nuclear Medicine; Radionuclide Imaging; Radiopharmaceuticals; Stomach Neoplasms; Thyroid Diseases | 1998 |
Can dual-headed 18F-FDG SPET imaging reliably supersede PET in clinical oncology? A comparative study in lung and gastrointestinal tract cancer.
Topics: Colorectal Neoplasms; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Gamma Cameras; Gastrointestinal Neoplasms; Humans; Lung Neoplasms; Neoplasm Metastasis; Neoplasm Recurrence, Local; Neoplasm Staging; Pancreatic Neoplasms; Prospective Studies; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, Emission-Computed; Tomography, Emission-Computed, Single-Photon | 1998 |
Whole-body PET proves superior to CT for staging primary colorectal carcinoma.
Topics: Aged; Colorectal Neoplasms; Fluorodeoxyglucose F18; Humans; Male; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, Emission-Computed; Tomography, X-Ray Computed | 1999 |
Utility of 18F-FDG positron emission tomography scanning on selection of patients for resection of hepatic colorectal metastases.
Topics: Adult; Aged; Colorectal Neoplasms; Female; Fluorodeoxyglucose F18; Hepatectomy; Humans; Liver Neoplasms; Male; Middle Aged; Patient Selection; Peritoneal Neoplasms; Predictive Value of Tests; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, Emission-Computed | 1999 |
Impact of 18F-FDG-positron emission tomography for decision making in colorectal cancer recurrences.
Topics: Adult; Aged; Aged, 80 and over; Colorectal Neoplasms; Diagnosis, Differential; False Positive Reactions; Female; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Lung Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Recurrence, Local; Prospective Studies; Tomography, Emission-Computed; Tomography, X-Ray Computed | 2000 |
FDG positron emission tomography in colorectal cancer.
Topics: Blue Cross Blue Shield Insurance Plans; Cicatrix; Colorectal Neoplasms; Device Approval; Drug Approval; Evaluation Studies as Topic; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Outcome Assessment, Health Care; Radiopharmaceuticals; Technology Assessment, Biomedical; Tomography, Emission-Computed; United States; United States Food and Drug Administration | 2000 |
Image fusion using an integrated, dual-head coincidence camera with X-ray tube-based attenuation maps.
Topics: Adult; Aged; Brain Neoplasms; Colorectal Neoplasms; Female; Fluorodeoxyglucose F18; Gamma Cameras; Humans; Image Interpretation, Computer-Assisted; Liver Neoplasms; Male; Middle Aged; Neoplasms; Radiopharmaceuticals; Reproducibility of Results; Tomography, Emission-Computed | 2000 |
[Fusion of CT and PET data: methods and clinical relevance for planning laser-induced thermotherapy of liver metastases].
Topics: Algorithms; Colorectal Neoplasms; Fluorodeoxyglucose F18; Humans; Hyperthermia, Induced; Image Processing, Computer-Assisted; Laser Therapy; Liver Neoplasms; Magnetic Resonance Imaging; Neoplasm Recurrence, Local; Radiopharmaceuticals; Tomography, Emission-Computed; Tomography, X-Ray Computed | 2000 |
FDG PET and immunoscintigraphy with 99mTc-labeled antibody fragments for detection of the recurrence of colorectal carcinoma.
Topics: Antibodies, Monoclonal; Bone Neoplasms; Colorectal Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Lung Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Recurrence, Local; Organotechnetium Compounds; Predictive Value of Tests; Radioimmunodetection; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, Emission-Computed; Tomography, Emission-Computed, Single-Photon | 2000 |
The role of positron emission tomography with fluorine-18-deoxyglucose in identifying colorectal cancer metastases to liver.
Topics: Colorectal Neoplasms; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Tomography, Emission-Computed; Tomography, X-Ray Computed | 2000 |
Decision analysis for the cost-effective management of recurrent colorectal cancer.
Topics: Colorectal Neoplasms; Cost-Benefit Analysis; Decision Trees; Direct Service Costs; Fluorodeoxyglucose F18; Humans; Life Expectancy; Liver Neoplasms; Models, Theoretical; Neoplasm Staging; Radiopharmaceuticals; Sensitivity and Specificity; Survival Analysis; Tomography, Emission-Computed; Tomography, X-Ray Computed | 2001 |
Unexplained rising carcinoembryonic antigen (CEA) in the postoperative surveillance of colorectal cancer: the utility of positron emission tomography (PET).
Topics: Adult; Aged; Carcinoembryonic Antigen; Colorectal Neoplasms; False Negative Reactions; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Postoperative Care; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Tomography, Emission-Computed | 2001 |
18F-labeled fluorodeoxyglucose positron emission tomography-guided surgery for recurrent colorectal cancer: a feasibility study.
Topics: Beta Particles; Colorectal Neoplasms; Feasibility Studies; Fluorodeoxyglucose F18; Gamma Rays; Half-Life; Humans; Intraoperative Period; Neoplasm Recurrence, Local; Sensitivity and Specificity; Tomography, Emission-Computed | 2001 |
Impact of 18F-FDG PET on managing patients with colorectal cancer: the referring physician's perspective.
Topics: Adult; Aged; Aged, 80 and over; Colorectal Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Male; Medicine; Middle Aged; Neoplasm Staging; Radiopharmaceuticals; Referral and Consultation; Specialization; Surveys and Questionnaires; Tomography, Emission-Computed | 2001 |
Clinical value of whole-body emission tomography in potentially curable colorectal liver metastases.
Topics: Adult; Aged; Colorectal Neoplasms; Diagnostic Errors; Female; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Male; Middle Aged; Patient Selection; Prospective Studies; Radiopharmaceuticals; Sensitivity and Specificity; Survival Rate; Tomography, Emission-Computed; Whole-Body Irradiation | 2001 |
Fluorodeoxyglucose positron emission tomography as an adjunct to carcinoembryonic antigen in the management of patients with presumed recurrent colorectal cancer and nondiagnostic radiologic workup.
Topics: Adult; Aged; Carcinoembryonic Antigen; Colorectal Neoplasms; Fluorodeoxyglucose F18; Humans; Middle Aged; Neoplasm Recurrence, Local; Tomography, Emission-Computed | 2001 |
The impact of FDG-PET on the management algorithm for recurrent colorectal cancer.
Topics: Aged; Algorithms; Colorectal Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Male; Neoplasm Recurrence, Local; Predictive Value of Tests; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, Emission-Computed; Tomography, X-Ray Computed | 2001 |
Usefulness of intraoperative sonography for revealing hepatic metastases from colorectal cancer in patients selected for surgery after undergoing FDG PET.
Topics: Aged; Colorectal Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Male; Middle Aged; Monitoring, Intraoperative; Preoperative Care; Radiopharmaceuticals; Retrospective Studies; Tomography, Emission-Computed; Ultrasonography | 2002 |
Survival of patients staged by FDG-PET before resection of hepatic metastases from colorectal cancer.
Topics: Clinical Trials, Phase II as Topic; Colorectal Neoplasms; Fluorodeoxyglucose F18; Hepatectomy; Humans; Liver Neoplasms; Neoplasm Staging; Radiopharmaceuticals; Randomized Controlled Trials as Topic; Tomography, Emission-Computed | 2002 |
Decision analysis for the cost-effective management of recurrent colorectal cancer.
Topics: Colorectal Neoplasms; Cost-Benefit Analysis; Decision Support Techniques; Fluorodeoxyglucose F18; Humans; Neoplasm Recurrence, Local; Neoplasm Staging; Radiopharmaceuticals; Tomography, Emission-Computed | 2002 |
Glucose utilisation and cell proliferation in colorectal cancer.
Topics: Cell Division; Colorectal Neoplasms; Fluorodeoxyglucose F18; Glucose; Radionuclide Imaging; Radiopharmaceuticals; Thymidine | 2002 |
The clinical impact of (18)F-FDG PET in patients with suspected or confirmed recurrence of colorectal cancer: a prospective study.
Topics: Adult; Aged; Aged, 80 and over; Colorectal Neoplasms; Diagnostic Errors; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Prospective Studies; Radiopharmaceuticals; Tomography, Emission-Computed | 2002 |
[Impact of [18F]-FDG-PET on medical decision making in oncology: evaluation by the referring physicians during the opening year].
Topics: Colorectal Neoplasms; Decision Making; Fluorodeoxyglucose F18; France; Health Care Surveys; Lung Neoplasms; Lymphoma; Melanoma; Neoplasms; Otorhinolaryngologic Neoplasms; Radionuclide Imaging; Radiopharmaceuticals; Surveys and Questionnaires | 2002 |
Fluoro-deoxi-glucose uptake and angiogenesis are independent biological features in lung metastases.
Topics: Adult; Aged; Colorectal Neoplasms; Female; Fluorodeoxyglucose F18; Genital Neoplasms, Female; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Metastasis; Neovascularization, Pathologic; Prognosis; Radiopharmaceuticals; Retrospective Studies; Sarcoma; Tomography, Emission-Computed | 2002 |
Role of (18)F-FDG dual-head gamma-camera coincidence imaging in recurrent or metastatic colorectal carcinoma.
Topics: Adult; Aged; Aged, 80 and over; Colorectal Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neoplasm Metastasis; Neoplasm Recurrence, Local; Radionuclide Imaging; Retrospective Studies; Tomography, X-Ray Computed | 2002 |
PET studies of fluorodeoxyglucose metabolism in patients with recurrent colorectal tumors receiving radiotherapy.
Topics: Adult; Aged; Aged, 80 and over; Carcinoembryonic Antigen; Colorectal Neoplasms; Deoxyglucose; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Male; Middle Aged; Neoplasm Recurrence, Local; Palliative Care; Radiotherapy, High-Energy; Tomography, Emission-Computed | 1991 |
A comparison of 131I-labeled antibodies, 2-deoxy-2-[18F]fluoro-D-glucose and 68Ga-EDTA in the imaging of human tumor xenografts in nude mice.
Topics: Animals; Antibodies, Monoclonal; Antigens, Tumor-Associated, Carbohydrate; Colorectal Neoplasms; Deoxy Sugars; Deoxyglucose; Edetic Acid; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Gallium Radioisotopes; Humans; Iodine Radioisotopes; Melanoma; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Mice, Nude; Neoplasm Transplantation; Radionuclide Imaging; Transplantation, Heterologous | 1990 |